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Abstract
There is a substantial emerging interest for fundamental and applied research on the
reinforcement of polymeric materials using nanotechnology. In the biomedical industry,
development of novel bone cement composite materials with enhanced mechanical
properties is of tremendous potential importance. The most universally used injectable
bone cement is made of poly(methyl methacrylate) (PMMA); however, the major
disadvantage of PMMA is its non-biodegradability. Polymers such as poly(propylene
fumarate) (PPF) and polycaprolactone (PCL) are biodegradable, but suffer from a lack of
mechanical properties. The aim of this research was to test the efficacy of these
biodegradable polymers integrating nanotechnology for the development of composite
biomaterials with improved mechanical properties sufficient for bone cements.
This goal was investigated through a range of different studies. Focusing on
nanostructured titania (n-TiO2) initially, titania nanofibers (n-TiO2 fibers) and nanowires
(n-TiO2 wires) were introduced into a PPF matrix for potential use as an orthopaedic
biomaterial to treat skeletal bone defects and diseases such as osteonecrosis. PPF was
modified with maleic anhydride to provide functionality for the coordination of PPF to
the surface of TiO2 nanofibers through a ring-opening reaction. The synthesis and
modification of PPF were confirmed by NMR (1H and
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C) and XPS. The reaction

chemistry of the functionalized PPF and nano-TiO2 was also investigated by XPS and
FTIR analyses. The PPF-grafted nano-TiO2 was further employed in the development of
bone cement composites by crosslinking/polymerization in the presence of N-vinyl
pyrrolidone. Mechanical testing of the resulting bone cement composites demonstrated a
significant enhancement of the tensile and flexural properties attributed to the chemical
bonding between the PPF matrix and TiO2 nanofibers. On the basis of the determined
mechanical properties, an optimum composition was found at 5 wt% loading of n-TiO2
fiber (0.5% in the starting composition) which provided a significant increase in Young’s
modulus (153%), tensile strength (113%), flexural modulus (196%), and flexural strength
(126%) when compared with the unfilled PPF. These improvements were attributed to
the chemical linkage of the filler to the polymer matrix which enhances the transfer of a
ii

mechanical load to the n-TiO2 fiber, leading to an increase in the mechanical properties
of the bone cement composite.
Secondly, bone formation is an angiogenesis-dependent process, and the need for
treatment modalities that enhance neovascularization is especially important for bone
regeneration in necrotic bone. A bone cement system capable of delivering an angiogenic
modulator in a controlled manner may have the ability to boost the angiogenic response
when injected to an osteonecrotic lesion. Therefore, an angiogenic agent, ginsenoside
Rg1, was incorporated into an orthopedic PPF-based cement. Additionally, Sr-doped
TiO2 nanofibers synthesized in supercritical CO2 were added to the cement formulation
as an alternative radiopacifier to enable visualization of the bone cement composites and
potential monitoring of the healing and loosening processes. XPS analysis showed that
Sr2+ was doped in the crystalline matrix of anatase with the formation of SrTiO3. The
strong interfacial adhesion between PPF and nanofibers were characterized by SEM,
FTIR, XPS, and thermal analyses and mechanical testing. The Sr-doped n-TiO2 fibers
were shown to provide reasonably higher radiopacity to the PPF matrix, which is 0.32 ±
0.03 mm Al, than the unmodified fibers at the same loading level (0.20 ± 0.01 mm Al). In
addition, bone cement composites loaded with ginsenoside Rg1 were found to provide a
high drug release without sacrificing the mechanical properties of the bone cement.
Furthermore, tube formation bioassays suggested that human umbilical vein endothelial
cell lines would rearrange and align into a tubular structure in the presence of ginsenoside
Rg1. Consequently, the proposed cement combines the immediate mechanical support
given by the chemical bonding between the filler/polymer and optimum radiopacity (0.30
± 0.12 mm Al) due to the incorporation of the Sr-doped TiO2 nanofibers to PPF matrix.
Thirdly, because of the unique biological activities of ginsenoside Rg1, upregulating in
vitro proliferation, migration, chemo-invasion, and tube formation in human umbilical
vein endothelial cells (HUVECs), Rg1 can be incorporated into scaffold materials for
bone tissue engineering applications. This incorporation could be achieved by
encapsulation of ginsenoside Rg1 in biodegradable microspheres of PPF. Rg1-loaded PPF
microspheres were prepared by both a double emulsion and a microfluidic technique for
the first time in this research. The size and morphology of the Rg1-loaded PPF
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microspheres were characterized by SEM, showing unimodal 50-65 µm size diameters
using the microfluidic technique, ideal for easy flowing powders required in commercial
formulations. The PPF microspheres produced from the microfluidic technique gave high
encapsulation efficiencies of up to 95.35 ± 0.82%, while those obtained from a
conventional double emulsion method gave a much broader size distribution in the range
of 2-45 µm with lower encapsulation efficiencies of 78.48 ± 1.68%. Release profiles
were studied and quantified by UV-Vis spectrophotometry, with the results showing a
lower initial burst in the release of Rg1 from the unimodal microspheres prepared by the
microfluidic technique than from the double emulsion method. The burst effect was
followed by a slow release profile which can be used for long term drug delivery
applications to maintain the ginsenoside Rg1 concentration for an extended time period.
Moreover, the released Rg1 showed a significant stimulatory effect on angiogenesis
behavior and tube formation in human umbilical vein endothelial cells (HUVECs).
Therefore, PPF microspheres developed in this study have potential for next-generation
biomedical agents in drug-release devices for bone tissue engineering.
Finally, the use of hydroxyapatite HAp is rather limited for heavy load-bearing
applications due to low mechanical reliability and poor processability. Therefore,
immobilization of a biocompatible metal/metal oxide on the surface of HAp has been
receiving increased attention for applications involving the enhancement of mechanical
properties of biocompatible prostheses. A novel nanostructured HAp and a composite of
HAp and TiO2 with ultrafine structure and significantly improved mechanical properties
were prepared using combined co-precipitation and sol-gel method in the green solvent,
scCO2, and incorporated into poly(ε-caprolactone) (PCL) matrix to develop scaffolds
with enhanced physical and mechanical properties for bone regeneration. SEM and TEM
analyses were employed to examine the morphology of the HAp nanoplates and HApTiO2 nanocomposites. The presence of Ti, O, Ca, and P in the HAp-TiO2 nanocomposites
was detected by EDX. In addition, the effect of metal alkoxide concentration, reaction
temperature, and pressure on the morphology, crystallinity, and surface area of the
resulting nanostructured composites was examined using SEM, XRD, and the BET
method. Chemical composition of the products were characterized using FTIR, XPS, and
XANES analyses. TGA analysis was performed to investigate thermal behavior of the
iv

synthesized nanomaterials. Mechanical testing revealed a significant increase in the
Young’s modulus (88.6%), tensile strength (122%), flexural modulus (47%), and flexural
strength (59.6%) of PCL/HAp-TiO2 composites containing 20 wt % HAp-TiO2 compared
to PCL/HAp composites.

Keywords
TiO2 nanofibers, Poly(propylene fumarate), Functionalization, Maleic anhydride,
Nanocomposite, Mechanical enhancement, Bone cement, Sr-doped TiO2 nanofibers,
Radiopacity, Angiogenesis, Ginsenosied Rg1, Hydroxyapatite-Titania nanocomposite,
Morphology, Super critical carbon dioxide, Sol-gel method, Biodegradable microsphere,
Drug delivery, Microfluidics, Monodispersity.
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Chapter 1
1

General Introduction and Literature Review

1.1 Vascular necrosis of femoral head
Blood circulation is a key factor to have healthy bone tissue, since it transports oxygen,
nutrition, carbon dioxide, waste, and other materials to and from bone cells.[1] However,
there are many risk factors which can cause the temporary or permanent loss of blood
supply to bone. Reduced blood flow to bones will result in osteonecrosis, which mainly
occurs in the weight-bearing parts of the body, for example the anterosuperior aspect of
the femoral head, as shown in Figure 1.1.[2] Osteonecrosis is a disease with a wide
ranging etiology and poorly understood pathogenesis,[3] being most common in adults
between the ages of 20 and 50 years.[4] Regardless of what causes the death of the bone
cell, the cellular events and therefore the tissue responses constituting the repair are the
same whether the cells are killed by interfering with their blood supply, by freezing them,
or killing them with cytotoxic chemical agents.[5] Because of this common path for
repair and the fact that the actual cause of cell death is unknown in most cases, the term
“osteonecrosis” is used rather than “avascular necrosis”, which indicates a distinct
etiology for cell death.[5]
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Figure 1.1. The lack of normal blood supply to the femoral head causes the bone to die.
Etiology is the study of the factors that cause a disease. Trauma-induced avascular
necrosis of the femoral head represents the most common type of aseptic
osteonecrosis.[6] With the stress of weight-bearing, the necrotic segment of bone is likely
to collapse leading to painful degenerative arthritis of the hip.[7] Therefore, the term
“avascular necrosis” is exclusively used for this post-traumatic group, as they originate in
ischemia resulting from blood flow interruption.[6] When the mechanism of necrosis is
not clearly understood, the etiology is often presumed on the basis of an association with
a particular risk factor.[2] For example, obesity and gout are considered to be frequent as
noted by R. Merle d'Aubigne, but their role is uncertain.[8] Moreover, alcoholism is
implicated as a risk factor for avascular necrosis as Ono and Sugioka identified an
increased risk for avascular necrosis in people who drank as little as 400 milliliters of
alcohol per week.[9] In addition, steroid therapy in which corticosteroids were
dministered before pain appeared in the hip accounts for a rising incidence of necrosis of
the femoral head.[10, 11] Exposure to corticosteroids and alcohol consumption are
responsible for approximately 90% of all reported causes of avascular necrosis.[2] Age is
also considered to be a modulating factor having an influence on the development of
avascular necrosis, although the reported data are contradictory.[12] According to Brown
there is a strong relationship between older age and higher incidence of avascular
necrosis;[13] however, Barnes et al. reported a decrease in the avascular necrosis
incidence beyond the age of 75.[14] Furthermore, women have shown a higher tendency
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towards avascular necrosis than men.[12] Besides, there is a higher number of avascular
necrosis incidence among patients with a higher level of activity before fracture.[6]
Pathogenesis deals with the cellular events, reactions, and other pathological mechanisms
happening in the progression and development of a disease.[2] Multiple theories about
the mechanism of interruption of the blood supply to the femoral head have been
formulated.[2, 8] Some of these theories comprise thromboemboli in the blood supply to
bone resulting from circulating fat or nitrogen bubbles,[15] abnormally shaped red blood
cells causing sickle-cell anaemia,[16] infection and vasculitis leading to vessel wall
injury,[2] and radiation damage or release of vasoactive factors as in Gaucher
disease.[17]
Osteonecrosis of the femoral head leads to end-stage degenerative arthritis, which is
responsible for approximately 10% of the primary total hip arthroplasties performed in
the United States.[18] If no treatment is applied, more than 70% of osteonecrotic femoral
heads will collapse and require prosthetic replacement within three to four years of
diagnosis.[19] In early stages of osteonecrosis, the goal is to avoid collapse.[20] Present
surgical treatments such as core decompression and bone grafting have been the most
effective treatments for necrosis of the femoral head at an early stage.[4] However, these
methods consume time for biologic incorporation of bone graft, revascularization, or
replacement of dead bone by creeping substitution, and are less efficacious in Stages III
and IV.[20] When lesions are large and collapse has already occurred, the goal is to halt
additional collapse and to restore femoral head sphericity.[21] Bone grafting techniques
are less successful at joint restoration once collapse occurs (Stage III osteonecrosis), so
the open reduction and cement fixation (cementation) can be more efficacious;[4, 20]
total hip arthroplasty is the most successful treatment for Stage IV.[22]
The Association Research Circulation Osseous (ARCO) international classification
system classifies osteonecrosis into five stages (0-IV) using computer tomography (CT)
scanning, magnetic resonance imaging (MRI), and bone scanning findings summarized in
Table 1.1.[23] Stage 0 includes at-risk patients, who have shown no positive
radiographic, MRI, or scintigraphic findings. Patients with Stage I osteonecrosis have
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normal radiographs and CT scans with positive MRI or scintigraphic findings or both,
and they are treated by core decompression. In Stage II osteonecrosis, a mottled and
sclerotic rim around the area of necrosis is evident in radiographs and CT scans in
addition to the MRI changes diagnostic for osteonecrosis. These patients are treated with
vascularized free fibular grafts. Based on the location and extent of infarct size, Stages I
and II are subcategorized into three types (A, B, and C). Patients with Stage III
osteonecrosis show a crescent sign, flattening, or both in radiographs and CT scan, and
they are treated by open reduction and cementation. Stage III is also subdivided (A, B,
and C) using the quantification of collapse.[20] In Stage IV osteonecrosis, arthritic
findings become evident, and total hip arthroplasty is the most successful treatment for
Stage IV.[20]
Table 1.1. ARCO international classification of osteonecrosis.[24]
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1.2 Cementation
Cement fixation is a recently introduced method for treating stage III osteonecrosis of
femoral heads. Bone cementation involves the injection of fluid material, which instantly
hardens in the defect, and provides mechanical support to prevent collapse.[20] Bone
cement is considered to make the treatment of irregular defects easier. It is also easier to
use for clinical practice, providing immediate symptomatic relief and faster recovery of
the patient, while allowing improvement in mobility.[23, 25] Cement augmentation has
the potential to maintain reduction and restore femoral head sphericity and prevent
further collapse before progression to stage IV disease.[21, 25] However, the long term
results in regard to progression of disease and secondary arthritis is unknown. The
possible indication for this procedure is a young patient with stage III osteonecrosis who
has active, unresolved disease.[4, 20]
The procedure is performed with the patient in the lateral decubitus position. A 20-cm
incision is made centered over the greater trochanter, and a T-shaped capsulotomy is
made at the base of the femoral neck. Using a skeletal traction device, subluxation and
distraction of the femoral head and observation of the pathologic area of articular
cartilage is performed. Then, a 6-mm hole is drilled in the neck (Figure 1.2(A)), which
allows access for debridement of dead bone and insertion of cement. A joker is used to
elevate the necrotic bone and reduce the collapse. Next, the high or low viscosity cement
is pressurized by injection with a cement gun into the femoral head, and the injection is
completed when the shape of the femoral head is restored. Reduction of the collapsed
segment is performed under direct observation, and the cement is allowed to harden with
contouring and molding of the femoral head by the acetabulum. A small bone dowel graft
from the greater trochanter is used to plug the hole (Figure 1.2(B)). After the operation,
the patient is encouraged to mobilize the hip, while weight-bearing is only permitted after
3 weeks with the assistance of crutches for as many as 6 months.[4, 20]
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Figure

1.2.

The

operative

procedure

of

cementation

for

osteonecrosis

of femoral head.
A small burr hole is created at the base of the cartilage allowing for debridement of
necrotic bone and access for the cement (small arrow). Cartilage deformity is shown
(large arrow) (A). A small bone dowel taken from the greater trochanter is placed in the
entry hole (small arrow). The cartilage deformity has been reduced (large arrow)
(B).[20]

1.2.1

PMMA-based bone cements

The history of bone cements goes back more than 100 years ago. Gluck et al. reported the
use of ivory ball-and-socket joints in the treatment of hip joint diseases.[26] They used a
cement composed of colophony, pumice powder, and plaster to stabilize these joints in
the bone.[27] The most universally used injectable bone cement is made of poly(methyl
methacrylate) (PMMA).[28] Haboush presented a self-curing acrylic dental cement to
secure a total hip replacement.[26, 29] At this time, PMMA cements were mostly used in
dentistry to produce partial dentures, artificial teeth, orthodontic retainers, denture repair
resins, and so forth. However, Charnley pioneered the use of PMMA in total hip
replacement (THR) in 1964 to secure fixation of the acetabular and femoral components
and to transfer loads to bone.[30, 31] Nowadays, several million joint replacements are
performed worldwide each year with more than half of them using bone cements, with an
increasing trend.[32] In 1982 Ewald et al. performed hip arthroplasties that preserved a
normal articular surface, whereby the trabecular bone of the femoral head was replaced
with PMMA in experimental animals.[33] In addition, Wood et al. first practiced the use
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of PMMA in cement augmentation for the treatment of stage III vascular necrosis of the
femoral head in 2000, and found that the use of this procedure should be restricted to
symptomatic, young patients (less than 40 years), preferably with mild to moderate Stage
III osteonecrosis.[4]

1.2.1.1

Drawbacks associated with PMMA

PMMA is reportedly bioinert and shows good biocompatibility over long-term followup.[34] Several inherent advantages to PMMA include familiarity for operating
physicians, ease of handling, good biomechanical strength and stiffness, and costeffectiveness.[35] However, there are several disadvantages associated with PMMA bone
cements.[26] Firstly, PMMA is nonbiodegradabile; thus, it cannot be replaced with new
bone formation.[36, 37] Secondly, the high exothermic reaction during polymerization,
ranging between 67 and 124 C at the center of the cement mantle in vivo results in
impaired local blood circulation and thermal necrosis of the surrounding bone at the
cement-bone interface.[38] Thirdly, the release or leakage of unreacted monomer liquid
before polymerization of the cement in the bone bed may cause chemical necrosis of the
bone.[38] Forthly, the foreign body reaction at the cement-bone interface indicates that
PMMA cement is not bioinert and biocompatible. The cellular responses or tissue
reactions might be associated with the chemical effects from unreacted MMA monomer
produced during the setting process, and may be involved as the possible cause of
junctional tissue damage and cement loosening.[36] According to Herman et al., PMMA
cement particles evoke inflammatory periprosthetic tissue responses directly affecting the
bone resorption at the cement-bone interface.[39] Fifthly, PMMA bone cements suffer
from shrinkage during polymerization.[38] In addition, toxic substances or unreacted
monomers released during the setting process may jeopardize the repairing process such
as cell proliferation, neovascularization, and the dead bone resorption by osteoclasts or
new woven bone formation by osteoblasts.[36, 37] Therefore, it is of great necessity to
develop a bioactive bone cement which is nontoxic, isothermic curing, mechanically
capable, and has osteoconductive and osteoinductive properties.
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1.2.2

Poly(propylene fumarate)-based bone cements and properties

Recently, poly(propylene fumarate) (PPF) has attracted considerable interest as a
promising degradable material for treating skeletal defects.[40] PPF is a linear and
unsaturated polyester made of repeating units, which contain one unsaturated carboncarbon double bond allowing for cross-linking of the polymer into a covalent polymer
network and two ester linkages for hydrolysis of the polymer into biocompatible products
fumaric acid and propylene glycol, both of which can be absorbed by the body.[41, 42]
Cross-linked PPF is often incorporated with calcium phosphates found to provide
comparable mechanical properties to those of human trabecular bone.[43] Although the
double bonds of PPF can cross-link with itself to form cross-linked polymer
networks,[44] a variety of cross-linking agents such as N-vinyl pyrrolidinone (N-VP),
poly(propylene fumarate)-diacrylate (PPF-DA), poly(ethylene glycol)-dimethacrylate
(PEG-DMA), diethyl fumarate, and methylmethacrylate (MMA) have been explored in
combination with PPF.[45] When combined with an appropriate initiator system, it may
be cross-linked in situ during surgery to form a solid biodegradable bone cement via an
addition polymerization reaction between PPF and cross-linking reagents.[46] The
chemical structure of PPF and PPF-DA and cross-linking reaction of PPF and PPF-DA
are shown in Figure 1.3. As the cross-linking reaction proceeds, the viscous polymer is
transformed to a putty-like state before solidifying. During this transition, the material
may be injected or molded into a bone defect. It is particularly interesting for orthopaedic
applications in filling irregularly shaped bone defects, which are relatively inaccessible,
with minimal surgical intervention.[41] Addition polymerization reactions are generally
exothermic as in the case of PMMA bone cements, which may cause some local tissue
necrosis. In the case of PPF with N-VP used as a cross-linker, the generated heat by the
addition polymerization reaction between PPF and N-VP is milder with no local tissue
necrosis noted in vivo after implantation compared to the curing temperature measured
for PMMA bone cement.[47] For example, the maximum cross-linking temperature
reported for a range of formulations based on PPF, N-VP, benzoyl peroxide, and
tricalcium phosphate (TCP) varied from 38 to about 48 C.[48, 49] Besides, the curing
times varied between 1 and 121 min allowing the composites to be tailored to specific
applications.[49]
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The properties of cross-linked PPF networks, including mechanical strength, degradation
kinetics, and handling of the polymer are dependent on the molecular characteristics of
the constituent polymer, including the molecular weight and polydispersity of PPF.[46] It
has been reported that achieving high molecular weight PPF is difficult. Typically PPF
molecular weights vary from 500 to 4,000 Da, and polydispersities are generally below
1.4.[46] The major disadvantage of PPF is that it is a viscous liquid at room temperature,
which makes handling of the polymer somewhat cumbersome.[50] As PPF molecular
weight increases, its viscosity also increases, which often impacts the handling of the
polymer and the intended applications.[46] Furthermore, a higher molecular weight PPF
and a more viscous polymer solution may cause greater autoacceleration of the
polymerization, leading to rapid release of heat.[48] However, the total heat released
upon crosslinking decreased by an increase in PPF molecular weight.[51]

Figure 1.3. Cross-linking reaction of PPF and PPF-DA to synthesize PPF/PPF-DA
polymer networks.[45]
PPF-based materials undergo only bulk degradation by hydrolysis of the ester linkages
within its chemical structure.[52] PPF degrades to fumaric acid, a naturally occurring
substance, found in the tri-carboxylic acid cycle (Krebs cycle), and propylene glycol,
which is a commonly used diluent in drug formulations.[53, 54] Degradation time is
dependent upon polymer structure as well as other factors.[54, 55] According to Timmer
et al., PPF/PPF-DA systems represent a fairly slow in vitro degradation over 52 weeks in
buffered saline solution at 37 C.[56] They also demonstrated that low quantities of
acrylic acid and poly(acrylic acid-co-fumaric acid) along with fumaric acid and
propylene glycol were obtained upon degradation of PPF/PPF-DA via ester hydrolysis as
illustrated in Figure 1.4.[45] According to Peter et al. PPF-based materials do not exhibit
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a deleterious long-term inflammatory response when implanted subcutaneously in rats
and rabbits.[54] In addition, in vitro cytotoxicity studies by Timmer et al. demonstrated
favorable cell viability in the presence of the water-soluble extracts of PPF/PPF-DA.[45]
Consequently, PPF-based polymers have been widely explored for a number of
biomedical applications, such as the fabrication of orthopedic implants, scaffolds for
tissue engineering, controlled bioactive factor delivery systems, and cell transplantation
vehicles owing to their injectability, biocompatibility, and biodegradability.

Figure 1.4. Degradation scheme of PPF/PPF-DA networks.[57]

1.2.2.1

Mechanical properties

The mechanical properties of PPF networks differ greatly depending on the synthesis
method and the cross-linking agent.[58] Mechanical properties of PPF polymeric
networks can be tailored by varying the molecular weight of PPF, the molecular weight
of the cross-linking agent used for the formation of PPF-based network, and the ratio of
the cross-linking agent to PPF.[56] Yaszemski et al. showed that PPF-based scaffolds
have a greater degradation from the surface region compared to the interior of the
scaffold specimen. When this material was used as a temporary replacement, it was able
to provide the reconstructed skeletal region with adequate mechanical strength from the
time of surgery, through the time that the material degraded and the region reconstituted
itself with new bone, until the new bone provided the required mechanical properties.[59]
As the PPF-based scaffold degrades from its surface and has new bone continually
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advance against that surface, it may allow the remaining bulk of nondegraded material
farther from the surface to retain its mechanical properties and provide strength to the
reconstructed region.[59] He et al. prepared PPF-based polymer networks by radical
polymerization using PPF and PPF-DA macromers, and demonstrated a dramatic
increase in the compressive strength of PPF/PPF-DA polymer networks as the double
bond ratio of PPF/PPF-DA decreased.[60] Additionally, incorporation of ceramic filler
materials such as hydroxyapatite (HAp),[42] tricalcium phosphate (TCP),[51] dicalcium
phosphate dehydrate,[61] calcium carbonate,[54, 62] calcium sulfate,[54] or bioactive
glasses[63] could be used to enhance the mechanical strength. Particularly β-TCP has
been shown to be useful for reinforcement, and compositions without TCP reinforcement
disintegrated very early in the implant.[54, 64] However, the development of composite
materials combining PPF and inorganic particles has not been investigated to a large
extent, in comparison with the extensive research efforts dedicated to PMMA-based
composites.
Shi et al. investigated the effects of the dispersion of single-walled carbon nanotubes
(SWNTs) and functionalized SWNTs (F-SWNTs) in unsaturated PPF, and examined the
rheological properties of un-cross-linked nanocomposite formulations as well as the
electrical and mechanical properties of cross-linked nanocomposites.[65, 66] F-SWNTs
were produced from individual SWNTs by a diazonium-based method, and showed better
dispersion than unmodified SWNTs in both un-cross-linked and cross-linked PPF
matrixes. Mechanical testing demonstrated a 3-fold increase in both compressive
modulus and flexural modulus and a 2-fold increase in both compressive offset yield
strength and flexural strength of crosslinked nanocomposites compared to the pure PPF
networks. Low SWNT concentrations of the order of 0.05 wt% gave the best
properties.[65] In another attempt, Sitharaman et al. studied the effects of size and surface
area of the carbon nanostructures on the rheological properties of un-cross-linked PPF
nanocomposites and the mechanical properties of cross-linked nanocomposites as a
function of the nanostructure loading. It was found that the rheological properties of uncross-linked nanocomposites depend mainly on the carbon nanostructure size, while the
mechanical properties of the cross-linked nanocomposites are dependent on the carbon
nanostructure surface area.[67] However, there is a sustained debate regarding the
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biocompatibility of carbon nanotubes, and bone cement reinforced with carbon nanotubes
may have adverse effects on the surrounding living cells.[68] Horch et al. studied the
mechanical enhancement of cross-linked PPF using surface-modified carboxylate
alumoxane nanoparticles.[69] They investigated various surface-modified nanoparticles,
including a surfactant alumoxane, an activated alumoxane, a mixed alumoxane
containing both activated and surfactant groups, and a hybrid alumoxane containing both
groups within the same substituent. They found that hybrid alumoxane nanoparticles
dispersed in PPF/PPF-DA exhibited over a 3-fold increase in flexural modulus at 1 wt %
loading compared to the polymer resin alone. This dramatic improvement in flexural
properties is attributed to the fine dispersion of nanoparticles into the polymer and the
increased covalent interaction between the polymer chains and the surface-modified
nanoparticles.[69]

1.2.2.2

Radiopacity

Radiopacity refers to the relative inability of electromagnetic radiation, specifically Xrays, to pass through a particular material. Radiopaque substances do not allow X-rays or
similar radiation to pass through, and exhibit a white appearance in radiographic imaging
using X-rays.[70, 71] Radiopacity is a desirable property in bone cements allowing postoperative assessment using X-radiography.[72] It is important that the orthopaedic
surgeon can easily monitor healing and loosening processes to differentiate between
bone, bone cement, and osteolysis after a joint replacement surgery.[73]
PMMA itself is a radiolucent material, and PMMA cement did not contain any
radiopaque materials until 1972; therefore, it was impossible to directly determine the
boundaries of bone cement of pure PMMA matrix during the surgery by ordinary X-ray
imaging techniques.[73] For this reason, 8-15 wt% X-ray radiopaque media, barium
sulphate (BaSO4) or zirconium dioxide (ZrO2), have been added to all commercially
available PMMA bone cements.[74] Poor wetting and weak interfacial interactions
between the inorganic particulates and the non-polar polymer matrix often result in
detrimental effects on the mechanical properties of the cement.[72] According to Lewis
et al. incorporation of strontium oxide (SrO) particles as an alternative radiopacifier in an
acrylic cement matrix provided a radiopacity as high as that exhibited by a cement
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containing BaSO4. It also gave improved biocompatibility while inhibiting bacterial
growth. However, SrO fillers did not provide a significant increase in fracture toughness
and fatigue properties compared to a BaSO4-containing cement.[75] Hernandez et al.
used radiopaque strontium hydroxyapatite (SrHA) treated with MMA as filler particles in
a PMMA based cement to enhance the compressive properties of the composites by
improving the integration between the filler particles and the acrylic matrix.[76] Abboud
et al. incorporated alumina (Al2O3) particles treated with the coupling agent 3(trimethoxysilyl)propyl methacrylate (c-MPS) into a PMMA matrix in an attempt to
produce reinforced radiopaque cements. This coupling agent enhanced the reinforcement
effect, while the formulations required high processability because of poor wetting of the
filler surface with liquid monomer.[77] Gomoll et al. achieved a significant enhancement
in tensile strength of an acrylic bone cement by incorporating nanosized radiopaque
BaSO4 particles.[78] Ricker et al. investigated the effect of nano MgO and nano BaSO4
on the PMMA matrix in an attempt to improve the cytocompatibility and radiopacity of
the PMMA based bone cements. They found that poor osteoblast function of PMMA
could be improved by incorporation of MgO or BaSO4 nanoparticles.[79] In another
attempt, Goto et al. incorporated silanized n-TiO2 particles (60 wt%, average diameter
200 nm) into a cement matrix, but did not obtained a composite with improved flexural
modulus.[80] Khaled et al. added functionalized n-SrO-TiO2 tubes to a PMMA matrix
presenting

significantly

enhanced

mechanical

properties,

radiopacity,

and

biocompatibility.[72]
On the contrary, a very limited number of studies have been performed to improve the
radiopacity of PPF-based bone cements. Kim et al. introduced PPF biopolymer
containing 30% barium sulfate as a suitable alternative for kyphoplasty.[81] However, a
major drawback associated with the presence of barium sulphate is poor dispersion of
these radiopacifiers through the polymer resin, which can affect both crack initiation and
crack propagation in the hardened cement.[75, 82] In another study, Wu et al. attempted
to improve radiopacity and visual control of PPF cement using a newly developed bone
filler, a-TCP/HAp, and sought to quantify the radiopacity by CT scan.[83] Therefore,
there is a sustained interest and need for innovative development of PPF-based bone
cements

exhibiting

sufficient

mechanical

properties,

radiopacity,

improved
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biocompatibility, and reasonable handling properties in order to overcome the prevailing
limitations of the current commercial bone cements.

1.2.2.3

Angiogenesity

It is also believed that delivery of bioactive molecules from the PPF-based composite or
delivery of osteoblasts and osteoid cultured on the material may promote bone growth in
a surgical site where it would otherwise not occur.[84] However, without a sufficient
vascular support, these approaches are not considered to be effective in a necrotic
environment. The need for treatment modalities that enhance neovascularization in
necrotic femoral head is especially important for bone regeneration, because bone
formation is an angiogenesis-dependent process.[85, 86] Therefore, a system capable of
delivering an angiogenic growth factor in a controlled and localized manner may have the
ability to boost the angiogenic response when implanted subcutaneously.
Angiogenesis is a complex multi-step process which consists of activation, chemotactic
invasion and migration, morphological alteration, proliferation, and capillary tube
formation of endothelial cells (ECs) from preexisting vasculature (shown in Figure
1.5.);[87]. Angiogenesis is a key step in many physiological and pathological situations
including development, wound healing, and tumor growth. There is a dynamic balance
between inhibitors and stimulators of angiogenesis in the mature organism. Stimulators
include an adequate matrix such as fibrin or collagen, and angiogenic growth factors.[86]
A variety of growth factors that direct angiogenesis have been identified. The most
important angiogenesis inducer is vascular endothelial growth factor (VEGF) owing to its
potency, selectivity for endothelial cells, and ability to regulate key steps in angiogenesis,
including proliferation and migration of endothelial cells.[88] Nitric oxide (NO) is also
considered to be a critical angiogenesis stimulator. Kaigler et al. showed that by
delivering VEGF from a biodegradable polymeric scaffold made of PLGA, blood vessel
formation and vascular perfusion could be sufficiently enhanced in osseous defects where
the blood supply had been compromised by radiation therapy.[89] It is believed that
localized VEGF delivery may be acting not only on the vasculature, but also directly on
osteoprogenitor cells, osteoblasts, osteoclasts, and conjunctively with osteoinductive
factors resident in the osseous defects. Other studies have investigated the use of large
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quantities of osteoinductive protein, BMPs, in the repair of irradiated osseous defects.
Leach et al. hypothesized that the addition of an osteoconductive surface to VEGFreleasing scaffolds would enhance bone regeneration through improved vascularization
and integration with native tissues. They incorporated VEGF into three-dimensional,
porous scaffolds made from PLGA for localized protein delivery, then coated the surface
with bioactive glass to enhance the osteoconductivity and potentially the osteoinductivity
of the construct.[90] Similarly, Murphy et al. synthesized a biomineral coating on the
surface of three-dimensional, porous PLGA scaffold via a biomimetic approach to serve
as an osteogenic substrate, and VEGF was incorporated into the scaffolds for localized
delivery to direct simultaneous regeneration of bone and vascular tissue.[91]
It is important to note that promoting bone regeneration via induced angiogenesis could
be particularly important in larger-sized defects, in which the presence of a vascular
supply is perhaps more vital.[91] In addition, it is noteworthy that the clinical delivery of
VEGF in patients undergoing reconstruction can potentially be harmful, particularly if the
defect area was originally created by resection of a malignancy as it is well documented
that VEGF contributes to the growth of tumors.[89]

Figure 1.5. Multi-step process of blood vessels formation.
(i) reception of angiogenic signals (yellow spot) from the surrounding by endothelial
cells (EC); (ii) retraction of pericytes from the abluminal surface of capillary and
secretion of protease from activated endothelial cells (aEC) and proteolytic degradation
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of extracellular membrane (green dash-line); (iii) chemotactic migration of EC under the
induction of angiogenic stimulators; (iv) proliferation of EC and formation of
lumen/canalisation by fusion of formed vessels with formation of tight junctions; (v)
recruitment of pericytes and deposition of new basement membrane and initiation of
blood flow.[87]

1.3 Angiostimulating activity of ginsenoside Rg1
Ginsenoside Rg1, the most prevalent active constituent of ginseng, has been demonstrated
to be a highly stable proangiogenic compound by upregulating in vitro proliferation,
migration, chemo-invasion, and tube formation in human umbilical vein endothelial cells
(HUVECs) as well as ex vivo aortic sprouting and in vivo neovascularization.[92] Rg1 is
a functional ligand of the glucocorticoid receptor. Leung et al. suggested that Rg1 can
activate the glucocorticoid receptor triggering non-transcriptional pathways to produce
NO production.[92] Basically, Rg1 increases the phosphorylation of GR and endothelial
nitric oxide synthase (eNOS) leading to an increase in NO production in human umbilical
vein endothelial cell.[92] NO is an important transcellular signaling molecule
contributing to anti-tumor, anti-microbial, anti-inflammatory, anti-oxidative, and
immunosuppressive activity of macrophages. Thus, NO-related endothelial proliferation
and angiogenesis has been shown to be part of the activities of Rg1.[92] In addition,
Cheung reported that Rg1 increases interaction between the glucocorticoid receptor and
the fibroblast growth factor receptor-1 (FGFR-1) and mediates its ligand-independent
transactivation,

resulting

in

eNOS

phosphorylation,

ultimately

enhancing

angiogenesis.[93] Leung et al. showed for the first time that Rg1 is a potent stimulator of
vascular endothelial growth factor (VEGF) expression in human umbilical vein
endothelial cells.[94] VEGF can upregulate the expression of endothelial NO synthase
(eNOS), thereby inducing the release of NO and subsequent activation of endothelial
cells and smooth muscle cells in vessels, keratinocytes and macrophages in wounds, and
tumor cells.[87] Furthermore, NO can increase VEGF synthesis in a positive feedback
manner. In other words, VEGF and nitric oxide (NO) are critical angiogenic stimulators,
closely related to ginsenoside-mediated angiomodulation.[87] VEGF and NO work
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closely with one another in the modulation of angiogenesis. The schematic overview of
ginsenoside Rg1-mediated angiogenic action in HUVEC is shown in Figure 1.6.

Figure

1.6.

The

schematic

overview

of

ginsenoside

Rg1-mediated

angiogenic action in HUVEC.
Ginsenoside Rg1 acts as a functional ligand of glucocorticoid receptor (GR). It increases
nitric oxide (NO) production via the PI3K-Akt pathway: GR → phosphatidylinositol-3
kinase (PI3K)/Akt pathway → endothelial nitric oxide synthase (eNOS) pathway. Rg1
also increases vascular endothelial growth factor (VEGF) production through the GR →
PI3K/Akt → GSK3β → β-catenin/TCF pathway. Gene expression profiling data
indicated that Rg1 could increase the expression of a group of genes, which are related to
cell-cell adhesion, migration and cytoskeletal remodeling.[87]
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1.4 Inorganic reinforcing agents
1.4.1

Hydroxyapatite

Calcium phosphates [95], in particular hydroxyapatite (HAp), has attracted a great deal of
attention for dental and orthopedic applications owing to its excellent biocompatibility,
remarkable ability to bond directly to bone (bioactivity), high osteoconductivity, and
close chemical and crystallographic structure with the mineral phase of human hard
tissues, bone and teeth.[96, 97] Stoichiometric HAp, with the chemical formula
Ca10(PO4)6(OH)2, has a hexagonal crystal structure (Figure 1.7).[98] The mineral
constituent of bone, enamel, and dentin consists of one phase known as B-type HAp
having phosphate groups in the HAp crystal lattice substituted with a carbonate ion. HAp
crystals grow along the c-axis when nucleated on collagen fibers in mineralized tissue
(Figure 1.7).[99, 100]
HAp can be synthesized by many chemical processing routes such as solid state
reaction,[101] co-precipitation,[102] sol-gel method,[103] pyrolysis of aerosols,[104]
microemulsion,[105] hydrothermal, sol-gel hydrothermal,[106] and surfactant-assisted
hydrothermal techniques.[107, 108] Solid state reactions usually give stoichiometric and
well-crystallized products but they require relatively high temperatures and long heattreatment times.[107] Wet precipitation represents a common commercial route for the
preparation of nanometer size HAp. Here, the drop-wise addition of phosphoric acid to a
suspension of calcium hydroxide, or reactions between calcium nitrate and ammonium
phosphate results in a calcium-deficient apatite precipitate.[102] Sol-gel chemistry
involves the hydrolysis of phosphorous containing alkoxides and calcium salt and
subsequent polycondensation providing molecular level mixing leading to excellent
control over the composition and chemical homogeneity of the product. However, to
produce crystalline HAp powders using this method, calcination at elevated temperature
is required, which may cause the formation of secondary phases such as β-TCP and
granular particle shapes.[109] Hydrolysis methods are also used to prepare HAp using
acid calcium phosphates such as dicalcium phosphate dihydrate (DCPD), octacalcium
phosphate (OCP), or anhydrous dicalcium phosphate.[110] The hydrothermal technique
usually results in HAp powders with a high degree of crystallinity and the Ca/P ratio
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close to the stoichiometric value, 1.67. However, the obtained powders have typical
agglomeration with very poor control on morphology, and their size distribution is
relatively wide.[111] Surfactant-assisted hydrothermal method has been used to
synthesize HAp nanopowders, nanorods, and nanoneedles.[112] This method inhibits the
excess agglomeration of the particles, since the surfactants can adsorb onto the surface of
the particles. In addition, the surfactants can serve as a versatile “soft” template for the
synthesis of 1 D nanostructured materials.[107, 113] Furthermore, the hydrothermal
treatment can effectively improve the crystallinity of the HAp product.[113]
The principal limitation of HAp in its clinical use as load bearing implants, such as
artificial bones or teeth, is its poor mechanical properties, especially in a wet
environment. Therefore, regardless of its favorable biological properties, the poor
mechanical properties of HAp can lead to instability and unsatisfactory performance of
the implant or scaffold in the presence of body fluids and under local loading.[114, 115]
The diameter and aspect ratio of the HAp powders are important characteristics for
biomedical applications. Studies have shown that diameters in the nano-scale are
desirable for optimal biological and mechanical performances. Mechanical properties,
such as fracture strength and fracture toughness, of the ceramic materials could be
improved remarkably by making one dimensional (1-D) nanoscale building blocks such
as nanorods, nanofibers, nanowires, and nanotubes.[113, 116] Nanomaterials have also
shown superior osteoconductive and bioactive properties as compared to their micronsized counterparts.[117, 118] In addition, according to Chung et al. the nano-sized HAp
provided nanocomposites with superior stiffness and strength, and induced greater
trabecular bone formation at the tissue-implant interface.[119]
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Figure 1.7. Crystal structure of stoichiometric hydroxyapatite.
In mineralized tissues, apatite develops primarily along the c-axis of the hexagonal
structure, and is oriented along the extended collagen microfibril (A).[99] Hexagonal
crystal structure of hydroxyapatite projected onto the 001 plane (as visualized down the
c-axis) (B).[100]

1.4.2

Hydroxyapatite/titania nanocomposites

The artificial HAp suffers from its intrinsic low mechanical reliability; thus, the use of
HAp is still rather limited for heavy load-bearing applications.[114] Immobilization of a
biocompatible metal/metal oxide on the surface of HAp will enhance the mechanical
properties of HAp along with improved cellular responses and biocompatibility.[120] Li
et al. studied the reinforcement effect of alumina in Al2O3-HAp composites showing that
the mechanical strength of HAp ceramics increased with increasing the alumina content,
with 30 wt% alumina (70Al2O3-HAp) exhibiting a 2-fold increase in strength compared
with pure HAp.[121] In another attempt, Sung et al. successfully synthesized
homogeneous mixtures of hydroxyapatite (HAp) and yttria-stabilized zirconia (YSZ)
nanoparticles using chemical co-precipitation and subsequent calcination. The prepared
nanocomposites showed improved mechanical properties, such as flexural strength of
∼155 MPa and fracture toughness of ∼2.1 MPa m1/2 owing to the YSZ contribution to
the HAp matrix.[122] Furthermore, Santos et al. reported the preparation of bioglasshydroxyapatite composite samples by a liquid phase sintering process, using a 2.5 wt %
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addition of Bioglass to HAp. The addition of Bioglass to hydroxyapatite helped the rapid
formation of the Ca, P-layer, as the time required for nucleation to start was much shorter
for the composite than for HAp alone. This behavior is attributed to the presence of a
highly soluble tricalcium phosphate phase formed from the reaction between Bioglass
and the HAp matrix during the liquid phase sintering process.[123]
Among the different HAp-based composites, HAp-TiO2 composites have attracted
considerable attention, due to the combined advantages of both materials, namely HAp
providing bioactivity and TiO2 overcoming the poor adhesion to the implant.[124] Such
composites are expected to have improved mechanical properties, better structural
integrity, and flexibility than pure HAp ceramics.[125, 126] In addition, HAp-TiO2
composites have the ability to adsorb and decompose bacteria and organic materials, and
it is beneficial in antibacterial applications, environmental purifications, and also for
photocatalytic decomposition of biomaterials, such as proteins and lipids.[127]
Various processing techniques such as sol-gel,[128] hydrolysis of Ti-bearing dicalcium
phosphate powders,[129] hydrothermal method,[130] combined high gravity and
hydrothermal process,[115] electropinning method,[126] and microwave-assisted coprecipitation process[131] have been utilized to synthesize HAp-TiO2 nanocomposites.
Even though all the aforementioned techniques involve simplified preparation
procedures, obtaining a crystalline powder in most of these cases requires costly heat
treatments at a high temperature or for a long reaction period. Besides, they are not
environmentally friendly, and suffer scale-up problems.[125] Therefore, it is necessary to
develop more efficient methodology of synthesis to prepare HAp-TiO2 composites.

1.4.3

Titania

Titanium is a common clinically used biomaterial exhibiting corrosion resistance,
biocompatibility, and excellent mechanical performance.[132] A TiO2 coating on the
surface of titanium provides a passive surface layer to the implant increasing its corrosion
resistance and impeding the passage of metal ions (Ti4+) into the body.[133] Furthermore,
the TiO2 coating displays high external hardness. Therefore, titanium alloy implants
coated with TiO2 exhibit excellent biocompatibility as well as high mechanical
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strength.[132] The high biocompatibility of titanium is beneficial in load-bearing
implants, implants intended to stimulate metabolic responses, and also cell-culture
substrate for in vitro culture and tissue engineering.[134]
TiO2 particles (>100 nm) have been shown to be biologically inert in both humans and
animals.[135] With the development of nanotechnology, it has been considered that
nanoparticles might be more toxic than larger particles of the same substance because of
their larger surface area, enhanced chemical reactivity, and easier penetration into
cells.[136] However, several studies have shown that the cytotoxicity of nano-sized
titania was negligible as compared to other nanoparticles.[74] Besides, without UV
irradiation, titania nanoparticles have shown no inflammatory effect or genotoxicity in
rats, and induced no DNA damage in human cells. Moreover, high photocatalytic
efficiency of nanophase titania results in potential phototoxic effects on bacteria, cancer
cells, and tumors. This is because of the reactions between the oxidizing agents produced
from the redox reaction of the photogenerated holes and electrons and the biomolecules
leading to the damage of the biomolecular structure. Therefore, due to the low
cytotoxicity and fair biocompatibility, this material is overwhelmingly used as a
replacement for teeth and bones. Moreover, titania nanotubes/fibers have high aspect
ratios and high surface area to volume ratios, which may lead to significantly enhanced
physical and mechanical properties. In addition, biocompatible and radiopaque SrO or
ZrO2 components can be incorporated into the titania nanotube/fibers to provide higher
radiopacity compared to the nonmodified nanoparticles.

1.4.4

Synthesis of nanostructured materials in supercritical CO2

Supercritical fluids exhibit a range of unusual properties that can be exploited for new
reactions and new routes to process materials beneficial for the fine chemical and
pharmaceutical industries.[137, 138]
In the past decade, it has been shown that a sol-gel process in scCO2 is a promising
technique for synthesizing metal oxide nanomaterials. However, due to the low solubility
of precursors in CO2, various surfactants have been examined in the sol-gel process in
CO2 affecting the morphology of the nanomaterials. For example, Tadros et al. studied
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the synthesis if TiO2 nanoparticles in scCO2 by hydrolysis and condensation of titanium
alkoxides using the anionic fluorinated surfactant, [F(CF2CF2)zCH2CH2O]xP(O)(ONH4)y
(where x=1 or 2, y=2 or 1, z=1–7).[139] In another attempt, Tatsuda et al. prepared TiO2coated activated carbon by the penetration of titanium (IV) isopropoxide (TIP) dissolved
in supercritical CO2 into the nano-spaces of activated carbon.[140] In the past decade, it
has been shown that sol-gel processes using a green solvent such as supercritical carbon
dioxide (scCO2) are attractive to synthesize metal oxide nanomaterials. Reverchon et al.
synthesized amorphous TiO2 nanoparticles on the pilot scale in scCO2 without the
assistance of surfactant.[95] Also, Sun et al. prepared titania-silica binary oxides using
the inorganic precursors, tetraethyl orthosilicate (TEOS) and TIP, simultaneously or
sequentially impregnated into a polypropylene (PP) matrix using scCO2 as a swelling
agent and carrier.[141] Recently, Sui et al. synthesized TiO2 nanofibers with a typical
diameter ranged from 9 to 100 nm by esterification and condensation of titanium
alkoxides using acetic acid as the polymerization agent in scCO2.[142] The Charpentier
lab also synthesized porous ZrO2 aerogels,[143] ZrO2-modified TiO2 nanotubes,[144]
and N-doped ZrO2/TiO2 bimetallic materials,[145] nano TiO2/graphene composites,[146]
and Fe-doped TiO2 nanowires grown on the surface of graphene sheets[147] using a
similar approach in supercritical CO2.

1.5 Microencapsulation of bioactive molecules into a polymer
matrix
Controlled-release drug-delivery systems are becoming increasingly important in
biomedicine, showing several advantages compared to the conventional approaches. One
of the most important limitations of conventional dosage forms is that partial degradation
of the drug happens before it reaches the intended target in the body. However, controlled
drug delivery systems preserve the active agent from spoilage caused by enzyme attack.
A drug delivery system increases the penetration of the drug into the diseased tissue, so
bioavailability of the drug is enhanced along with an increase in the efficacy and toxicity
reduction.[148] The delivery system acts as a reservoir of the drug, with specific timerelease profiles of the drug, and it leads to a partial control of the pharmacokinetics.[149]
Also, a better compliance and convenience for the patient is provided.[149]
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Microencapsulation of bioactive molecules into a polymer matrix has been developed as
a method for local delivery of the active pharmaceutical ingredient (API) in a controlled
manner, over a prolonged period of time.[149] The polymer protects the API, thus
reducing the need for multiple doses during a prolonged therapy.[150] A variety of
systems based on natural or synthetic polymers have been examined to deliver API's in a
sustained manner.[151] Haesslein et al. designed an intraocular drug delivery systems
based on biodegradable polymer, PPF, which could be effectively utilized for the
treatment of chronic diseases of the posterior segment of the eye. Based on the hypothesis
that crosslinked PPF matrices are suitable long-term delivery devices for the sustained
release of the anti-inflammatory drug fluocinolone acetonide (FA), they fabricated FAloaded rods of 10 mm length and 0.6 mm diameter by photocrosslinking PPF with Nvinyl pyrrolidone (NVP), and studied the release behavior of FA over a period of almost
400 days.[152] Hacker et al., also designed a preliminary rabbit implantation study to
investigate the function of a photocrosslinked PPF/poly(N-vinyl pyrrolidone) (PVP)
matrix for the sustained release of three ophthalmic model drugs, acetazolamide (AZ),
dichlorphenamide [7], and timolol maleate (TM). They suggested that monolithic
implants (i.e. discs, rods, plugs, pellets or sheets) are relatively easy to fabricate, sterilize,
and provide very good control of drug release rate indicating the potential of
photocrosslinked PPF-based matrices as polymeric carriers for long-term ophthalmic
drug delivery.[153] In another attempt, Ueda et al. developed an injectable formulation
for long-term ocular delivery of the FA by dissolving the API and PPF in the
biocompatible, water-miscible organic solvent, N-methyl-2-pyrrolidone (NMP).[154]
Their strategy aimed at combining the advantages of a monolithic polymeric implant with
the benefits of injectable drug delivery systems involving the formulation of injectable in
situ forming implants.[154] In another study, Kempen et al. investigated the effect of the
incorporation of PLGA microspheres encapsulating growth factor, BMP-2, in PPF
scaffolds in a goat ectopic implantation model. Some of the scaffolds were combined
with autologous BMSCs before implantation to test the influence of progenitor cells on
the bone regeneration capacity of the composite.[155] Kempen et al., also tried to
examine the release kinetics of TRD from PPF/PLGA blend microspheres as well as the
degradation of these microspheres.[150] In another attempt, the same group developed
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PPF microspheres to enhance the bonding between the particulate and the continuous
phases of the composite scaffold. The resulting PPF microspheres were expected to
covalently bind to the PPF matrix through the carbon-carbon double bonds along the
polymer backbone on the microsphere surface resulting in increased mechanical
properties.[156] This suggests that the pro-angiogenic mediator, ginsenoside Rg1, can
potentially be incorporated into the cement formulation or designed scaffolds after
encapsulation in biodegradable PPF microspheres.

1.5.1

Techniques for bioactive molecules-loaded microspheres
preparation

Microstructured systems encapsulating therapeutic agents can be prepared using several
techniques, including emulsion-solvent evaporation/extraction methods, polymer solution
separation method, spray drying, microfluidics, with each method has its own pros and
cons. The choice of a particular method depends on drug and polymer features, site of
action, and therapy regimes.[157] In an optimized preparation process, the chemical
stability and biological activity of the incorporated drug should be guaranteed.[149] An
ideal microparticle preparation process should have reasonably high encapsulation
efficiency, loading capacity, and sustained release of the loaded drug with retained
bioactivity.[158] In addition, the prepared microspheres should display a homogeneous
size distribution. Besides, preparation and purification processes must result in
reproducible products, and the release-profile of the drug should meet the specific final
application requirements.[149] High drug loading and encapsulation efficiencies are
critical factors due to the extremely high price of API's such as Rg1, which is of interest
for this thesis.[158]

1.6 Scope of the research
The main objective of this project was to investigate our hypothesis that biocompatible
TiO2 and Sr-doped TiO2 nanoparticles could be used as a reinforcement and
radiopacifying agent to significantly enhance the mechanical properties and radiopacity
of PPF bone cement matrix. These novel PPF-TiO2 bone cement nanocomposites are
proposed for treatment of stage III osteonecrosis. Towards this goal, the use of
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supercritical carbon dioxide (scCO2) for the synthesis of TiO2 and Sr-doped
nantubes/fibers was investigated. In order to enhance the reinforcing effect of TiO2, PPF
was functionalized with maleic anhydride (MA) using a ring opening reaction producing
carboxyl groups at each end point of the polymer for coordination to the n-TiO2.
Moreover, a PPF-based bone cement capable of delivering an angiogenic agent,
ginsenoside Rg1, in a localized and sustained manner would direct regeneration of bone
and vascular tissue. In addition, inorganic fillers including hydroxyapatite and
hydroxyapatite/titania nanocomposites were synthesized in scCO2 and also using a
hydrothermal technique to strengthen the mechanical and physical properties of poly(εcaprolactone) (PCL) for tissue engineering applications.
The following were identified as specific objectives of this project:
I.

Functionalization of PPF with maleic anhydride (MA) and preparation of
TiO2-PPF nanocomposites followed by mechanical properties analysis of the
crosslinked bone cement nanocomposites.

II.

Synthesis of Sr-dopped TiO2, preparation of Sr-dopped TiO2-PPF
nanocomposites, and radiopacity measurement of the cross-linked bone cement
nanocomposites.

III.

Synthesis of hydroxyapatite and hydroxyapatite-TiO2 in supercritical CO2 and
hydrothermal method to prepare polymer nanocomposites.

IV.

Encapsulation of ginsenoside Rg1 within PPF microspheres prepared using
double emulsion and microfluidic technique, examining the release kinetics of
Rg1 from these microspheres.

V.

Incorporation of ginsenoside Rg1 within Sr-dopped TiO2-PPF based bone
cement nanocomposites and release kinetic study of the ginsenoside Rg1 from
these bone cement formulation.

VI.

Tube formation (angiogenesis behavior) analysis of ginsenoside Rg1 in vitro
before encapsulation and after release from the PPF microspheres and PPFbased bone cement nanocomposites.
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Chapter 2
2

Synthesis and Characterization of Novel TiO2Poly(propylene fumarate) Nanocomposites for
Bone Cementation

Abstract
This work reports on a new methodology for synthesizing poly(propylene fumarate)
(PPF)/titania nanowire composites which would be beneficial in tissue engineering for
orthopaedic bone cements. The synthetic procedure reacted PPF with maleic anhydride to
create HOOC-PPF-COOH species in a ring-opening reaction at room temperature. These
species were then coordinated to titania nanowires by metal carboxylate bonding through
the end -COOH groups. These PPF-grafted nano-TiO2 assemblies were then further
polymerized and crosslinked in the presence of N-vinylpyrrolidone to produce the bone
cements. The synthesis and modification of PPF was confirmed by NMR (1H and

13

C)

and XPS, while the reaction chemistry of the functionalized PPF and nano-TiO2 was also
investigated by XPS and FTIR. Mechanical testing of the resulting composites
demonstrated a significant reinforcement of the tensile and flexural properties, showing
the utility of this synthetic approach for bone tissue engineering.
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2.1 Introduction
Developing new materials for bone cementation and bone tissue engineering is of
emerging scientific interest,[1] requiring new synthetic approaches that provide both
mechanical strength and biocompatibility.[2] Driving forces include our longer life spans
and the potential to treat skeletal bone defects and diseases such as osteonecrosis, which
is caused by the temporary or permanent loss of blood supply to bone.[3] Cementation
involves the injection of a liquid polymeric material, which hardens in the defect,
providing mechanical support to the bone.[4] The most universally used injectable bone
cement is made of poly(methyl methacrylate) (PMMA).[5-7] However, there are several
drawbacks associated with PMMA bone cements including: (1) exothermic
polymerization that can lead to impaired local blood circulation and thermal necrosis of
the surrounding bone, (2) release of unreacted MMA monomer leading to chemical
necrosis of the bone, (3) non-biodegradability, so PMMA cannot be replaced with new
bone formation, and (4) non-bioinertness.[8] Recently, poly(propylene fumarate) (PPF)
has attracted considerable interest as a promising biodegradable material for treating
skeletal defects.[9-11] PPF is a linear and unsaturated polyester containing one
unsaturated C=C double bond per repeating unit. The double bonds of PPF can crosslink
with itself or a variety of crosslinking agents such as 1-vinyl-2-pyrrolidinone (N-VP) to
form crosslinked polymer networks.[12, 13] In addition, the ester linkage allows for
hydrolysis of the polymer into biocompatible and excretable degradation products of
fumaric acid and propylene glycol, shown in Figure 2.1.[14, 15]
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Figure 2.1. Crosslinking and degradation scheme of PPF-PPF-PVP networks.
Even though crosslinked PPF can be considered as a material for trabecular bone tissue
regeneration, significant mechanical reinforcement is needed for the use of this material
under load bearing conditions.[16, 17] Nanoparticles such as calcium phosphates
including tetracalcium phosphate (TTCP), dicalcium phosphate (DCPA), and
hydroxyapatite (HAp) have been investigated for PPF-based cements, enhancing the
mechanical strength of the composite and osteoconductivity.[18-20] Shi et al. and
Sitharaman et al. used single-walled carbon nanotubes (SWNTs) as reinforcing fillers in
PPF because of their excellent mechanical properties and high aspect ratios; however, the
addition of carbon nanotubes may impose negative effects on the aesthetic requirements
and biocompatibility of the bone cement.[16, 21] It is believed that one-dimensional
oxides, such as nanowires or nanotubes of SiO2, ZrO2, Al2O3, and TiO2 would be
promising for the reinforcement of bone cement compositions due to their unique
properties and low cost compared to carbon nanotubes.[22, 23] Horch et al. and Mistry et
al. designed a composite material utilizing surface-modified carboxylate alumoxane
nanoparticles and PPF network, which showed a significant improvement in flexural
properties.[17, 24] However, alumina-based implants have rarely shown to initiate apatite
formation and cannot directly attach to bone.[25, 26] Essentially no studies have
examined the incorporation of 1D nano-structured oxides into PPF bone cement matrix to
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enhance its mechanical properties. To the best of our knowledge, this is the first study to
incorporate 1D nano-structured titania into a PPF matrix, which requires a new synthetic
methodology. TiO2 nanofibers or wires are expected to be superior to alumina
nanoparticles owing to their excellent biocompatibility and unique oseointegration.
Titania nanofibers or wires can directly bond to bone through the formation of a
biologically active bone-like apatite layer on the surfaces of implants within the body
(oseointegration).[26, 27] In addition, titania nanofibers or wires have high aspect ratios
which enhances their interfacial interaction with the resin matrix leading to dramatically
enhanced mechanical properties.[23, 28]
In this work we present a new method for the synthesis of functionalized PPF containing
a carboxyl group at each end of the PPF chains using a ring opening reaction at room
temperature in the presence of a highly nucleophilic tertiary amine catalyst, 4dimethylaminopyridine.[29, 30] The carboxyl group allowed for coordination of PPF to
nano-TiO2, and the subsequent crosslinking reaction with 1-vinyl-2-pyrrolidinone to form
crosslinked TiO2-PPF nanocomposites. The mechanical properties of the synthesized
crosslinked TiO2-PPF nanocomposites were measured, showing potential applications in
bone cementation.

2.2 Experimental details
2.2.1

Materials

Titanium isopropoxide (99.999%), glacial acetic acid (>99.7%), diethyl fumarate (98%),
propylene

glycol

(1,2-propanediol)

(≥99.5%), anhydrous

zinc

chloride

(ZnCl2,

≥99.995%), hydroquinone (99%), maleic anhydride (95%), 4-dimethylaminopyridine
(DMAP), hydrochloric acid (37%), anhydrous magnesium sulfate (99.0%), anhydrous
diethyl ether (≥99.0%), anhydrous dichloromethane (DC , ≥99.8%), anhydrous
tetrahydrofuran (THF, ≥99.9%), 1-vinyl-2-pyrrolidinone (N-VP), benzoyl peroxide
(BPO), and N-dimethyl-p-toluidine (DMT) were purchased from Sigma-Aldrich Canada
and used as received. Instrument grade carbon dioxide (99.99%) was purchased from
BOC Canada.
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2.2.2

Characterization

Scanning electron microscopy images were collected using a Leo(Zeiss) 1540XB SEM.
Imaging was performed at either low voltage (1 kV) for morphology or at 10 kV for
backscatter imaging. Samples were coated with 5nm of osmium metal in a Filgen
OPC80T. For studying the fracture surface, samples were broken by submersing in liquid
nitrogen in a stainless steel mortar and broken with a stainless steel pestle. The particle
diameter and aspect ratio frequency distribution of TiO2 nanoparticles were obtained by
measuring over 100 TiO2 nanoparticles using Image J software (NIH, version 1.37).
Transmission electron microscopy images were recorded using a Philips CM10
transmission electron microscope with an AMT digital camera (Eindhoven, Netherlands)
operated at 100 kV.
Attenuated total reflection-Fourier transform infrared (ATR-FTIR) spectra were
measured using a Nicolet 6700 FTIR spectrometer (Thermo Scientific) equipped with a
smart iTR (diamond ATR). The spectra were recorded in the range of 600-4000 cm−1
with a resolution of 4 cm−1 over 32 scans. X-ray photoelectron spectroscopy (XPS)
analyses were carried out with a Kratos AXIS Ultra spectrometer using a monochromatic
Al K(α) source (15mA, 14kV). Samples were placed on a carbon-based double-sided
adhesive tape for analysis. The Kratos charge neutralizer system was used on all
specimens. Survey scan analyses were carried out with an analysis area of 300 µm × 700
µm and a pass energy of 160 eV. High resolution analyses were carried out with an
analysis area of 300 µm × 700 µm and a pass energy of 20 eV. Spectra were charge
corrected to the main line of the carbon 1s spectrum set to 284.8 eV. Spectra were
analyzed using CasaXPS software (version 2.3.14). 1H and

13

C NMR spectra were

measured using either a Varian INOVA 600 or a Varian INOVA 400 spectrometer at 25
o

C. CDCl3 was used as the solvent and chemical shifts were referenced to

tetramethylsilane (TMS; 0.0 ppm). Thermogravimetric analysis (TGA) was performed
using a TA Q500 TGA at a heating rate of 10 ºC/min under an inert (nitrogen)
atmosphere.
Mechanical tensile properties were measured using an Instron 5943 universal testing
machine (Instron, Canton, MA) equipped with a 500 N (tension) load cell. Tensile testing
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was conducted in accordance with ASTM D638-91a. Dogbone specimens with overall
length of 60 mm and width of grip section of 10 mm were used for tensile testing. Stressstrain relationship was obtained from the load and displacement data. Young’s modulus
was determined by calculating the slope of the linear portion of the stress-strain curve,
and tensile strength was defined as the maximum applied stress prior to failure. For each
group, 5 independent specimens (n=5) were tested in tension at a crosshead speed of 10
mm/min. Flexural strength and flexural modulus of the nanocomposites were determined
in accordance with ASTM D790M-92 using a dynamic mechanical analyzer, DMA Q800
(TA instruments). Flexural testing samples, rectangular bar specimens (n=5) (50 mm  25
mm  2 mm), were placed on a three-point bending apparatus with two supports spanning
40 mm from each other and loaded at the cross-head speed of 10 mm/min to the center of
each specimen until failure. In an approach similar to that of tensile testing, flexural
modulus was calculated as the slope of the initial linear region of the stress-strain curve,
while flexural fracture strength was determined as the maximum applied stress prior to
failure.

2.2.3

Preparation of materials

2.2.3.1

Synthesis of poly(propylene fumarate) (PPF)

PPF was synthesized using a two-step transesterification method described in the
literature.[31] In a typical experiment, diethyl fumarate (31.56 g, 183 mmol) and
propylene glycol (41.38 g, 549 mmol) were reacted in an inert atmosphere under stirring,
with ZnCl2 (0.250 g, 1.83 mmol) and hydroquinone (0.0403 g, 0.366 mmol) being added
as a catalyst and a crosslinking inhibitor, respectively. After the reaction temperature had
been increased to 110 ºC, the temperature was further increased from 110 ºC to 150 ºC in
an increment of 10 ºC every 15 min. Bis(hydroxypropyl) fumarate (1) was formed with
the continuous removal of the byproduct ethanol, as a distillate. This step was terminated
by cooling down to 100 oC when ~ 90% of the theoretical yield of ethanol was collected.
The second step of the reaction, transesterification of the intermediate bis(hydroxypropyl)
fumarate to form PPF (2), was conducted under reduced pressure (<1 mm Hg), producing
propylene glycol as a byproduct. The temperature was raised gradually from 100 ºC to
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150 ºC in an increment of 10 ºC every 30 min, and the reaction proceeded until the
desired molecular weight of PPF was obtained. The polymer product was then dissolved
in dichloromethane followed by several acid washes with a 5% v/v solution of 1 N HCl,
two washes with distilled water, and two washes with brine. After drying with
magnesium sulfate, the organic phase was concentrated by rotary evaporation and then
precipitated in diethyl ether to remove the hydroquinone inhibitor. The precipitated
polymer was washed with diethyl ether and dried under vacuum. Yield: 73% (21 g).
FTIR (cm-1): 1713 (νC=O), 1645 (νC=C), 1251 (νC-O-C(as)), 1148 (νC-O-C(s)). 1H NMR (CDCl3,
600

H ) δ (ppm): 6.85 (O=C-CH=CH-C=O), 5.29 (O-CH(CH3)-CH2), 4.33 & 4.25 (O-

CH(CH3)-CH2), 1.34 (O-CH(CH3)-CH2), 5.10, 4.22, 4.09, 3.70, 1.29, and 1.23 (end
groups of the PPF polymer chain).

13

C N R (CDCl3, 100

H ) δ (ppm): 164.0-

164.3(O=C-CH=CH-C=O), 133.3-134.0 (O=C-CH=CH-C=O), 69.2 (O-CH(CH3)-CH2),
66.6 (O-CH(CH3)-CH2), 16.3 (O-CH(CH3)-CH2), 73.1, 70.3, 65.8, 65.5, 19.2, and 16.0
(end groups of the PPF polymer chain).

2.2.3.2

Functionalization of PPF

In order to functionalize the PPF chain with maleic anhydride, to a solution of PPF (1g,
0.91 mmol of -OH group) in 10 mL of anhydrous dichloromethane were added DMAP
(0.11 g, 0.91 mmol) and maleic anhydride (0.36 g, 3.64 mmol). The reaction mixture was
stirred under argon at room temperature for 24 h. After completion of the reaction, 5 mL
of dichloromethane was added to the flask followed by washing with 10 mL of 1 N HCl
solution and distilled water. The organic phase was subsequently dried over anhydrous
magnesium sulfate. After

that, the organic phase was filtered and the solvent was

removed by rotary evaporation to afford maleic anhydride-functionalized PPF (MA-PPF)
(3). Yield: 59% (0.64g). 1H NMR (CDCl3, 600

H ) δ (ppm): 8.19 (-COOH). 6.85

(O=C-CH=CH-C=O), 5.29 (O-CH(CH3)-CH2), 4.33 & 4.25 (O-CH(CH3)-CH2), 1.34 (OCH(CH3)-CH2).

13

C NMR (CDCl3, 100

H ) δ (ppm): 164.0-164.3(O=C-CH=CH-

C=O), 133.3-134.0 (O=C-CH=CH-C=O), 69.2 (O-CH(CH3)-CH2), 66.6 (O-CH(CH3)CH2), 16.3 (O-CH(CH3)-CH2).
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2.2.3.3

Synthesis of TiO2 nanofibers via sol-gel reaction in supercritical
CO2

High surface area TiO2 nanofibers were synthesized using supercritical CO2 (scCO2) as
reported by Sui et al.[32] Briefly, in a typical experiment, titanium isopropoxide (1 g)
was quickly placed in a 10-mL stainless steel view cell, followed by addition of acetic
acid (4 g). CO2 was then added to the view cell using a syringe pump (Isco 260D) to the
desired pressure (6000 psig) while increasing the temperature to 60 °C. A magnetic stirrer
was used for mixing the reaction mixture. Stirring was stopped after 24 h, and normally
several days of aging were required for a complete reaction. After aging, the formed gel
was washed continuously using 80 mL of CO2 at a rate of approximately 0.5 mL/min,
followed by controlled venting at 0.5 mL/min to prevent collapse of the solid network.
The as-prepared powder was calcined at 450 °C in air for 2 h with a heating rate of 10
°C/min and a cooling rate of 0.5 °C/min to room temperature. The calcined powder was
kept in a vacuum oven at 80 °C.

2.2.3.4

Synthesis of TiO2-PPF nanocomposites

To prepare TiO2-PPF nanocomposites (4), 0.5, 1.25, or 2.5 wt% of the synthesized TiO2
nanofibers (0.005, 0.0125, or 0.0250 g) was dispersed in 20 mL of THF with the aid of
ultrasonic agitation for 1 h, followed by reacting with the above synthesized MA-PPF (1
g) at 70 °C under argon with constant stirring for 24 h. After filtering off the solvent and
the unreacted MA-PPF, the product was further purified by dispersion in THF,
centrifugation, and removal of the supernatant. This purification process was repeated
several times until the supernatant became clear. Finally, the resulting solid product was
dried at 55 ºC under vacuum overnight. The composition of the synthesized
nanocomposites and the nano-TiO2 concentration in each nanocomposite formulation
reviewed by TGA analysis are presented which are listed in Table 2.1.
FTIR (cm-1): 1713 (νC=O), 1645 (νC=C), 1570 & 1377 (νCO2-(as)), 1251 (νC-O-C(as)), 1165 (ν
CO2-(s)), 1148 (νC-O-C(s)).
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Table 2.1. Formulation of the TiO2-PPF nanocomposites.
MA-PPF
(g)

nano-TiO2
(g)

*nano-TiO2 wt% in the
synthesized nanocomposite

1g

0.005 g

5 wt%

TiO2-PPF
nanocomposite-1

1g

0.0125 g

10 wt%

TiO2-PPF
nanocomposite-2

1g

0.0250 g

22 wt%

TiO2-PPF
nanocomposite-3

Sample Name

Note: * the weight percentage of nano-TiO2 in each TiO2-PPF nanocomposite formulation is
obtained from the TGA analysis.For comparison of XPS study, a mechanically mixed PPF-

TiO2 nanocomposite was fabricated by mechanical mixing of the PPF (1 g) and TiO2
nanoparticles (0.10 g).

2.2.3.5

Synthesis of bone cement composites

The bone cement composites (5) were prepared by crosslinking the synthesized TiO2-PPF
nanocomposites (details are provided in Table 2.1) using N-VP. In a typical experiment,
the above synthesized TiO2-PPF nanocomposite (1 g) was mixed with N-VP (0.4 g) for 2
h. Initiator, BPO (0.05 g), was dissolved in 250 μL of N-VP. The 50 μL of BPO solution
was then combined and mixed with the TiO2-PPF nanocomposite solution. Subsequently,
40 μL of accelerator solution (20 μL of D T in 980 μL of dichloromethane) was added
with rapid mixing to accelerate the crosslinking reaction.[4, 19] The resulting paste was
placed in a Teflon mold, then loaded in an oven at 60 °C for 1 h to facilitate crosslinking.
After that, the mold was cooled down to room temperature, and the formed bone cement
composite was removed before being subject to mechanical testing. Three different bone
cement composites were prepared using the TiO2-PPF nanocomposites synthesized with
different amounts of TiO2, which are listed in Table 2.2.
For comparison of mechanical testing, bone cement composites were prepared by
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crosslinking the mechanically mixed 1 g of PPF and 0.05 g of nano-TiO2 (corresponding
to the actual TiO2 concentration in the TiO2-PPF nanocomposite-1 reviewed by TGA
analysis represented in Table 2.1) following the above procedure. The composition of the
prepared mechanically mixed bone cement composite is also listed in Table 2.2.
Table 2.2. Formulation of the bone cement composites.
Entry
No.

TiO2-PPF

nano-TiO2

1

PPF

1g

Formed Product
Crosslinked PPF

2

1 g of TiO2-PPF synthesized
using 0.005 g of TiO2

Bone cement
composite-1

3

1 g of TiO2-PPF synthesized
using 0.0125 g of TiO2

Bone cement
composite-2

4

1 g of TiO2-PPF synthesized
using 0.0250 g of TiO2

Bone cement
composite-3

5

0.05 g

1g

Mechanically mixed
bone cement

Note: Additionally, 0.4 g of N-VP, 50 μL of BPO solution, and 40 μL of D T solution
were added in the preparation of these materials.

50

2.3 Results and Discussion
2.3.1

Synthesis of poly(propylene fumarate) (PPF)

The synthesis of PPF involves firstly a transesterification reaction of diethyl fumarate
with propylene glycol (Step a in Figure 2.2) to produce bis(hydroxypropyl) fumarate (1).
In

step

b,

poly(propylene

fumarate)

(PPF)

(2)

is

produced

by

the

transesterification/polymerization of 1 with ZnCl2/hydroquinone. In this step, the alkoxy
group of the intermediate, bis(hydroxypropyl) fumarate), is replaced with an alcohol from
a second bis(hydroxypropyl) fumarate intermediate, propagating PPF polymerization and
producing propylene glycol as a byproduct. The synthesized PPF was then reacted with
maleic anhydride to form maleic anhydride-functionalized PPF (MA-PPF) (3 of Figure
2.2). A small amount of ZnCl2 was added in the transesterification reaction as a catalyst,
while a small amount of hydroquinone was added as an inhibitor to prevent the C=C
double bond from being polymerized at high temperatures up to 150 °C. Continuous
removal of the byproducts ethanol in the first transesterification reaction and propylene
glycol in the second transesterification reaction as the condensates is necessary to drive
the step-growth condensation polymerization reactions. The esterification reaction of
maleic anhydride and PPF provided PPF with a functional carboxyl group at both ends of
the polymer chains (3), in order to provide potential coordination of the functionalized
PPF to the surface of TiO2 nanofibers.
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Figure 2.2. Synthetic Scheme for the Preparation and Functionalization of PPF.
Reagents and conditions: (a) propylene glycol, ZnCl2, hydroquinone; (b) ZnCl2,
hydroquinone; (c) maleic anhydride, DMAP, DCM.
The synthesis and functionalization of PPF was confirmed by NMR (1H,

13

C). The 1H

NMR spectra of propylene glycol and the synthesized PPF and MA-PPF are compared in
Figure 2.3. There are four distinct peaks present in the spectrum of propylene glycol
(Figure 2.3a), with the peaks at 1.16, 3.39 & 3.62, and 3.90 ppm attributed to the methyl
(CH3), methylene (CH2), and methine (CH) protons, respectively. In the spectrum of PPF
(Figure 2.3b), major peaks appeared at 6.85, 5.29, 4.33 & 4.25, and 1.34 ppm,
attributable to the olefinic (O=C-CH=CH-C=O), methine, methylene, and methyl protons
in the repeating unit, respectively. Some minor peaks are also present in the spectrum at
5.10, 4.22, 4.09, 3.70, 1.29, and 1.23 ppm, which are attributed to the end group of the
PPF polymer chain (see Figure 2.3b). By integrating these major and minor peaks (Figure
2.3), the number average molecular weight (

) of the synthesized PPF (2) was

estimated as ~ 2200 Da, which is within the reported range between 500 and 4,000
Da.[31] When PPF was converted to MA-PPF (3), these major peaks were still present in
the spectrum, but the minor peaks disappeared (Figure 2.3c). In addition, a minor broad
peak appeared at 8.19 ppm in the 1H NMR spectrum of MA-PPF, attributable to the
carboxyl proton (-COOH) located at both ends of the polymer chains. Together with the
disappearance of the minor peaks present in the spectrum of PPF, this minor carboxyl
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peak in the 1H NMR spectrum of MA-PPF suggested successful conversion of PPF to
MA-PPF.
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The successful conversion of PPF to MA-PPF was also evidenced by 13C NMR results. A
comparison of the 13C spectra of propylene glycol, PPF, and MA-PPF is shown in Figure
2.5. In the spectrum of propylene glycol (Figure 2.5a), three carbon peaks appear at 68.2,
67.8, and 18.6 ppm, which are attributed to the methyl (CH3), methylene (CH2), and
methine (CH) carbons, respectively. In the spectrum of PPF (Figure 2.5b), there are five
major peaks appearing at 164.0-164.3, 133.3-134.0, 69.2, 66.6, and 16.3 ppm, attributable
to the carbonyl (O=C-CH=CH-C=O), olefinic (O=C-CH=CH-C=O), methine, methylene,
and methyl carbons in the repeating unit, respectively. Some minor peaks are also present
in the spectrum at 73.1, 70.3, 65.8, 65.5, 19.2, and 16.0 ppm, which are attributed to the
end group of the PPF polymer chains (Figure 2.5b). When PPF was converted to MAPPF, these major peaks were still present but the minor peaks disappeared (Figure 2.5c).
Although the peak of the carboxyl carbon at the end of the PPF-g-MA polymer chains
was not observed due to its low concentration, the absence of the minor peaks in the
spectrum of MA-PPF confirmed successful conversion of PPF to MA-PPF.
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2.3.2

Preparation of TiO2-PPF nanocomposites and bone cement
composites

To prepare TiO2-PPF nanocomposites, TiO2 nanowires/fibers were synthesized prior to
reaction with 3. The morphology and size of the nano-TiO2 synthesized in scCO2 and
calcined at 450 °C were characterized by SEM and TEM, as shown in Figure 2.6a-b and
Figure 2.6c-d, respectively. The mean diameter and aspect ratio of the synthesized fiberlike nanostructures of TiO2 were determined to be 50±10 nm and 30±5, respectively
(Figure 2.6c-d). These results are in good agreement with those reported in the
literature.[32, 33] The advantage of this synthetic approach in scCO2 is that high aspect
ratio nanowires with high porosity and high surface area are produced.
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Figure 2.6. (a) SEM and (b) TEM images and the distribution of (c) diameter and (d)
aspect ratio of the synthesized TiO2 nanofibers.

With TiO2 nanofibers being synthesized, TiO2-PPF nanocomposites were prepared by
coordination reaction of MA-PPF (3) to the surface of TiO2 nanofibers, as shown in
Figure 2.7. The synthesized TiO2-PPF nanocomposites (4) were further crosslinked to
form the desired bone cement composites (5).
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Figure 2.7. Synthetic Scheme for the preparation of (4) TiO2-PPF nanocomposites and
(5) bone cement composites.
Reagents and conditions: (a) TiO2 nanofibers, THF; (b) N-VP, BPO, DMT.
The synthesized TiO2-PPF nanocomposites (4) and cross-linked bone cement composites
(5) were characterized with FTIR, XPS, and TGA to examine the reaction chemistry. The
FTIR spectra of TiO2, PPF, TiO2-PPF nanocomposite (4), and bone cement composite (5)
are compared in Figure 2.8. Several major characteristic peaks appeared at 1713, 1645,
1251, and 1148 cm-1 in the spectrum of PPF (Figure 2.8b), attributed to the C=O
stretching, C=C stretching, asymmetric C-O-C stretching, and symmetric C-O-C
stretching bands, respectively.[4, 34] The peak at 1645 cm-1 in the FTIR spectrum of both
PPF and TiO2-PPF nanocomposite shows the C=C double bond was unaffected in the
polymer chains after the reaction of MA-PPF and nano-TiO2. Additional peaks appearing
at 1570, 1377 and 1165 cm-1 in the FTIR spectrum of the TiO2-PPF nanocomposite
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(Figure 2.8c) are attributed to the asymmetric and symmetric CO2- stretching bands,
respectively, indicating successful coordination of PPF to the TiO2 nanofibers. Rotzinger
et al. described three possible coordination structures of carboxylate to the surface of
TiO2, i.e., chelating bidentate, monodentate, and bridging bidentate (Figure 2.9).[34]
These structures can be distinguished in infrared spectra by the separations between the
carboxylate stretching bands (Δυ). The band separation (Δυ=405 cm-1) between 1570 and
1165 cm-1 falls into the monodentate range (350-500 cm-1) while another band separation
(Δυ=193 cm-1) between 1570 and 1377 cm-1 might be indicative of a structure of bridging
bidentate (150-180 cm-1).[35] These coordination peaks remained evident in the spectrum
of the crosslinked bone cement composite, although the peak at 1645 cm-1 (C=C
stretching band) disappeared (Figure 5d). The disappearance of the C=C stretching band
confirmed the crosslink reaction which consumed the C=C double bond (Figure 2.7).[36]
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Figure 2.8. ATR-FTIR spectra of (a) TiO2, (b) PPF, (c) TiO2-PPF nanocomposite, and
(d) crosslinked bone cement composite.
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Figure 2.9. Binding modes of RCOO- with TiO2 surface (R= H or CH3).
(a) chelating bidentate (b) monodentate, and (c) bridging bidentate.[34]
X-ray photoelectron spectroscopy (XPS) was further employed for characterization of the
synthesized PPF (2), MA-PPF (3), and non-crosslinked TiO2-PPF (4) nanocomposites.
The high resolution XPS scan of C 1s region for both PPF and MA-PPF (Figure 2.10a-b)
represent similar patterns as expected for the chemistries involved. In both spectra, three
major carbon peaks are observed with binding energies of 285 eV, 286.5, and 289.0 eV,
which correspond to aliphatic carbon (C–C, C-H), alcohol and ether functionality (C–OH,
C–O–C), and ester and carboxylic acid type functionality (O–C=O), respectively [6] with
relatively equal peak intensities for the peaks at 286.5 eV and 289.0 eV. Some of the
intensity associated with the aliphatic carbon are attributed to adventitious carbon on the
surface of the samples. In addition, the core level spectrum of O 1s for both PPF and
MA-PPF, shown in Figure 2.10c-d, are resolved into two peaks at binding energies of
532 eV and 533.5 eV, which are attributed to O-C=O* and O*-C=O, respectively (*
denotes the O of interest).[6]
In the recorded survey spectrum for the non-crosslinked TiO2-PPF nanocomposite, the
expected peaks for O, C, and Ti were detected (Figure 2.10e). In the high resolution XPS
scan of the C 1s region (Figure 2.10f), the three major peaks observed for PPF and MAPPF are still evident. In addition, a new peak appeared at 288.2 eV, which is assigned to
the C atom of the carbonyl group from the successful covalent interaction of carboxylate
to TiO2.[37, 38] In order to verify the coordination of MA-PPF to the surface of TiO2
nanofibers, a C 1s spectrum of the mechanically mixed TiO2-PPF nanocomposite sample
prepared by mechanical mixing of PPF (1g) with nano-TiO2 (0.10 g) was measured
(Figure 2.10g). As expected, no peak shifting or extra peaks were seen in the C 1s
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spectrum, indicating no chemisorption of PPF to the surface of nano-TiO2. In the high
resolution O 1s spectrum of non-crosslinked TiO2-PPF-nanocomposite (Figure 2.10h), a
new peak appeared at 529.3 eV, which is related to the lattice oxygen atoms in TiO2 (TiO bonds).[39] Furthermore, the core level spectrum of Ti 2p for the non-crosslinked
TiO2-PPF-nanocomposite (Figure 2.10i) could be resolved into two spin-orbit pairs of
2p3/2 and 2p1/2 with binding energies of 458.3 eV and 464 eV, respectively, attributable
to Ti4+ implying that the chemical state of titanium remains as Ti4+.[39, 40] Therefore,
this XPS data confirms the successful coordination of MA-PPF to the surface of TiO2
nanofibers without changing the state of nano-TiO2.
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Figure 2.10. High resolution XPS record of C 1s region of (a) PPF and (b) MA-PPF,
high resolution XPS record of O 1s region of (c) PPF and (d) MA-PPF, (e) XPS full-scan
spectrum of the TiO2-PPF nanocomposite, high resolution XPS scan of the C 1s region of
(f) the TiO2-PPF nanocomposite and (g) the mechanically mixed TiO2-PPF
nanocomposite, high resolution XPS scan of the O 1s region of (h) the TiO2-PPF
nanocomposite, and high resolution XPS scan of the Ti 2p region of (i) the TiO2-PPF
nanocomposite.
Thermogravimetric analysis (TGA) was also employed in the measurement of PPF
attached to the surface of nano-TiO2 in the synthesized TiO2-PPF nanocomposites. The
TGA characteristics of the nanocomposites are shown by the thermal weight loss and
derivative of weight loss (DTG) of the composites with temperature. Figure 2.11
compares the calcined TiO2, non-crosslinked PPF (2) and crosslinked PPF, noncrosslinked TiO2-PPF (4) nanocomposites, and crosslinked TiO2-PPF (5) bone cement
composites. A typical TGA result of TiO2-PPF nanocomposite shows two obvious
regions when the temperature increased: the first region started from 30 °C and ended at
200 °C with a relatively small slope (due to evaporation of the entrapped water, solvent,
or free carboxyl groups); while the second region started at 200 °C and ended at 400 °C
with a large slope indicating more weight loss, which is attributed to the random internal
scission of the PPF chains chemically attached to the TiO2 nanoparticles. The sample of
TiO2-PPF nanocomposite displayed a weight loss of 74% compared to the calcined TiO2
with the weight loss of 3%. PPF functionalization allowed a relatively high number of
polymer chains to be attached on the surface of TiO2 nanofibers, resulting in an increased
weight loss for the TiO2-PPF nanocomposites.
In addition, the effect of functionalization of the PPF on the nanocomposites can be
observed by an enhanced thermal stability of the synthesized bone cement composite
compared to the unmodified PPF. As shown in Figure 2.12, the onset degradation
temperature Td for non-crosslinked PPF, crosslinked PPF, TiO2-PPF nanocomposites, and
bone cement composite is 332 ºC, 345 ºC, 336 ºC, and 355 ºC, respectively, with bone
cement composite representing the highest thermal dissociation temperature. This thermal
stability enhancement is attributed to the strong interfacial adhesion between the nano-
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TiO2 and PPF matrix, which results from the excellent chemical interaction of nano-TiO2
and functionalized polymer chains, with this strong adhesion providing a barrier effect to
the polymer molecules evaporated during the thermal degradation of the nanocomposites.

Figure 2.11. TGA curves of: (a) TiO2, (b) PPF, (c) crosslinked PPF, (d) TiO2-PPF
nanocomposite (synthesized using 1 g of MA-PPF and 0.0250 g of TiO2) and (e)
crosslinked bone cement composite (made of 1 g of TiO2-PPF synthesized using 0.0250 g
of TiO2).
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Figure 2.12. Derivative thermogravimetric (DTG) curves of: (a) PPF, (b) crosslinked
PPF, (c) (d) TiO2-PPF nanocomposite (synthesized using 1 g of MA-PPF and 0.0250 g of
TiO2) and (e) crosslinked bone cement composite (made of 1 g of TiO2-PPF synthesized
using 0.0250 g of TiO2).

2.3.3

Mechanical properties of crosslinked PPF and bone cement
composites

The Young’s modulus and tensile strength were measured for the crosslinked PPF and
bone cement composites with varying nanowire-TiO2 concentrations, and mechanically
mixed bone cement composites. The incorporation of nano-TiO2 reinforced the
mechanical properties of the PPF, as shown in Table 2.3. The Young’s modulus and
ultimate tensile strength of crosslinked composites increased with the initial relatively
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low concentrations of TiO2, peaked for bone cement composite-1 and bone cement
composite-2, and then plateaued or decreased at higher loading concentrations. There was
a 2.5-fold increase in the Young’s modulus for the bone cement composite-1 compared to
the pure polymer. Moreover, the tensile strength, similar to the Young’s modulus,
decreased with loading of nano-TiO2 over 0.5-1% in the starting composition. It is clear
from Table 2.3 that bone cement composite-1 (Sample 2) possesses the highest value of
Young’s modulus and ultimate tensile strength amongst the different composites tested.
This high value of Young’s modulus and tensile strength is attributed to the strong
interfacial bonding of the functionalized PPF with nano-TiO2 fibers as shown by Figure
2.13, which facilitates the transfer of interfacial stress from the filler to the matrix. It can
be seen that the unfilled polymer exhibited a smooth plain surface (Figure 2.13a), while
the bone cement composite-1 showed a rough surface with the nano-TiO2 fibers
delaminated from the PPF matrix (Figure 2.13b). Figure 2.13b also reveals that the
individual nano-TiO2 fibers were dispersed homogeneously throughout the bone cement
composite-1, with strong adhesion to the matrix when reacted to the PPF after being
functionalized. The dispersion of individual nanofibers in a polymer matrix may prevent
slippage between TiO2 nanowires while enhancing the transfer of applied load to the
nano-TiO2, which further enhances the mechanical reinforcement. This synthesis
methodology provided better compatibility with nano-TiO2 while establishing chemical
bonding through the carboxylic group, resulting in strong interfacial adhesion between
the fibers and the matrix as the partially broken or pulled out fibers on their surface is
shown by the arrows in Figure 2.13b. In addition to the strong adhesion with the matrix,
these partially pulled out fibers are also shown to bridge the cracks in the matrix (Figure
2.13c). However, at higher loading concentration (bone cement composite-2), the
measured mechanical properties of these nanocomposites began to decline. This is
attributed to the nano-TiO2 fibers agglomerating at higher concentrations within the
polymer matrix, i.e., 10 wt% (Figure 2.13d). The formed agglomerates are considered to
be responsible for accelerating crack propagation through local stress concentrators
(voids).
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Table 2.3. Mechanical Properties of the crosslinked PPF and the synthesized bone
cement composites.
**TiO2 (g)

***TiO2

Young’s

Tensile

Flexural

Flexural

for 1 g of

(g) for 1 g

modulus

strength

modulus

strength

MA-PPF

of PPF

(MPa)

(MPa)

(MPa)

(MPa)

1

0

-

228 ± 42

10.6 ± 2.1

365 ± 66

18.8 ± 2.6

2

0.005

578 ± 37

22.6 ± 2.9

1084 ± 115

42.5 ± 6.1

*Sample

3

0.0125

-

512 ± 26

22.3 ± 3.3

815 ± 83

35.9 ± 0.5

4

0.0250

-

378 ± 65

15.8 ± 0.9

983 ± 34

28.2 ± 6.8

5

-

0.05

318 ± 40

14.7 ± 1.4

583 ± 58

20.6 ± 8.7

Note: the average values and deviations were calculated from 5 sets of repeating
experiments.* The sample number corresponds to the entry number in Table 2.2. ** The
TiO2 concentration corresponds to the amount of nanowires/fibers used for the formation
of TiO2-PPF nanocomposites, presented in detail in Table 2.1. *** The TiO2
concentration corresponds to the actual TiO2 concentration in the TiO2-PPF
nanocomposite-1 obtained by TGA analysis represented in Table 2.1.
In addition, flexural modulus and flexural strength values of the bone cement composite
reflect its resistance to flexural loading which is a combination of tension and
compression forces. Similarly, dramatic reinforcements in the flexural properties (FS and
FM) were achieved with bone cement composites, as evident in Table 2.3. This
extraordinary mechanical reinforcement provided by bone cement composites exceeded
the enhancements observed with the mechanically mixed bone cement composite
(Sample 5), indicating the importance of mechanical coupling between the nanowire and
the functionalized PPF matrix. Bone cement composite-1 formulation exhibited a roughly
3-fold increase in flexural modulus and a greater than 2-fold increase in flexural strength
compared to blank polymer. Loadings beyond 0.5 wt% nano-TiO2 in the starting material
led to a decrease in the flexural properties of these bone cement composites, due in part
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to aggregation of nanowires (Figure 2.13d).
Due to the complexity of bone cement preparation chemistry including the type of
polymers, nanofillers, and crosslinking agents, as well as the loading concentration, it is
difficult to compare their mechanical properties. Previously Khaled et al. prepared bone
cement materials by incorporating TiO2-SrO nanotubes into PMMA, achieving a flexural
modulus of 2220 ± 100 MPa and a flexural strength 69.98 ± 1.40 MPa.[41] The highest
flexural modulus and flexural strength measured in the present study are 1084 ± 115 MPa
and 42.5 ± 6.1 MPa, respectively. These values are comparable with those obtained by
utilizing high molecular weight PMMA (207 kDa),[41] although much lower molecular
weight of PPF (2.2 kDa) was employed in this study. Studies employing functionalized
single-walled carbon nanotubes in PPF showed flexural modulus of 769 ± 114 MPa and a
flexural strength of 42.8 ± 3.7 MPa,[16] although the crosslinker, poly(propylene
fumarate)-diacrylate (PPF-DA), used in their work may also be contributing to the
reported improved mechanical properties. Considering previously reported flexural
modulus of human trabecular bone, our results show that TiO2-PPF nanocomposites have
sufficient mechanical strength for bone tissue engineering applications.[17]
It should be noted that nano-titania is an established biocompatible material.[28, 41] The
maleic anhydride-functionalized PPF having two small functional groups at each end of a
biocompatible polymer (PPF) chain should also be biocompatible. Hence, the prepared
TiO2-PPF bone cement materials are expected to be biocompatible; however, a future
study will be needed to further explore the biocompatibility of functionalized-PPF and
TiO2-PPF bone cement composites. From the above discussion it can be deduced that
TiO2 nanofibers can act as an excellent reinforcing agent for an experimental
functionalized PPF matrix in order to produce a new generation of bone cements.
Chemical bonding between the filler and the polymer helps the resulting bone cement
composites exhibit significantly enhanced mechanical properties. In addition, a study of
degradation behavior of the prepared bone cement composites is planned as the next
stage for this work.
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Figure 2.13. SEM images of the fracture planes of (a) crosslinked unmodified PPF, (b)
bone cement composite-1, (c) crack bridging within the bone cement composite-1, and
(d) bone cement composite-2.
(the arrows show TiO2 nanofibers are covered by polymer and aligned perpendicularly to
the fracture surface).

2.4 Conclusions
Poly(propylene fumarate) (PPF) was synthesized and then functionalized with maleic
anhydride. Successful synthesis and functionalization of PPF was confirmed by 1H and
13

C NMR and XPS. The functionalized PPF was grafted to the surface of TiO2 nano-

fibers synthesized using a sol-gel reaction in supercritical CO2. Bone cement composites
were obtained by polymerization of the PPF-grafted nano-TiO2 and a crosslinker Nvinylpyrrolidone. The polymerization was confirmed by FTIR while TGA results
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revealed improved thermal stability of the crosslinked bone cement composites.
Mechanical testing demonstrated much enhanced tensile and flexural properties of the
bone cement composites after the incorporation of TiO2 nano-fiber into the polymer
matrix, suggesting potential application in bone cementation.
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Chapter 3

3

Delivery of an angiogenic mediator for bone
regeneration
in
a
radiopaque
Sr-doped
TiO2/poly(propylene fumarate) based bone cement

Abstract
Recently

developed

TiO2-poly(propylene

fumarate)

nanocomposites

for

bone

cementation showed significantly enhanced mechanical properties. However, bone
formation is an angiogenesis-dependent process, and the need for enhanced
neovascularization in necrotic bone is especially important for bone regeneration.
Moreover, it is very important to monitor healing and loosening processes to differentiate
between bone, bone cement, and osteolysis after surgery. In the present study, a novel
bone cement composite was developed by incorporation of an agniogenic modulator,
ginsenoside Rg1, and a radiopaque component, Sr-doped TiO2 nanofiber, into
poly(propylene fumarate) (PPF), a biodegradable polymer. Sr-doped TiO2 nanofibers
were synthesized using the green solvent, supercritical carbon dioxide and characterized
by SEM, EDX, and XPS, showing a new phase, SrTiO3, in the crystalline matrix of
anatase. The strong interfacial adhesion between PPF and nanofibers was examined by
SEM, FTIR, XPS, thermal analyses, and mechanical testing. The radiopacity, drug
release, and angiogenesis behavior of the formed bone cement composites were tested
and compared with control samples, demonstrating superior radiopacity and excellent
release of ginsenoside Rg1 in vitro, as well as a dose-dependent increase in the branching
point numbers, suitable for the development of next generation bone cement materials.
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3.1 Introduction
Osteonecrosis is a disease with a wide ranging etiology and poorly understood
pathogenesis, most common in grownups between the ages of 20 and 50 years.[1] There
are many risk factors, including trauma,[2] obesity,[3] gout,[2] alcoholism,[4] exposure
to corticosteroids,[5] and radiation damage[6] which can cause the temporary or
permanent loss of blood supply to bone.[7] Certain diseases such as sickle-cell
anaemia,[8] Gaucher disease,[9] and altered lipid metabolism[10] are also associated with
the development of this condition. Reduced blood flow to bone causes bone cell death,
termed osteonecrosis, which mainly occurs in the weight-bearing parts of the body, and
therefore with the stress of weight-bearing the necrotic segment of bone is likely to
collapse leading to painful degenerative arthritis.[7, 11]
Cement fixation is a recently introduced method in treating osteonecrosis of the femoral
head.[7, 12] Bone cementation involves the injection of fluid material, which instantly
hardens in the defect, and provides mechanical support to prevent collapse. Bone cements
make the treatment of irregular defects easier. They are also easy to use for clinical
practice, providing immediate symptomatic relief and faster recovery for the patient,
while allowing improvement in mobility.[13]
Bioactive bone cements possessing easy injectability, good biocompatibility, high
radiopacity, and mechanical efficiency are required for cement fixation.[14, 15] Only a
few bone cement formulations, acrylic cements based on polymethylmethacrylate
(PMMA) and calcium phosphate cements, are specifically designed for use in these
procedures, and even these formulations are not considered as ideal injectable bone
cements. There are several disadvantages associated with commercial formulations of
both bone cements families including an exothermic reaction during the curing process,
release of cytotoxic methylmethacrylate monomer, high rigidity, nonbiodegradability,
nonbioactivity, and poor adhesion to bone surfaces for acrylic cements based on
PMMA[16, 17] and early resorption, poor mechanical properties, and poor handling for
calcium phosphate cements.[18]
Recently, poly(propylene fumarate) (PPF) has attracted considerable interest as a
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promising degradable, injectable, and non-toxic material for cement augmentation of
necrotic bone.[19] However, PPF does not provide for bone growth,[20, 21] and
development of endothelial cell-based microvascularization and microcirculation is
undoubtedly critical for the structure preservation and bone regeneration, because bone
formation is an angiogenesis-dependent process.[22, 23] Angiogenesis is defined as the
process of new blood vessel formation from pre-existing vessels from the surrounding
tissues.[24] The vasculature provides enhanced mass transport requirements for the
tissue, and delivers circulating stem cells participating in bone formation. It also
facilitates cross-talk between endothelial cells and pre-osteoblasts to direct their
differentiation. [25, 26]
A variety of growth factors that direct angiogenesis including vascular endothelial growth
factor (VEGF) have been identified.[26, 27] Also, among numerous pro-angiogenic
mediators, ginsenoside Rg1 has been shown to be a highly stable pro-angiogenic
compound by upregulating in vitro proliferation, migration, chemo-invasion, and tube
formation in human umbilical vein endothelial cells (HUVECs).[28] Rg1 stimulates
angiogenesis through enhancing the production of nitric oxide (NO) and vascular
endothelial growth factor (VEGF).[29, 30] So, we hypothesized that a synthetic system
based on PPF capable of delivering an angiogenic agent in a localized and sustained
manner would direct simultaneous regeneration of bone and vascular tissue. Chang et al.
reported the formation of ginsenoside-Rg1 incorporated PPF-tetracalcium phosphate
(TTCP)/dicalcium phosphate (DCPA) orthopedic composite formulation.[12] However,
the limition of Chang's study is that the proposed bone cements did not possess high Xray contrast along with extremely low Young’s modulus. Alike to conventional polymers,
radiopacity of PPF is expected to be similar to soft tissue, since both are primarily
composed of hydrogen, oxygen, nitrogen, and carbon yielding poorly resolved
images.[31] Therefore, it is impossible to directly monitor new bone formation and
determine the boundaries of bone cement having a pure PPF matrix during the surgery by
ordinary X-ray imaging techniques, since the image resolution is limited. [32]
Radiopacity is a desirable property in bone cements allowing post-operative assessment
using X-radiography.[33] It is important that the orthopaedic surgeon can easily monitor
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healing and loosening processes to differentiate between bone, bone cement, and
osteolysis after surgery.[32] Therefore, to use PPF bone cement as a bone substitute, it is
necessary to add X-ray contrast agents, such as zirconium dioxide or barium sulphate, to
improve radiopacity and visual control.[34] Only once did Kim et al. introduce PPF
biopolymer containing 30 Wt% barium sulfate as a radiopaque PPF cement suitable for
kyphoplasty.[16] However, a major drawback associated with the presence of barium
sulphate or zirconium dioxide is poor dispersion of these radiopacifiers into the polymer
resin, which can affect both crack initiation and crack propagation in the hardened
cement, as the radiopacifier agglomerates act as sites of high stress concentration leading
to degradation of physical and mechanical properties.[14, 35] Later Wu et al. examined a
newly developed bone filler, a-TCP/HAp, with PPF, and sought to quantify the
radiopacity by CT scanning.[18] However, CT scanning costs more and takes more time
than a regular X-ray. In addition, patients are exposed to higher doses of radiation
compared to X-ray since a CT scan takes a much greater number of X-ray images.[36] In
this work, biocompatible and radiopaque Sr2+ component (SrTiO3) is incorporated into
the titania nanorods/fibers using a sol-gel reaction in supercritical CO2 as a green solvent.
Then, a bioactive bone cement is prepared by incorporating Sr-doped titania
nanorods/fibers into a cement formulation based on PPF. There are very few studies
regarding the Sr2+-modification of TiO2 nanostructures. Bhattacharyya et al. immobilized
strontium in the crystalline matrix of rutile titania using a co-precipitation method
presenting some structural changes with the formation of new phases, SrTiO3+Sr2TiO4
and SrTiO3.[37] Khaled et al. incorporated strontium oxide (SrO), into the n-TiO2 tube
in-situ during the synthesis of the tubes through the alkaline hydrothermal technique.[33]
Also, Kumaresan et al. synthesized Sr2+-doped TiO2 nanoplates by sol-gel method.[38]
However, this is the first study, to our knowledge, to synthesize Sr-doped TiO2
nanorods/fibers in scCO2. There are several favorable characteristics that make CO2 an
attractive solvent for the synthesis and processing of high-quality materials, as previously
described.[39, 40]
TiO2 itself is an oxidized metal and a highly radiopaque material.[41] Moreover, TiO2
nanorods/fibers have a high aspect ratio and high surface area to volume ratio, and their
incorporation into cement formulation may lead to significantly enhanced mechanical
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properties.[42, 43] Besides, TiO2 has shown excellent in vitro apatite-forming ability and
in vivo osteoconductivity.[41, 44] On the other hand, strontium is currently included as a
radiopacifier in some commercially available dental cement brands improving their antibacterial effectiveness.[35] Therefore, the Sr-doped TiO2 nanoparticles synthesized in
this study are expected to provide reasonably higher radiopacity and also mechanical
characteristics to the PPF matrix. In addition, to avoid the problem of phase separation
and agglomeration of nanofillers in the polymer matrix and improve the compatibility
between PPF and nanofillers, the polyester matrix was functionalized using maleic
anhydride through the alcoholytic ring opening reaction, which produces carboxyl groups
at each end point of the polymer for coordination onto the Sr2+-doped n-TiO2.[42] The
hypothesis of this study is that Sr2+-doped TiO2 rods/fibers added to the functionalized
PPF matrix will significantly enhance its mechanical properties and radiopacity as well as
the angiogenesis characteristics provided by ginsenoside Rg1.

3.2 Experimental details
3.2.1

Materials

Titanium isopropoxide (TIP, 99.999%), glacial acetic acid (>99.7%), zirconium (IV)
propoxide solution 70 wt. % in 1-propanol (ZPO), barium sulfate (BaSO4, 99%),
strontium nitrate (Sr(NO3)2, ≥99.0%) were received from Sigma-Aldrich Canada. A stock
solution of Sr(NO3)2 in water was prepared by dissolving strontium nitrate (6.6 g) in 10
mL of double distilled water, which was generated from Milli-Q water purification
system (18.2

Ω·cm resistivity, Barnstead EasyPureII, Thermo Scientific, USA).

Diethyl fumarate (98%), propylene glycol (1,2-Propanediol) (≥99.5%), zinc chloride
anhydrous (ZnCl2, ≥99.995%), hydroquinone (99%), maleic anhydride (95%), 4dimethylaminopyridine (DMAP), hydrochloric acid (37%), anhydrous magnesium sulfate
(≥99.0%), diethyl ether anhydrous (≥99.0%), anhydrous methylene chloride (DCM,
≥99.8%), anhydrous tetrahydrofuran (THF, ≥99.9%), benzoyl peroxide (BPO), Ndimethyl-p-toluidine (DMT), and 0.1 mol/L phosphate-buffered saline solution (PBS, pH
7.4) were purchased from Sigma-Aldrich Canada and used as received. Calcium nitrate
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tetrahydrate (Ca(NO3)2.4H2O), diammonium hydrogen phosphate ((NH4)2HPO4),
cetyltrimethylammonium bromide (CTAB), polyethylene glycol (PEG 600), ammonium
hydroxide (NH4OH, 30%), and anhydrous ethanol (EtOH) were also obtained from
Sigma-Aldrich, Canada and used with no further purification. Instrument grade carbon
dioxide (99.99%) was obtained from BOC Canada. Ginsenoside Rg1 was donated by Dr.
Edmund Lui, Department of Physiology and Pharmacology, the University of Western
Ontario, London, Canada. Human umbilical vein cell lines (EA.hy926) were provided by
Dr. Jeff Dixon, Department of Physiology and Pharmacology, the University of Western
Ontario, London, Canada. Growth factor-reduced Matrigel was purchased from VWR.
Cell culture medium and reagents were purchased from Gibco laboratories (USA).

3.2.2

Characterization

Scanning electron microscopy (SEM) images were collected using a Leo(Zeiss) 1540XB
SEM. Imaging was performed at either low voltage (1 kV) for morphology or at 10 kV
for backscatter imaging. Samples were prepared by applying the powder directly to a
carbon adhesive tape, and coated with 5 nm of osmium metal in a Filgen OPC80T. The
bulk composition was analyzed using energy-dispersive Quartz XOne x-ray spectroscopy
(EDX) attached to a Hitachi S-4500 field emission scanning electron microscopy to
investigate the dispersion of Sr2+ in the n-TiO2. EDX analysis was performed by taking
spectra at three different sites in the sample. For studying the fracture surface, samples
were broken by submersing in liquid nitrogen in a stainless steel mortar and broken with
a stainless steel pestle.
To identify the functional chemical groups in the synthesized polymer and coordination
of carboxylate groups to Sr-doped n-TiO2 in the Sr2+-TiO2/PPF nanocomposites,
attenuated total reflection-Fourier transform infrared (ATR-FTIR) spectra were measured
using a Nicolet 6700 FTIR spectrometer (Thermo Scientific) equipped with a smart iTR
(diamond ATR). The spectra were recorded in the range of 600-4000 cm-1 with a
resolution of 4 cm-1 over 32 scans. Structural analysis of the Sr-doped TiO2 particles was
performed using an x-ray powder diffractometer (Rigaku Miniflex XRD, TX, USA),
fitted with a rotating sample holder, a scintillation counter detector and a divergent beam
utili ing a CuKα source of x-rays (λ=1.5418A°). X-ray photoelectron spectroscopy
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(XPS) analyses were carried out with a Kratos AXIS Ultra spectrometer using a
monochromatic Al K(α) source (15mA, 14kV). Samples were placed on a carbon-based
double-sided adhesive tape for analysis. The Kratos charge neutralizer system was used
on all specimens. Survey scan analyses were carried out with an analysis area of 300 µm
× 700 µm and a pass energy of 160 eV. High resolution analyses were carried out with an
analysis area of 300 µm × 700 µm and a pass energy of 20 eV. Spectra were charge
corrected to the main line of the carbon 1s spectrum set to 284.8 eV. Spectra were
analyzed using CasaXPS software (version 2.3.14).
Thermogravimetric analysis (TGA) was performed using a TA Q500 TGA at a heating
rate of 10 ºC/min under an inert (nitrogen) atmosphere.
Mechanical tensile properties were measured using an Instron 5943 universal testing
machine (Instron, Canton, MA) equipped with a 500 N (tension) load cell. Tensile testing
was conducted in accordance with ASTM D638-91a. Dogbone specimens with overall
length of 60 mm and width of grip section of 10 mm were used for tensile testing. Stressstrain relationship was obtained from the load and displacement data. Young’s modulus
was determined by calculating the slope of the linear portion of the stress-strain curve,
and tensile strength was defined as the maximum applied stress prior to failure. For each
group, 5 independent specimens (n=5) were tested in tension at a cross-head speed of 10
mm/min. Flexural strength and flexural modulus of the nanocomposites were determined
in accordance with ASTM D790M-92 using a dynamic mechanical analyzer, DMA Q800
(TA instruments). Flexural testing samples, rectangular bar specimens (n=5) (50 mm  25
mm  2 mm), were placed on a three-point bending apparatus with two supports spanning
40 mm from each other and loaded at the cross-head speed of 10 mm/min to the center of
each specimen until failure. In an approach similar to that of tensile testing, flexural
modulus was calculated as the slope of the initial linear region of the stress-strain curve,
while flexural fracture strength was determined as the maximum applied stress prior to
failure.
The radiopacity of the bone cement composites reinforced n-TiO2 nanotubes/nanofibers,
ZrO2-modified TiO2 nanofibers, Sr-doped TiO2 nanofibers, and hydroxyapatite nanorods,
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as well as the control (crosslinked unfilled PPF and specimen containing BaSO4 as
radiopacifier) was determined in terms of equivalent aluminum thickness according to a
technique introduced by Amirouche et al.[45] using rectangular specimens (n = 5) (30
mm  3 mm  2 mm) with a dental X-ray source (accelerating voltage: 40 kVp, intensity:
0.1 mAs, source-to-film distance: 80 cm, and exposure time: 1 ms). To measure
radiopacity, specimens were placed on a medical X-ray film along with a high-purity
aluminum (Al) step-wedge of varying thickness from 0.5 to 5.0 mm with increments of
0.5 mm. To minimize back-scatter, the X-ray film was positioned on a sheet of lead, and
a standard dental X-ray source was positioned perpendicularly to the radiographic film.
Following standard techniques, the films were developed in an automatic X-ray
processor. Then, a transmission densitometer was employed to measure the optical
density of each material image on the film. Five readings were taken for each image of
each material as well as for each step of the Al step-wedge, and the average of these five
readings was calculated. The optical density data obtained from the Al step-wedge
images were used to construct a calibration curve of optical density of aluminum as
function of its thickness. Finally, the radiopacity of bone cement specimens was
expressed in terms of the equivalent thickness of aluminum (mm Al) per unit thickness of
material, deducted in reference to the calibration curve of the radiographic optical density
of the Al step-wedge.
For the drug release assay, bone cement composite samples (30 mm  3 mm  2 mm) of
optimal formulation were loaded with the angiogenic agent, ginsenoside Rg1, and
immersed in 10 mL of pH 7.4 phosphate-buffered saline (PBS) in a small vial and
incubated at 37 °C. At specific time points, 2 ml of the extract was collected and replaced
with 2 ml fresh PBS. The collected supernatant was stored at -20 °C. After all the
samples were collected, the absorption at 189 nm wavelength was measured using a UVVis spectrophotometer (Shimadzu UV-Vis 3600) to determine the amount of ginsenoside
Rg1 within the bone cement composites. Cumulative release of ginsenoside Rg1 profiles
were acquired with the volume loss correction and plotted against time. All the
experiments were repeated in triplicate for each time interval. Collected extracts were
also used for following bioassay studies.
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In order to measure angiogenic activity of ginsenoside Rg1 before incorporation into and
after release from the bone cement composites, tube formation bioassays were performed
using the EA.hy926 cell line derived from the fusion of human umbilical vein endothelial
cells (HUVEC) with the A549 human pulmonary adenocarcinoma cell line. EA.hy926
cell line was used to show the ability to attach, migrate, and form tubular structures after
seeding on a Matrigel substrate. EA.hy926 cell lines were cultured in Dulbecco’s
modified Eagle medium (DMEM) supplemented with ECGS (20 mg/ml), 10% fetal
buvine serum (FBS), 1% antibiotic, and 1 ml (5X) per 50 ml of medium Hat media
supplement. The cells were grown at 37 °C in humidiﬁed air with 5% CO2 incubator.
When the cell cultures were 80-90% confluent, cells were harvested following trypsin
treatment and released cells were resuspended to the cell density required for tube
formation assay. To examine the angiogenic activity of ginsenoside Rg1 in vitro, tube
formation bioassay was performed on 96-well tissue culture plates coated with 10 mL of
growth factor-reduced Matrigel per well. An amount of 4.5×104 cells/well of EA.hy926
cell line was seeded on the Matrigel-coated plate loaded with medium and various
concentrations of ginsenoside Rg1 before incorporation into the bone cement composites
and after release from the bone cement formulations. After incubation for eighteen hours,
images from a total of ﬁve microscopic ﬁelds per well were captured by an inverted
microscope (Nikon TMS, Japan) using a 40x objective. The angiogenic effect was
estimated by counting the branch points of the formed tubes, and the average numbers of
branch points were calculated. Each experiment is repeated at least three times, with each
experiment yielding essentially identical results. Data were expressed as mean ± standard
deviation (SD).
All the mechanical property measurements and bioassay experiments were conducted in
quintuplicate and triplicate, respectively, and were measured with statistical analyses
accomplished using GraphPad prism 4.0a Software (GraphPad Software Inc., USA). The
data were expressed as mean ± SD.

81

3.2.3

Preparation of materials

3.2.3.1

Synthesis of Sr-doped TiO2 nanotubes/fibers via sol-gel reaction
in scCO2

The schematic diagram of the experimental setup and details of the synthesis procedure
can be found in Sui’s work.[46] To synthesize the Sr-doped TiO2 in scCO2, a 10 mL
stainless steel view cell was connected to a syringe pump for pumping CO2. In a typical
experiment, titanium isopropoxide (1 g) was quickly placed in the view cell, followed by
addition of an aqueous Sr(NO3)2 (5 wt% of the TIP concentration, 0.05 g or 20 wt% of
the TIP concentration, 0.2 g), acetic acid (6 g), and CO2 to the desired pressure and
temperature. A magnetic stirrer was used for mixing the reaction mixture. It was found
that the mixture of strontium nitrate/water, titanium isopropoxide, and acetic acid was
miscible with CO2 at 60 °C and 6000 psig pressure. Stirring was stopped after 24 h, and
6-7 days of aging were required for complete reaction. After aging, the formed gel was
washed continuously using 80 ml of CO2 at a rate of approximately 0.5 mL/min, followed
by controlled venting at 0.5 mL/min to prevent collapse of the solid network. The asprepared powder was calcined at 450 °C in air for 2 h using a heating rate of 10 °C/min,
and the cooling rate to room temperature was 0.5 °C/min. The calcined powder was kept
in a vacuum oven at 80 °C to remove moisture.

3.2.3.2

Synthesis of other radiopacifiers: TiO2 nanotubes/nanofibers,
ZrO2-modified TiO2 nanofibers, and hydroxyapatite nanorods

For comparative radiopacity measurements, nano-structured TiO2, ZrO2-modified TiO2,
and hydroxyapatite were also synthesized. TiO2 nanoparticles were prepared using the
method described in Salarian et al.[42] Briefly, titanium isopropoxide (1 g) was quickly
placed in a 10-mL view cell, followed by adding acetic acid (4 g). CO2 was then added to
the view cell up to 6000 psig pressure while increasing the temperature to 60 °C. After
stirring for 24 h and four days of aging, the formed gel was washed continuously using
80 mL of CO2, followed by controlled venting. The as-prepared powder was calcined at
450 °C in air for 2 h and kept in a vacuum oven at 80 °C.
ZrO2-modified TiO2 nanoparticles were synthesized and loaded within the bone cement
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composite. To synthesize ZrO2-modified TiO2, in a typical experiment, TIP (1 g) was
quickly placed in the view cell, followed by addition of acetic acid (6 g), ZPO (0.5 g) and
CO2 up to the desired temperature (60 °C) and pressure (6000 psi), and a magnetic stirrer
system was used for mixing the reaction mixture. The aging, washing, and calcination
were conducted following the reported procedure for the synthesis of Sr-doped TiO2
nanoparticels.
In addition, nanorods of hydroxyapatite were prepared following the experimental
procedure introduced in Salarian et al.[47] Briefly, 0.03 mole of (NH4)2HPO4 and 0.021
mole of CTAB were dissolved completely in 125 ml of deionized water, and stirred with
a magnetic stirrer for 30 min. Then, the pH value was adjusted to 4.5 by adding pure
acetic acid. Next, 0.05 mole of Ca(NO3)2.4H2O was dissolved in 175 ml of deionized
water, and PEG 600 (20 wt%) was added to the solution under constant stirring for 30
min. After that, the mixed solution of Ca(NO3)2.4H2O and PEG 600 was added to the
latter dropwise under continuous magnetic stirring in air, and the pH value of reaction
solution was adjusted to 11 using ammonia. The final milky suspension was transferred
to a stainless steel autoclave; sealed tightly, and hydrothermally treated in an oven at 120
°C for 22 h. The precipitates were separated from the suspension by centrifuging, washed
three times with ethanol and three times with deionized water, and freeze-dried to yield
white powder.

3.2.3.3

Synthesis and functionalization of PPF

PPF was synthesized using a two-step transesterification method[48] and functionalized
using a recently introduced method by Salarian et al.[42] Figure 3.1 displays the synthetic
scheme for the preparation and funtionalization of PPF and the synthesis of Sr2+TiO2/PPF nanocomposite and bone cement composite. In a typical experiment, diethyl
fumarate and propylene glycol were reacted in an inert atmosphere. Additionally, ZnCl2
and hydroquinone were added as a catalyst and a crosslinking inhibitor, respectively. The
first step of the reaction occurred with a gradual increase in temperature from 110 to 150
ºC resulting in the production of bis(hydroxypropyl) fumarate intermediate and ethanol,
which was collected as a distillate. This step was terminated when ~ 90% of the
theoretical yield of ethanol was collected. The second step of the reaction,
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transesterification of the bis(hydroxypropyl) fumarate intermediate, was conducted under
reduced pressure (<1 mm Hg) with a gradual increase in temperature from 100 to 150 ºC
producing propylene glycol as a byproduct. The reaction proceeded until the desired
molecular weight of PPF was obtained. The polymer product was then purified by several
acid washes with 1 N HCl, two washes with distilled water, and two washes with brine.
After drying with magnesium sulfate, the polymer was concentrated by rotoevaporation
and then precipitated in ethyl ether. The ethyl ether was decanted and the purified
polymer was vacuum dried to remove any residual solvent.
In order to functionalize PPF chain with maleic anhydride, PPF was dissolved in
anhydrous dichloromethane, and DMAP was added to the solution under argon, followed
by reacting with maleic anhydride with constant stirring for 24 h at room temperature.
The product was then washed with 1 N HCl solution and distilled water. Magnesium
sulfate was used to absorbed water. Finally, the solvents were removed from the product
by rotary evaporation and reduced pressure to afford maleic anhydride-functionalized
PPF. The obtained MA-PPF was well characterized in Salarian et al.[42]
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Figure 3.1. Synthetic scheme for the preparation and functionalization of PPF and the
synthesis of Sr2+-TiO2/PPF nanocomposite and bone cement composite.
Reagents and conditions: (a) propylene glycol, ZnCl2, hydroquinone; (b) ZnCl2,
hydroquinone; (c) maleic anhydride, DMAP, DCM; (d) Sr-doped TiO2, THF; (e) N-VP,
BPO, DMT, w/wo ginsenoside Rg1.
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3.2.3.4

Synthesis of Sr2+-TiO2/PPF nanocomposites

To prepare Sr2+-TiO2/PPF nanocomposites, 0.5, 1, 1.5, or 2 wt% of the synthesized Srdoped TiO2 nanofibers (0.005, 0.01, 0.015, or 0.02 g) were dispersed in 20 mL of THF
with the aid of ultrasonic agitation for 1 h, followed by reacting with the above
synthesized MA-PPF (1 g) at 70 °C under argon with constant stirring for 24 h. After
filtering off the solvent and the unreacted MA-PPF, the product was further purified by
dispersion in THF, centrifugation, and removal of the supernatant. This purification
process was repeated several times until the supernatant became clear. Finally, the
resulting solid product was dried at 55 ºC under vacuum overnight. The composition of
the synthesized nanocomposites and the Sr-doped TiO2 concentration in each
nanocomposite formulation reviewed by TGA analysis are presented in Table 3.1.
Table 3.1. Formulation of the Sr2+-TiO2/PPF nanocomposites.

MA-PPF
(g)

Sr-doped TiO2 (g)

*Content of Sr-doped TiO2 in
the synthesized nanocomposite

Sample Name

1g

0.005 g (synthesized from
20 wt% Sr(NO3)2)

5 wt%

Sr2+-TiO2/PPF
nanocomposite-1

1g

0.01 g (synthesized from 20
wt% Sr(NO3)2)

9 wt%

Sr2+-TiO2/PPF
nanocomposite-2

1g

0.015 g (synthesized from
20 wt% Sr(NO3)2)

14 wt%

Sr2+-TiO2/PPF
nanocomposite-3

1g

0.02 g (synthesized from 20
wt% Sr(NO3)2)

18 wt%

Sr2+-TiO2/PPF
nanocomposite-4

1g

0.01 g (synthesized from 5
wt% Sr(NO3)2)

9 wt%

Sr2+-TiO2/PPF
nanocomposite-5

Note: *the weight percentage of nano-Sr-doped TiO2 in each Sr2+-TiO2/PPF
nanocomposite is obtained from the TGA analysis.

3.2.3.5

Synthesis of bone cement composites

For preparation of bone cement composites, Sr2+-TiO2/PPF nanocomposite (1 g) was
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mixed with N-VP (0.4 g) for 2 h. The initiator, BPO, was dissolved in 250 μL of N-VP.
Then, 50 μL of BPO solution was added into Sr2+-TiO2/PPF nanocomposite solution and
mixed thoroughly into a paste formation. Afterwards, 40 μL of accelerator solution (20
μL of D T in 980 μL of dichloromethane) was added with rapid mixing to accelerate the
cross-linking reaction. The resulting paste was placed in a Teflon mold, then loaded in an
oven at 60 °C for 1 h to facilitate crosslinking. After that, the mold was cooled down to
room temperature, and the cross-linked samples were removed from the molds, and used
for mechanical testing and radiopacity measurement analyses.
For comparative mechanical testing, mechanically mixed bone cement composites were
prepared by mechanical mixing of the PPF and Sr-doped TiO2 nanoparticles. Briefly, 1 g
of PPF was mixed with 0.4 g of N-VP followed by adding 0.05 g and 0.09 g of Sr-doped
TiO2 nanoparticles (corresponding to the Sr-doped TiO2 concentration in the Sr2+TiO2/PPF nanocomposite-1 and Sr2+-TiO2/PPF nanocomposite-2, respectively, reviewed
by TGA analysis represented in Table 3.1). Then, BPO and DMT were added and mixed
thoroughly following the explained procedure for the preparation of bone cement
composites. The obtained pastes were molded and samples were used for mechanical
tensile and flexural testing and radiopacity measurements. The compositions of the
prepared mechanically mixed bone cement composites are also listed in Table 3.2.
For comparative radiopacity measurement studies, several PPF bone cement systems
containing different radiopaciers/ additives including TiO2 nanotubes/nanofibers, ZrO2modified TiO2 nanofibers, hydroxyapatite nanorods, and BaSO4 particles were prepared.
Specimens of the bone cement were prepared by mixing of the PPF solution in N-VP (1 g
of PPF dissolved in 0.4 g of N-VP) and TiO2 nanoparticles (0.09 g), ZrO2-modified TiO2
nanofibers (0.09 g), hydroxyapatite nanoparticles (0.09 g), or BaSO4 particles (0.09 g)
(corresponding to the Sr-doped TiO2 concentration in the Sr2+-TiO2/PPF nanocomposite2, reviewed by TGA analysis represented in Table 3.1), respectively. Then, the BPO
solution and DMT were added and mixed thoroughly to prepare bone cement composites.
In addition, for the drug release and tube formation assays, bone cement composites of
optimal formulations were loaded with the angiogenic agent, ginsenoside Rg1. In a
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typical procedure, Sr2+-TiO2/PPF nanocomposite-2 (1 g) was mixed with N-VP (0.4 g).
Next, the ginsenoside Rg1 (0.01, 0.05, and 0.1 g) was added to give a final concentration
of 1, 5, and 10 wt% of the PPF, followed by the addition of BPO (50 μL of BPO
solution). After that, 40 μL of D T solution was used to initiate the crosslinking
reaction. Three different angiogenic bone cement combinations were prepared using the
following ratios: 0.01 g of ginsenoside Rg1 to 1 g of Sr2+-TiO2/PPF nanocomposite, 0.05
g of ginsenoside Rg1 to 1 g of Sr2+-TiO2/PPF nanocomposite, and 0.1 g of ginsenoside
Rg1 to 1 g of Sr2+-TiO2/PPF nanocomposite. The composition of the prepared bone
cement composites are listed in Table 3.2.
Table 3.2. The different compositions for the bone cement composites in each system.
Entry
No.

Sr2+-TiO2/PPF

PPF

Additive

Ginsenoside
Rg1

Formed
Product

1

1g

Crosslinked
PPF

2

1g

Sr-doped TiO2
(0.05 g)

Mechanically
mixed bone
cement-1

3

1g

Sr-doped TiO2
(0.09 g)

Mechanically
mixed bone
cement-2

4

1 g of Sr2+-TiO2/PPF
nanocomposite-1

Bone cement
composite-1

5

1 g of Sr2+-TiO2/PPF
nanocomposite-2

Bone cement
composite-2

6

1 g of Sr2+-TiO2/PPF
nanocomposite-3

Bone cement
composite-3

7

1 g of Sr2+-TiO2/PPF
nanocomposite-4

Bone cement
composite-4

8

1 g of Sr2+-TiO2/PPF
nanocomposite-5

Bone cement
composite-5
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9

1g

TiO2 (0.09 g)

TiO2-loaded
bone cement

10

1g

ZrO2-modified
TiO2 (0.09 g)

ZrO2-TiO2loaded bone
cement

11

1g

hydroxyapatite
(0.09 g)

HAp-loaded
bone cement

12

1g

BaSO4 (0.09 g)

BaSO4loaded bone
cement

13

1 g of Sr2+-TiO2/PPF
nanocomposite-2

0.01 g

Rg1-loaded
bone cement
composite-1

14

1 g of Sr2+-TiO2/PPF
nanocomposite-2

0.05 g

Rg1-loaded
bone cement
composite-2

15

1 g of Sr2+-TiO2/PPF
nanocomposite-2

0.1 g

Rg1-loaded
bone cement
composite-3

Note: Additionally, 0.4 g of N-VP, 50 μL of BPO solution, and 40 μL of D T solution
were added in the preparation of these materials.

3.3 Results and Discussion
3.3.1

X-ray diffraction analysis of Sr-doped TiO2 nanoparticles
synthesized in supercritical CO2

XRD analysis was used to investigate the effect of the dopant composition on the phase
structure. Typical XRD patterns of the TiO2, ZrO2-modified TiO2, and Sr-doped TiO2
particles synthesized in scCO2 are illustrated in Figure 3.2. In the XRD pattern of the
TiO2 particles (Figure 3.2a) all diffraction peaks in the range of 20o < 2θ < 80o
correspond to the 101, 004, 100, 200, 105, 211, 204, 116, 220, and 215 reflections of
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anatase crystal structure of TiO2.[49] The as-prepared materials were amorphous, while
after calcination at 450 °C the material reorganized itself, and the anatase particles began
to grow, resulting in the crystalline material. The XRD pattern of ZrO2-modified TiO2
powder (Figure 3.2c) indicates that the ZrO2-TiO2 nanofibers consist of anatase crystals,
with no rutile phase. A new peak appeared at 2 = 30.4°, which is assigned to zirconium
titanium oxide (ZrTiO4).[50] In the XRD pattern of Sr-doped TiO2 nanoparticles shown
in Figure 3.2b, all peaks correspond to anatase phase, which indicates that the as-prepared
materials transferred from the amorphous to anatase phase during heat treatment. In
addition, there was no distinct SrO peak indicating no phase separation,[51] and that the
SrO is well-integrated into the anatase crystal structure for both investigated
compositions. It is also believed that it is difficult for the Sr2+ ion to enter the TiO2 lattice,
as its ionic radius is too high (1.12 Å) compared to Ti4+ (0.605 Å).[38] Therefore, it is
very difficult to predict whether Sr2+ exists as Sr-O on the surface of TiO2 or as SrTiO3
from the XRD pattern owing to the low dopant concentration.

Figure 3.2. Powder XRD spectra of (a) TiO2, (b) Sr-doped TiO2 synthesized using 20
wt% of Sr(NO3)2, and (c) ZrO2-modified TiO2 nanofibers.
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3.3.2

Scanning electron microscopy (SEM) and energy-dispersive Xray spectroscopy (EDX) analyses of Sr-doped TiO2
nanoparticles synthesized in supercritical CO2

The morphology and size of the calcined Sr-doped TiO2 synthesized in scCO2 with two
different dopant concentrations were characterized by SEM analysis. The presence of
Sr2+ in the TiO2 matrix results in the formation of rod-like and fiber-like structures
regardless of the dopant concentrations. However, a higher amount of Sr2+ precursor (20
wt% of Sr(NO3)2 solution) increased the mean particle size to 60-100 nm in diameter, as
can be seen in Figure 3.3a. Using a lower concentration of the same precursor (5 wt% of
Sr(NO3)2 solution), nanoparticles with typical diameters of about 30-60 nm and an
increased aspect ratio of about 40-50 (Figure 3.3b) were formed. EDX elemental analysis
was also performed to investigate the bulk atomic composition of the elements in the
synthesized Sr-doped TiO2 particles. EDX spectra of the two samples are presented in
Figure 3.3c & d. Carbon, oxygen, strontium, and titanium are evident in both cases, with
the elemental compositions of the two Sr-doped TiO2 samples along with the standard
deviation being provided in Table 3.3. It has been revealed that the amount of strontium
was less when the smaller amount of dopant was used. In addition, the atomic
composition of strontium is less than the atomic composition of Sr in the starting
precursor mixture; for example, Sr atomic% of 3.0 ± 0.1 was observed for the 20 wt% Srdoped TiO2. This indicates that not all Sr(NO3)2 (Sr2+) was integrated into the product,
and this free Sr2+ not integrated into the nanofibers are believed to be washed away
during the washing steps using CO2. The carbon in these samples arose from the reaction
under scCO2, unreacted acetic acid, and washing with scCO2.
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Figure 3.3. SEM images of (a) the 5 wt% Sr-doped TiO2 and (b) the 20 wt% Sr-doped
TiO2 and EDX Spectra of (c) the 5 wt% Sr-doped TiO2 and (d) the 20 wt% Sr-doped
TiO2.
Table 3.3. Elemental composition of Sr-doped TiO2 nanofibers (n = 3, mean ± SD).
Atomic %
Ti

O

Sr

C

5 wt% Sr-doped TiO2

18.6 ± 1.2

57.6 ± 1.7

1.6 ± 0.1

22.2 ± 0.1

20 wt% Sr-doped TiO2

15.2 ± 2.3

59.5 ± 1.3

3.0 ± 0.1

22.3 ± 0.1

3.3.3

X-ray photoelectron spectroscopy (XPS) measurement of Srdoped
TiO2
and
Sr2+-TiO2/PPF
nanocomposites
nanocomposites

X-ray photoelectron spectroscopy (XPS) was used to elucidate both the TiO2 structure
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and the chemical state of the Sr2+-doped TiO2 particles. In the recorded survey spectrum
for the Sr-doped TiO2 (prepared from 20 wt% of Sr(NO3)2 solution), the expected peaks
for O, C, Ti, and Sr were detected (Figure 3.4a). The high resolution XPS scan of the Ti
2p region of Sr-doped TiO2 shows two peaks (Figure 3.4c), the Ti 2p3/2 peak at 458.6 and
the Ti 2p1/2 peak at 464.3 eV binding energy, which are attributed to Ti in the 4+
state.[52] The O 1s XPS spectrum has two peaks (Figure 3.4b), with the first at 529.8 eV
assigned to the lattice oxygen atoms TiO2 (Ti-O bonds), and the second at 531.0 eV being
due to surface hydroxyl and defective oxide sites.[52] Besides, in the core level spectrum
of Sr 3d, the Sr 3d5/2 peak shows a binding energy of 133.5 eV, which can be assigned to
SrTiO3 (Figure 3.4d).[53]
In the high resolution XPS scan of the C 1s region of non-crosslinked Sr2+-TiO2/PPF
nanocomposite (Figure 3.4e), the three major carbon peaks are observed with binding
energies of 284.8, 286.3, and 288.9 eV, which correspond to aliphatic carbon (C–C, CH), alcohol and ether functionality (C–OH, C–O–C), and ester and carboxylic acid type
functionality (O–C=O), respectively.[54] In addition, a peak appearing at 287.8 eV is
assigned to the C atom of the carbonyl group from the successful covalent interaction of
carboxylate to Sr-doped TiO2.[42, 55, 56] The high resolution O 1s spectrum of noncrosslinked Sr2+-TiO2/PPF nanocomposite (Figure 3.4f), shows three different peaks at
binding energies of 529.4, 531.9, and 533.3 eV, attributable to the lattice oxygen atoms in
TiO2 (Ti-O bonds),[52] O–C=O*, and O*–C=O, respectively (* denotes the O of
interest).[54] Furthermore, the core level spectrum of Ti 2p for the non-crosslinked Sr2+TiO2/PPF nanocomposite (Figure 3.4g) could be resolved into two spin-orbit pairs of
2p3/2 and 2p1/2 with binding energies of 458.1 and 463.8 eV, respectively, attributable
to Ti4+ implying that the chemical state of titanium remains as Ti4+ that the chemical state
of titanium remains as Ti(IV)(TiO2), and does not change to Ti(II) and Ti(III) species.[42,
57] In addition, in the high resolution XPS scan of the Sr 3d region (Figure 3.4h), the two
peaks at binding energies of 133.1 and 135 eV are evident, which were observed for the
Sr-doped TiO2 nanoparticles. Therefore, the XPS results confirm the successful
coordination of MA-PPF to the surface of Sr-doped TiO2 nanofibers without changing the
oxidation state of nano Sr2+-doped TiO2, which indicates that any other Ti(II) and Ti(III)
oxides, TiO and Ti2O3, were not formed.
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Figure 3.4. (a) XPS full-scan spectrum of the Sr-doped TiO2 nanoparticles, high
resolution XPS record of O 1s region (b), high resolution XPS scan of the Ti 2p region
(c), and high resolution XPS scan of the Sr 3d region (d) of the Sr-doped TiO2
nanoparticles and high resolution XPS record of the C 1s region (e), high resolution XPS
record of the O 1s region (f), high resolution XPS scan of the Ti 2p region (g), and high

94

resolution XPS scan of the Sr 3d region (h) of the Sr2+-TiO2/PPF nanocomposite-3.

3.3.4

Fourier transform infrared (FTIR) spectroscopy of Sr2+TiO2/PPF nanocomposites

The FTIR spectra of TiO2 nanoparticles, Sr-doped TiO2 nanoparticles, PPF, noncrosslinked Sr2+-TiO2/PPF composite, and crosslinked bone cement composite-1 were
measured and compared. There was no significant difference between the spectra of TiO2
nanoparticles and Sr-doped TiO2 nanoparticles in the wavenumber range of 600-4000 cm1

(data not shown). This is because SrO2 vibrations occur only below 350 cm-1.[38] The

FTIR spectra of PPF, non-crosslinked Sr2+-TiO2/PPF composites, and cross-linked Sr2+TiO2/PPF bone cement composites are compared in Figure 3.5. PPF exhibits several
major characteristic peaks at 1713, 1645, 1251, and 1148 cm-1 (Figure 3.5a), attributed to
the C=O stretching, C=C stretching, asymmetric C-O-C stretching, and symmetric C-O-C
stretching bands, respectively. These characteristic peaks are evident in the FTIR
spectrum of non-crosslinked Sr2+-TiO2/PPF composites (Figure 3.5b), indicating the
well-preserved C=C groups during the functionalization of Sr2+-TiO2 using MA-PPF. In
addition, the FTIR spectrum of the non-crosslinked Sr2+-TiO2/PPF composites exhibits
new peaks at 1568, 1379, and 1173 cm-1. These peaks are assigned to the bridging or
chelating bidentate coordination between titanium atoms and the carboxyl groups. The
band separation (Δυ=395 cm-1) between 1568 and 1173 cm-1 falls into the monodentate
range (350-500 cm-1) while another band separation (Δυ=189 cm-1) between 1568 and
1379 cm-1 might be indicative of a structure of bridging bidentate (150-180 cm-1).[58]
These bands confirmed the coordination of the PPF-g-MA (functionalized PPF) with Srdoped TiO2. These coordination peaks appear in the FTIR spectrum of cross-linked Sr2+TiO2/PPF bone cement composites (Figure 3.5c), suggesting the well-preseved
coordination bonds during the crosslink reaction. The disappearance of the peak at 1645
cm-1 in Figure 3.5c confirmed the cross-link reaction where the C=C double bonds were
consumed.
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Figure 3.5. ATR-FTIR spectra of (a) PPF, (b) Sr2+-TiO2/PPF nanocomposite-3, and (c)
crosslinked bone cement composite-3.

3.3.5

TGA

In order to determine PPF attachment to the surface of Sr-doped TiO2 nanofibers and
investigate the effect of PPF functionalization on the thermal stability of the proposed
Sr2+-TiO2/PPF nanocomposites, thermogravimetric analysis (TGA) was performed on the
non-crosslinked PPF, crosslinked PPF, non-crosslinked Sr2+-TiO2/PPF nanocomposites,
and crosslinked Sr2+-TiO2/PPF bone cement composites. The sample of Sr2+-TiO2/PPF
nanocomposite-3 displayed a weight loss of 80% compared to the calcined Sr-doped TiO2
nanofibers with a weight loss of 3%. Therefore, it can be concluded that PPF
functionalization allowes a relatively high number of polymer chains to be attached to the
surface of Sr-doped TiO2 nanofibers, resulting in an increased weight loss for the Sr2+TiO2/PPF nanocomposite-3. A typical DTG curve of the unfilled PPF and Sr2+-TiO2/PPF
nanocomposite appears to have two degradation steps (Figure 3.6B), amongst which the
main peak (at 330-360 °C) is attributed to the scission of the polymer chains attached to
the Sr-doped TiO2 nanoparticles. For the Sr2+-TiO2/PPF nanocomposite-3, this peak is
shifted to a higher temperature by 7 ºC, which is attributed to the polymer chains being
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chemically attached to the nanofibers. The higher thermal dissociation temperature
revealed from the TGA results of the nanocomposites is attributed to the excellent
chemical interaction of nano-Sr-doped TiO2 and functionalized polymer chains,
providing a barrier effect to the polymer molecules evaporated during the thermal
degradation of the nanocomposites.

A

B

Figure 3.6. (A) TGA curves of: (a) TiO2, (b) PPF, (c) crosslinked PPF, (d) Sr2+TiO2/PPF nanocomposite-3 (synthesized using 1 g of MA-PPF and 0.015 g of Sr-doped
TiO2), and (e) crosslinked bone cement composite-3 (made of 1 g of Sr2+-TiO2/PPF
synthesized using 0.015 g of Sr-doped TiO2). (B) Derivative thermogravimetric (DTG)
curves of: (a) PPF, (b) crosslinked PPF, (c) Sr2+-TiO2/PPF nanocomposite-3 (synthesized
using 1 g of MA-PPF and 0.015 g of Sr-doped TiO2), and (d) crosslinked bone cement
composite-3 (made of 1 g of Sr2+-TiO2/PPF synthesized using 0.015 g of Sr-doped TiO2).

3.3.6

Mechanical testing (tensile and flexural strength and modulus)

Figure 3.7 summarizes the results of the tensile and flexural moduli and strengths of the
bone cement composites tested in this work. Bone cement composites prepared using Srdoped TiO2 nanoparticles showed no significant difference in flexural modulus and
strength compared to composites prepared using TiO2 nanofibers. The flexural modulus
of crosslinked PPF alone is 365 ± 66 MPa. With a loading of 0.5 wt % in the starting
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composition, bone cement composites-1 exhibited a flexural modulus of 1062 ± 90 MPa,
representing a roughly 3-fold increase compared to crosslinked PPF. The flexural
modulus increased to a maximum (1176 ± 152 MPa) and then slowly decreased with
increased Sr-doped TiO2 nanoparticles loading. Flexural strength of the reinforced bone
cement composites exhibits similar behavior as in the case of Flexural modulus with bone
cement composite-2 exhibiting a nearly 2.5-fold increase in the flexural strength (Figure
3.7d). Similar to the flexural modulus, a significant decrease in flexural strength was also
observed between the 0.5 and 2 wt % loadings. Flexural moduli and strengths of
reinforced bone cement composites are mainly influenced by the transfer of applied load
from matrix to filler.[33] The effectiveness of load transfer is controlled by a number of
factors such as distribution and orientation of fillers within the matrix and most
importantly interfacial shear strength between the fillers and matrix. In the case of one
dimensional nano-fillers (Sr-doped TiO2 nanofibers), the load is transferred from the
matrix to the filler via interfacial shear stresses between the two phases.[59]
Functionalization of PPF establishes an enhanced chemical bonding between the Srdoped TiO2 nanofibers and matrix, which ensures stronger interfacial shear strength
between the fillers and matrix, allowing flexural stress to be more effectively transferred
from the matrix to the filler and vice versa.[60] Therefore, bone cement composites
significantly exceeded the enhancements observed for the mechanically mixed
composites at the same loading concentration. In addition, bone cement composites-3
loaded with 14 wt% Sr-doped TiO2 nanofibers, demonstrated lower flexural properties,
which is partly due to the agglomeration of nanofibers as shown by arrows in Figure 8e.
The Young’s modulus of crosslinked PPF is 228 ± 46 MPa. The Young’s modulus values
of crosslinked composites increased with the initial low concentrations of Sr-doped TiO2
nanofibers, peaked for bone cement composite-2 and bone cement composite-3, and then
decreased at higher loading concentrations. Tensile strength showed little variation
between different cement formulations; however, a noticeable trend was observed with
respect to loading concentration (Figure 3.7b). The tensile strength starts decreasing with
increased loading of Sr-doped TiO2 nanofibers over 1 wt% in the starting composition,
which is also attributed to the observed agglomeration of nanofibers in the cement matrix.
The SEM micrographs of the fracture surfaces of the unfilled PPF and the bone cement
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composite-2 loaded with 9 wt% Sr-doped TiO2 nanofibers are shown in Figure 3.8. The
plain crosslinked PPF exhibits a smooth plain surface (Figure 3.8a), while the bone
cement composite-2 shows a rough surface (Figure 3.8b) with a certain amount of Srdoped TiO2 nanofibers “pull out” occurring within the fractured plane of the composite
(Figure 3.8d). These partially pulled out nanofibers can take part in bridging the crack
during propagation.[61] In addition to the strong interfacial adhesion between the fibers
and the matrix resulting from the chemical bonding through the carboxylic group, Srdoped TiO2 fibers are dispersed homogeneously throughout the bone cement composite-2
(Figure 3.8c), when reacted to the PPF after being functionalized.

Figure 3.7. Mechanical properties of cross-linked bone cement composites as a function
of the Sr-doped TiO2 nanofibers concentration.
(a) Young's modulus, (b) tensile strength, (c) flexural modulus, and (d) flexural strength.
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Figure 3.8. SEM images of the fracture planes of: (a) crosslinked unmodified PPF, (b-d)
bone cement composite-2, and (e) bone cement composite-3 (the arrows show Sr-doped
TiO2 nanofibers are agglomerating at higher concentrations within the polymer matrix).
It has been believed that drug-loaded cement is mechanically less strong than plain
cement.[62] However, our results show that plain bone cement displays a slightly better
flexural and tensile strength than those of the ginsenoside Rg1-loaded bone cement. For
example, Rg1-loaded bone cement-3 exhibited a Young's modulus and tensile strength of
545.2 ± 86 MPa and 21.3 ± 1.6 MPa and flexural modulus and strength of 1014 ± 105
MPa and 41.5 ± 5.4 MPa, respectively.
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3.3.7

Radiopacity

The radiopacity values in Al equivalent of 1mm specimen thickness for crosslinked
unfilled PPF and bone cement composites loaded with 9 wt% n-TiO2 nanofibers, ZrO2modified TiO2 nanofibers, Sr-doped TiO2 nanofibers, hydroxyapatite nanorods, as well as
BaSO4 particles (corresponding to the Sr-doped TiO2 concentration in the Sr2+-TiO2/PPF
nanocomposite-2 reviewed by TGA analysis represented in Table 3.1) are presented in
Table 3.4. As shown in this Table, crosslinked PPF loaded with 9 wt% BaSO4 exhibits a
radiopacity of 0.36 mm Al, which is the highest value of radiopacity among different
formulations examined in this study, while hydroxyapatite-loaded bone cement
composite exhibits the lowest value of radiopacity, 0.15 mm Al. Moreover, bone cement
composite containing 9 wt% n-TiO2 fibers exhibiting a low level of radiopacity (0.20 mm
Al), which is not significantly different from the unfilled PPF. The bone cement
composite-2 exhibited a slightly higher level of radiopacity (0.32 mm Al) compared to
the composite loaded with ZrO2-modified nanofibers at the same amount of loading
exhibiting a radiopacity of 0.29 mm Al. The bone cement composite-2 increased the
radiopacity of PPF matrix to approximately 88% of the radiopacity shown by the
specimen containing 9 wt% BaSO4, and is deemed sufficient. Besides, it is possible to
integrate more Sr2+ into the TiO2 nanofibers by adjusting the synthesis conditions.
In addition, as shown in Table 3.4, the radiopacity of bone cement composite-2
formulation does not decrease significantly when loaded with 0.1 g of ginsenoside Rg1.
Table 3.4. Radiopacity values (mm Al) of bone cement composites of equivalent Al
thickness (means ± SD).

Sample

Radiopacity (mmA1)

Crosslinked PPF

0.18 ± 0.01

Bone cement composite-1

0.30 ± 0.02

Bone cement composite-2

0.32 ± 0.03

Bone cement composite-3

0.32 ± 0.02
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3.3.8

Bone cement composite-4

0.35 ± 0.04

Bone cement composite-5

0.29 ± 0.03

TiO2-loaded bone cement

0.20 ± 0.01

ZrO2-TiO2-loaded bone cement

0.29 ± 0.01

HAp-loaded bone cement

0.15 ± 0.01

BaSO4-loaded bone cement

0.36 ± 0.03

Rg1-loaded bone cement composite-3

0.30 ± 0.12

Angiogenesis effect/tube formation of HUVEC cell line

Figure 3.9 displays the tube formation of EA.hy926 cell line seeded in a growth factorreduced Matrigel-coated 96-well plate untreated or treated with ginsenoside Rg1 at
different concentrations before and after incorporation into the bone cement composite
formulations. As shown in Figure 3.9a, after seeding for twelve to eighteen hours, the
EA.hy926 cell line aligned and formed tube-like structures on Matrigel. In the presence
of Rg1, the cells formed relatively complete, condensed, and narrow tube-like structures
indicating the proangiogenesis activity of ginsenoside Rg1, as shown in Figure 3.9b-g.
This stimulation occurs in a dose-dependent manner within the dose range of 1-32 μg/ml
Rg1 extract. Therefore, it is concluded that above a concentration of 1 μg/ml, Rg1
significantly stimulated the EA.hy926 cell line to proliferate. It was also found that the
tube formation was considerably augmented in the presence of 8 µg/ml Rg1 (Figure 3.9e),
as cells tend to aggregate to form a denser structure by stimulation of Rg1 leading to
higher area coverage per photographed field.
Tube formation stimulation activity of ginsenoside Rg1 did not change significantly
before and after release from the delivery carrier indicating that the prepared bone cement
composites did not significantly affect the angiogenic activity of Rg1. The extract liquid
in 2 mL of medium from the second day to the third day and from the ninetienth to
twentieth day of release was collected. The concentration of Rg1 in the collected medium
was measured using UV-Vis spectrophotometry. It was found that the Rg1 released from
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composites were above the functional concentration in our selected time intervals, 1
μg/ml, for the second day to the third day and the ninetieth to twentieth day, as the release
amount in PBS and lasted for twenty five days (Figure 3.9). These concentrations in
collected medium were diluted to different concentrations of 1-32 µg/ml. As illustrated in
Figure 3.10i-n, ginsenoside Rg1 released from the bone cements exhibits similar potency
towards the formation of networks of honeycomb-like or tube-like structures in the
EA.hy926 cell line in a dose-dependent manner. These results indicate that similar to
Chang's study cells treated with ginsenoside were incorporated into the developing
network to a greater extent;[12] however, we were able to show the dose-dependent
increase in the Rg1-induced angiogenic tube formation of HUVESc cell line.
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Figure
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extract-contained media from bone cements.
Effect of 18 h incubation with ginsenoside Rg1 (before incorporation into bone cement)
on tube formation of EA.hy926 cell line: Control (a), cells treated with 1 µg/ml (b), 2
µg/ml (c), 4 µg/ml (d), 8 µg/ml (e), 16 µg/ml (f), and 32 µg/ml ginsenoside Rg1 (g), Rg1induced angiogenic tube formation of EA.hy926 cell line cultured in media contained
extract released from Rg1-loaded bone cement composite-2 for the second day to the third
day of release at 1 µg/ml (i), 2 µg/ml (j), 4 µg/ml (k), 8 µg/ml (l), 16 µg/ml (m), and 32
µg/ml (n) ginsenoside Rg1 concentration compared to blank (h), a dose-dependent
increase in the branching points up to 32 μg/ml ginsenoside Rg1 released from Rg1-loaded
bone cement composite-2 for the second day to the third day (o), and for the ninetieth to
twentieth day (p) of release.

3.3.9

In vitro drug release behavior of Rg1

Bone cement composites should have the ability to deliver angiogenic agents such as
ginsenoside Rg1 as examined in this work. The optimal bone cement formulation, which
was found to be Sr2+-modified TiO2/PPF bone cement-2 for providing better mechanical
and radiopacity properties, was examined for drug release. As shown in Figure 3.10, the
three groups of drug-loaded bone cements have nearly identical release profiles; after a
high initial release of ginsenoside Rg1, a reduced yet constant, sustained release was
observed. In the first 5 days, 46.5% of the Rg1 was released promptly from Rg1-loaded
bone cement composite-3, which can be attributed to either dissolution of the adsorbed
particles or diffusion of ginsenoside Rg1 particles close to the surface of the bone
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cement.[62, 63] The burst phase, lasting approximately 5 days, ranged from 29.5% to
59.3% for Rg1-loaded bone cement composite-1 and Rg1-loaded bone cement composite2, respectively. After day 5, the profiles showed a decrease in the amount of Rg1 released
over time to the day 40. Typically, the release rate is decreased with time due to a
decreased driving force, as the Rg1 is depleted from the surface matrix. During this phase,
the release depends on various other chemical and physical processes, such as polymer
chain cleavage, diffusion of the drug (Rg1) and of polymer degradation products out of
the bone cement, and the breakdown of the polymeric structure.[64] After 40 days, the
release varied between 63% and 86.5% for Rg1-loaded bone cement composite-1 and
Rg1-loaded bone cement composite-3, respectively. Additionally, the amount of
ginsenoside Rg1 released from Rg1-loaded bone cement composite-3 was higher than that
from the Rg1-loaded bone cement composite-1 and Rg1-loaded bone cement composite-2
over the 40-day period, which is in agreement with the report by chang et al. presenting a
higher amount of ginsenoside Rg1 released in vitro from the bone cement composite
containing higher Rg1 content.[12]
The Rg1 release from bone cement formulations examined here is rather slow, as the PPF
matrix is hydrophobic and thus impervious to Rg1 diffusion. In addition, Sr2+-TiO2/PPF
based bone cement composites are crosslinked due to the interfacial covalent bonding.
Consequently, the ginsenoside Rg1 needs to diffuse entirely through the tightly
crosslinked PPF matrix, leading to a slow release.[65] The tube formation bioassays
showed that the optimal concentration for ginsenoside Rg1 to stimulate cell lines to
proliferate is 8 µg/ml. In our system, the Rg1 released from bone cement composites were
above this functional concentration and last for almost twenty five days (Figure 3.10).
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Figure 3.10. The cumulative amount of released ginsenoside Rg1 from Rg1-loaded bone
cement composite-1, Rg1-loaded bone cement composite-2, and Rg1-loaded bone cement
composite-3.
In addition, Sr is a natural bone-seeking trace element that accumulates in the skeleton,
since strontium is chemically closely related to calcium (both Sr and Ca are in the same
group in the periodic table), and it is incorporated into bone at the same rate as
calcium.[66] It is believed that Sr stimulates the proliferation and growth of bone cells as
a result of its chemical similarity to calcium.[33] Moreover, Sr stimulates bone formation
and reduces bone resorption, leading to increased bone mass in osteopenic subjects.[66]
Therefore, Sr2+ incorporated bone cement formulation can be potentially useful for the
treatment of osteonecrosis in humans. These factors may exert an important role in
biocompatibility of bone cements containing n-Sr-doped TiO2 nanoparticles. Therefore, a
study of biocompatibility behavior of these bone cement nanocomposites is
recommended for future work. From the above discussion it can be deduced that TiO2
nanofibers can act as an effective reinforcing agent for an experimental functionalized
PPF matrix in order to produce a new generation of bone cements when modified with
Sr2+. Chemical bonding between the filler and the polymer helps the resulting
nanocomposites retain the enhanced mechanical properties of the unmodified counterpart,
while the incorporation of ginsenoside Rg1 did not alter other important physical
properties of the bone cement such as radiopacity and mechanical characteristics.
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3.4 Conclusions
This study shows a novel pathway to develop an alternative radiopacifier for PPF-based
bone cement, which also can act as a reinforcing agent. Radiopaque Sr2+ component
(SrTiO3) was successfully incorporated into the titania nanorods/fibers using a sol-gel
reaction in supercritical CO2. In order to enhance the reinforcing effect, the polyester was
functionalized with maleic anhydride (MA) using a ring opening reaction. Sr-doped TiO2
particles showed strong chemical interaction with the functionalized polymer, as
confirmed by X-ray photoelectron spectroscopy (XPS) and micrographic analyses of the
nanocomposites. The prepared bone cement nanocomposites provided higher thermal
stability than mechanically mixed bone cement nanocomposites, confirmed by
thermogravimetric analysis (TGA) as well as higher mechanical properties. The
ginsenoside Rg1 release analysis revealed that the bone cement composites loaded with
higher Rg1 content released relatively higher Rg1 into the surrounding environment in
vitro. The tube formation stimulation of released Rg1 was statistically significant as Rg1
both before and incorporation into the cement composition. In addition. mechanical
testing of Rg1-loaded bone cement showed that the incorporation of ginsenoside Rg1 did
not adversely affect the mechanical properties.
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Chapter 4
4

Encapsulation of ginsenoside Rg1 within PPF
Microspheres using Microfluidic Technique

Abstract
This study sought to encapsulate the pro-angiogenic mediator, ginsenoside Rg1, into
biodegradable poly(propylene fumarate) (PPF) microspheres to induce bone formation.
We examine the fabrication of ginsenoside Rg1-loaded PPF microspheres using both an
emulsion method and a microfluidic device. These PPF microspheres were engineered
with defined sizes, ranging from 3 µm to 52 µm and standard deviations less than 10%
depending on the system flow rate. The morphology and size of the Rg1-loaded PPF
microspheres were characterized using SEM while FTIR was used to verify the formation
of Rg1-loaded PPF microspheres and the chemical stability of Rg1 in the microspheres.
X-ray diffraction (XRD) revealed that ginsenoside Rg1 was uniformly distributed in the
polymer matrix. Using synchrotron X-ray absorption spectroscopy, the interactions
between the ginsenoside Rg1 and PPF were studied on an atom-by-atom basis, showing
how the ginsenoside Rg1 could be loaded into the PPF microspheres. Release profiles
were studied and quantified by UV-Vis spectrophotometry. The results showed that the
microfluidic approach gave good physical properties (spherical and discrete) and high
encapsulation efficiency of Rg1-loaded PPF microspheres, 95.35 ± 0.82%. Kinetic
analysis showed that the release of Rg1 from PPF microspheres fabricated using the
microfluidic method was slower than that from conventional method of the same average
size giving a significantly smaller initial burst, is attributed to the uniform distribution of
Rg1 inside the particles generated using the microfluidic method. Moreover, on
investigating the angiogenesis behavior of the PPF-based Rg1 delivery systems, the
released ginsenoside Rg1 maintained its angiogenic effect in vitro. The obtained results
suggest that the PPF microspheres developed in this study are promising to serve as
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vehicles for long-term controlled drug delivery leading to therapeutic angiogenesis in
bone tissue engineering strategies.

4.1 Introduction
Biodegradable polymers are attractive as scaffold materials for bone tissue engineering
applications. Polymer scaffolds must possess a number of specific properties in order to
be successful, such as biocompatibility, biodegradability, highly porous and wellinterconnected structure sufficient for cellular infiltration, appropriate surface chemistry,
and mechanical properties similar to the surrounding host tissue.[1, 2] The scaffold must
also support cellular migration and proliferation to allow for the infiltration of osteoblasts
and the formation of bone.[3, 4]
One promising material for treating bone defects and non-unions caused by disease
trauma, or abnormal development is poly(propylene fumarate) (PPF) (Figure 4.1). PPF is
of interest as an injectable material for making preformed scaffolds for bone tissue
engineering applications.[5, 6] It is an unsaturated linear polyester that can be crosslinked through its carbon-carbon double bonds and can be degraded by simple hydrolysis
of the ester bonds into nontoxic products.[7, 8] An advantage of PPF over many other
biodegradable synthetic polymers is that it can be utilized as an injectable system,
allowing for direct application into a defect site and cross-linking in situ.[9, 10]
In

addition,

development

of

endothelial

cell-based

microvascularization

and

microcirculation is of critical importance for bone regeneration.[11] Angiogenesis is the

formation of capillaries as outgrowths from preexisting vasculature; it is a complex
multi-step process comprising activation, chemotactic invasion and migration,
morphological alteration, proliferation, and capillary tube formation of endothelial cells
from preexisting blood vessels. [11, 12] The influence of angiogenesis on osteogenesis
has been previously shown. Particularly, the vasculature provides for mass transport
requirements of the tissue, and delivers circulating stem cells participating in bone
formation. It also facilitates cross-talk between endothelial cells and pre-osteoblasts to
direct their differentiation.[13]
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Among the angiogenic regulators, vascular endothelial growth factor (VEGF) and nitric
oxide (NO) are the critical angiogenic stimulators that work closely with one another in
the modulation of angiogenesis. Also, among other angiogenic mediators and growth
factors, ginsenoside Rg1 (Figure 4.1) has been shown to be a highly stable pro-angiogenic
compound which stimulates angiogenesis through enhancing the production of NO and
up-regulating the VEGF expression.[14, 15] Interestingly, ginsenoside Rg1-induced
angiogenesis was found to be comparable to or even better than bFGF-induced
angiogenesis in vivo. So, we hypothesized that a synthetic system based on PPF capable
of delivering an angiogenic agent, ginsenoside Rg1, in a localized and sustained manner
would direct simultaneous regeneration of bone and vascular tissue.
To incorporate the pro-angiogenic mediator, ginsenoside Rg1, into the scaffolds, it can be
encapsulated in biodegradable microspheres.[16-18] These polymeric microspheres can
be used as a local delivery vehicle capable of preserving the injectability of the PPF
composite. [18] Controlled local delivery potentially optimizes local therapeutic
responses, which reduces the incidents of peak-related side effects and systemic toxic
effects.[19] Furthermore, these microspheres protect the pro-angiogenic mediator during
the crosslinking reaction of the PPF, thereby preserving the bioactivity of the ginsenoside
Rg1. They also offer more variables for the attenuation of the release kinetics of the
mediator from the scaffold adding the advantage of controlled release over a prolonged
period of time; therefore, there is no requirement for multiple doses during prolonged
therapy.[19] Besides, the microspheres have the potential capacity to covalently bind to
the PPF scaffold through carbon-carbon double bonds along the PPF backbone, thus
achieving better immobilization of the microspheres and improving the mechanical
properties of the microsphere/scaffold composite.[18, 20] Kempen et al. developed PPF
microspheres encapsulating the model drug Texas red dextran (TRD) and demonstrated
the effects of various processing parameters on the release kinetics of the model drug
from these microspheres prepared using a double emulsion-solvent extraction
technique.[20] However, monodispersity of PPF microspheres and its effect on
controlling the drug release kinetics, reproducibility, and bioavailability was not
investigated in their study.
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Recently, the microfluidic method has attracted considerable attention owing to the
flexibility to generate microdroplets with controlled morphology and size.[21, 22]
Conventional techniques such as double emulsion creates microspheres with broad size
distributions due to inhomogeneous forces involved, which results in an unpredictable
degradation rate and kinetics of drug release, limiting their clinical application.[23] The
microfluidic approach has been shown to produce microspheres with high-drug loading
and encapsulation efficiency, and sustained release behavior due to outstanding
monodispersity.[23, 24] To the best of our knowledge, no previous study has addressed
the fabrication of PPF microspheres via the microfluidics method and fundamental
differences between the drug delivery behavior of PPF microparticles produced via
traditional method to generate emulsions and those prepared via microfluidics. In
addition, very little is known about the interaction between the Rg1 molecules and the
PPF-based carriers. For the first time this paper reports the use of C K-edge XANES
spectroscopy, which is a type on syncotron radiation, to identify how ginsenoside Rg1
molecules interact with PPF microspheres. The success of the procedure showed a high
Rg1 carrying ability of PPF microspheres and excellent sustained release behaviors could
lead to new biomedical applications. The hypothesis underlying this study is that delivery
of ginsenoside Rg1, pro-angiogenic mediator, from PPF microspheres can sufficiently
enhance angiogenesis to enable bone regeneration in osseous defects. Hence, we
addressed the following questions: (1) How does alteration in the PPF microparticle
preparation in terms of spherical shape, narrow size distribution, and high encapsulation
efficiency, influence the kinetics of drug release? (2) How is the mechanism and kinetics
of ginsenoside Rg1 released from monodisperse PPF microspheres?, and (3) How does
the pro-angiogenic mediator, ginsenoside Rg1, maintain its angiogenic effect before
encapsulation into the PPF microspheres and after release from the microparticles?
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a)

b)
PPF

Figure 4.1. Chemical structure of (a) ginsenoside Rg1 and (b) PPF

4.2 Experimental details
4.2.1

Materials

Polymer synthesis: Diethyl fumarate (98%), propylene glycol (1,2-Propanediol)
(≥99.5%), zinc

chloride

anhydrous

(ZnCl2,

≥99.995%),

hydroquinone

(99%),

hydrochloric acid (37%), anhydrous magnesium sulfate (99.0%), anhydrous diethyl ether
(≥99.0%), diethyl ether anhydrous (≥99.0%), methylene chloride anhydrous (DCM,
≥99.8%) were purchased from Sigma-Aldrich Canada and used as received.
Microsphere preparation, microfluidic chip fabrication, in vitro release study, and
bioassays: Ginsenoside Rg1 was donated by Dr. Edmund Lui, Department of Physiology
and Pharmacology, the University of Western Ontario, London, Canada. Poly(vinyl
alcohol) (PVA) (87–89% hydrolyzed, Mw=13,000–23,000), methylene chloride
anhydrous (DCM, ≥99.8%), HPLC grade methanol (≥99.9%), and 0.1 mol/L phosphatebuffered saline solution (PBS, pH 7.4) were purchased from Sigma-Aldrich, and used as
received. Poly(dimethylsiloxane) (PDMS; Sylgard 184) was obtained from Dow Corning
(Midland, USA). Double distilled water used throughout the experiments was generated
from a Milli-Q water purification system (18.2

Ω·cm resistivity, Barnstead EasyPureII,
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Thermo Scientific, USA). Glass syringes (1000 series, Hamilton Co., NV) and syringe
pumps (KD scientific pump, Inc. Legato 2200, 1100) were used for sending liquids into
microchannels. Human umbilical vein cell lines (EA.hy926) were provided by Dr. Jeff
Dixon, Department of Physiology and Pharmacology, the University of Western Ontario,
London, Canada.

Growth factor-reduced Matrigel was purchased from VWR. Cell

culture medium and reagents were purchased from Gibco laboratories [25].

4.2.2

Characterization
ginsenoside Rg1

of

PPF

microspheres

encapsulating

The surface morphology of microspheres was analyzed using scanning electron
microscopy (SEM) (model: Hitachi S-4500). Samples for SEM imaging were prepared by
applying the powder directly to a carbon adhesive tape. Samples were sputter-coated for
1 min with gold to reduce charging problems. The particle size distribution was
characterized by measuring the particle diameter in the SEM images using version 1.37
Image J software, which is a Java based image processing program developed at the
National Institute of Health for analyzing images. The Image J software calculated the
mean diameters and standard deviations of the microspheres. FTIR-ATR (Nicolet 6700,
Thermo Scientific) was used to investigate the chemical structure of the PPF, Rg1, and
Rg1-loaded PPF microspheres. The spectra were recorded in the range of 500-4000 cm-1
with a resolution of 4 cm-1 over 32 scans. To evaluate the crystallinity of Rg1 after
encapsulation, XRD data for Rg1, placebo PPF microspheres, and Rg1-loaded PPF
microspheres were obtained using an Inel CPS Powder Diffractometer. The instrument
was equipped with a Cu-X-ray radiation Tube, an Inel XRG3000 generator, and an Inel
CPS 120 detector. The CPS is a curved detector and performed the simultaneous
collection of X-rays diffracted by the samples over 120 °2θ. Powder samples were
ground to a uniform composition and placed on a flat aluminum sample holder. To
investigate the interaction between the Rg1 and PPF, C K-edge X-ray absorption near
edge structures (XANES) of the Rg1 molecules, PPF microspheres and Rg1-loaded PPF
microspheres were measured at the high-resolution spherical grating monochromator
(SGM) beamline at the Canadian Light Source (CLS), the University of Saskatchewan.
The samples were mounted on indium foils with an angle of 20° facing toward the photon
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beam. XANES spectra were recorded in partial fluorescence yield (PFY) that was
measured by detecting the X-ray fluorescence photons emitted from the element of
interest (e.g.: carbon). All XANES spectra were normalized to the incident photon flux
(I0), which was measured using a silicon wafer as the photodiode.

4.2.3

Preparation of materials

4.2.3.1

Synthesis of poly(propylene fumarate) (PPF)

PPF was synthesized using a two-step transesterification method explained in Salarian et
al.[26] In a typical experiment, diethyl fumarate (31.56 g, 183 mmol) and propylene
glycol (41.38 g, 549 mmol) were reacted in an inert atmosphere. Additionally, ZnCl2
(0.250 g, 1.83 mmol) and hydroquinone (0.0403 g, 0.366 mmol) were added as a catalyst
and a crosslinking inhibitor, respectively. The first step of the reaction occurred with a
gradual increase in temperature from 110 to 150 ºC in an increment of 10 ºC every 15
min resulting in the production of bis(hydroxypropyl) fumarate intermediate and ethanol,
which was collected as a distillate. This step was terminated when ~ 90% of the
theoretical yield of ethanol was collected. The second step of the reaction,
transesterification of the bis(hydroxypropyl) fumarate intermediate to produce PPF, was
conducted under reduced pressure (<1 mm Hg) with a gradual increase in temperature
from 100 to 150 ºC in an increment of 10 ºC every 30 min producing propylene glycol as
a byproduct. The reaction proceeded until the desired molecular weight of PPF was
obtained. The polymer product was then dissolved in methylene chloride followed by
several acid washes with a 5% v/v solution of 1 N HCl to remove the ZnCl2 catalyst, two
washes with distilled water, and two washes with brine. Sodium sulfate was then used to
dry the organic polymer phase. After drying with magnesium sulfate, the polymer was
concentrated by rotoevaporation and then precipitated in ethyl ether to remove the
hydroquinone inhibitor. The ethyl ether was decanted and the purified polymer was
vacuum dried to remove any residual solvent.

4.2.3.2

Preparation of PPF microspheres encapsulating ginsenoside Rg1
using W/O/W double emulsion method

A water-in-oil-in-water (W/O/W) double emulsion-solvent extraction technique, which
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includes encapsulation of water-soluble therapeutic agents for targetable drug
delivery,[16] was employed to prepare PPF microspheres encapsulating ginsenoside Rg1,
as illustrated in Figure 4.2. Briefly, 100 mg of PPF was dissolved in 10 mL of
dichloromethane, and 10 mg of Rg1 was dissolved in 5 mL of solution
[V(methanol):V(double distilled water) = 4:6]. The ginsenoside Rg1 solution was added
to the PPF solution to create the first emulsion W/O. After stirring for 2h using a
magnetic stirring bar at 1200 rpm, the entire mixture was re-emulsified in 20 mL of an
aqueous PVA solution (4% w/v) to create the W/O/W double emulsion. After stirring for
0.5h using a magnetic stirrer bar at 400 rpm, the emulsion was poured into a beaker
containing 40 mL of an aqueous PVA solution (0.5% w/v) and stirred for 2h. This
solution was then added to double-distilled water and stirred for another 3h, at room
temperature. Finally, the emulsion was ultrasonically agitated for 10 min at 30 °C. After
removing DMC by evaporation, the formed microspheres were centrifuged at 5000 rpm
for 5 min, followed by washing with distilled water twice to remove PVA and freezedrying to remove water. The Rg1-loaded microspheres were stored at −20°C.

Figure 4.2. Schematic of the double emulsion method.

4.2.3.3

Fabrication of microfluidic device

Microfluidic chips with typical channel dimensions of 100 µm in depth and 200 µm in
width were fabricated using conventional soft lithography techniques in collaboration
with Dr. Jun Yang, Mechanical and Material Engineering Department, Western
University, Canada.[27] The microfluidic chip was molded by a mixture of PDMS
elastomer base/curing agent in 10:1 ratio from SU-8 mold, and bonded to a flat PDMS
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substrate under plasma treatment for 35 seconds in a PX-250 plasma chamber (March
Instruments, Concord, MA), and then immediately placed in contact to bond the surfaces
irreversibly. The devices were then bonded using a homemade UV-ozone generator.
Since there is a favorable wettability between the disperse phase and the inner surface of
the device, surface treatment is applied to the channels to make the PDMS surface
hydrophilic.[23] The plasma-treated chip was immediately filled with a 4% PVA aqueous
solution (continuous phase) and then placed at room temperature for 30 min. Then, the
channels were emptied by a vacuum pump and the PDMS chip was placed in a 60 °C
oven for 2h to dry and immobilize the PVA. The above procedure was repeated, resulting
in a two layer coating. Finally, the coating was thermally immobilized in an oven at 100
°C for 20 min, and then the chip was allowed to cool to room temperature inside the
oven.[28]

4.2.3.4

Preparation of PPF microspheres encapsulating ginsenoside Rg1
using droplet microfluidic method

The schematic drawing of the microfluidic device is shown in Figure 4.3. The disperse
phase was prepared by emulsifying the ginsenoside Rg1 solution (2 mg/ml or 10 mg of
Rg1 in 5 ml of solution of methanol/double distilled water (2:3 v/v)) in PPF organic
solvent solution (10 mg/ml or 100 mg of PPF in 10 ml of DCM), that flowed into inlet 1.
The continuous phase, an aqueous solution of PVA (4% w/v), flowed into inlet 2. Both
liquid phases were loaded into glass syringes, and digitally controlled syringe pumps
delivered to the microfluidic device using Teflon tubing (1.6 mm OD, 0.6 mm ID).
Following the previous studies in our group, the flow rate of the continuous phase ranged
between 0.05-0.2 ml/min while the flow rate of the dispersed phase was constant and held
at 0.01 ml/min.[28] The outlet of the device was a Teflon tubing submerged into a 10 ml
beaker containing 0.5% PVA aqueous solution to collect the monodisperse droplets.
Next, the solvent within the droplets was removed by evaporation at room temperature,
and hardened microparticles were then centrifuged (5000 rpm, 5 min), washed twice with
distilled water to remove excess PVA, freeze-dried, and stored at -20 ºC.
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Figure 4.3. Schematic of the microfluidic system.
(1) disperse phase inlet (ginsenoside Rg1 solution emulsified in PPF in DCM solution),
(2) continuous phase inlet (4% w/v PVA aqueous solution), and (3) outlet.

4.2.4

Determination of encapsulation efficiency (EE) of Rg1-loaded
PPF microspheres

Encapsulation efficiency (EE) for Rg1-loaded PPF microspheres prepared using the
conventional double emulsion and microfluidic methods was determined by dissolving
dried Rg1-loaded microspheres in NaOH solution. Specifically, 5mg microspheres were
dissolved in 1 ml of a 1N NaOH solution.[20] The Rg1 concentration was determined by
absorption at the λmax value of 189 nm in a UV-Vis spectrophotometer (Shimadzu UVVis 3600). A calibration curve was constructed from Rg1 solutions with known
concentrations. Encapsulation efficiency of Rg1 in the PPF microspheres was determined
by normalizing the amount of Rg1 actually entrapped to the starting amount,[18] the ratio
between the actual Rg1 content of the microspheres and the amount initially added to
them.[29] Each experiment was carried out in triplicate. The EE of drug was defined as:
EE % 

weight of Rg1 recovered in PPF microspheres which is measured by UVspectrometer
 100
weight of Rg1 initially added to the microspheres
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4.2.5

In vitro release of ginsenoside Rg1

For the release study, 5 mg of Rg1-loaded PPF microspheres was dispersed into 10 mL of
pH 7.4 phosphate-buffered saline (PBS) in a small centrifuge tube. The tubes were sealed
and placed in a shaking water bath with a rotation rate of 100 rpm at 37 °C. At specific
time intervals, the tubes were centrifuged at 2500 rpm for 5 min, and 2 ml of the
supernatant was collected and replaced by fresh PBS. The supernatant was stored at -20
°C. After all the samples were collected, the absorption at 189 nm wavelength was
measured using a UV-Vis spectrophotometer (Shimadzu UV-Vis 3600) to determine the
amount of released Rg1. Cumulative release of Rg1 profiles were acquired with the
volume loss correction and plotted against time. All the experiments were repeated in
triplicate for each time interval. Collected extracts were also used for the following
bioassay studies.

4.2.6

Angiogenic activity of ginsenoside Rg1 before encapsulation
into and after release from the PPF microspheres

Tube formation bioassays were performed using the EA.hy926 cell line derived from the
fusion of human umbilical vein endothelial cells (HUVEC) with the A549 human
pulmonary adenocarcinoma cell line. The HUVEC cell line has been shown to attach,
migrate, and form tubular structure after seeding on a Matrigel substrate.[30, 31] Cell
lines were cultured in Dulbecco’s modified Eagle medium (D E ) supplemented with
ECGS (20 mg/ml), 10% fetal buvine serum (FBS), 1% antibiotic, and 1 ml (5X) per 50
ml of medium Hat media supplement. The cells were grown at 37 °C in humidiﬁed air
with 5% CO2 incubator. When the cell cultures were 80%-90% confluent, cells were
harvested following trypsin treatment, and the released cells were resuspended to the cell
density required for tube formation assay. To examine the angiogenic activity of
ginsenoside Rg1 in vitro, 4.5×104 cells/well of EA.hy926 cell line were seeded in a
growth factor-reduced Matrigel-coated 96-well tissue culture plate loaded with medium.
Various concentrations of ginsenoside Rg1 were examined before encapsulation into the
PPF microspheres and after release from the microparticles. After incubation for eighteen
hours, images from a total of ﬁve microscopic ﬁelds per well were captured by an
inverted microscope (Nikon TMS, Japan) using a 40x objective. Tube formations were
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analyzed by Motic Image Plus 2.0 software (Motic Instruments Inc., Richmond, Canada).
The angiogenic effect was estimated by counting the branch points of the formed tubes,
and then the average numbers of branch points were calculated. Each experiment was
repeated at least three times, with each experiment yielding essentially identical results.

4.3 Results and Discussion
4.3.1

Surface morphology and particle size analysis of the Rg1loaded PPF microspheres

SEM images of the PPF microspheres encapsulating ginsenoside Rg1 prepared using both
a conventional solvent evaporation/extraction method based on the W/O/W double
emulsion method and a microfluidic approach are displayed in Figure 4.4. The size
distribution of the microspheres were analyzed using Image J software and are displayed
in Figure 4.5. The results show that polydisperse microspheres with an average size of
13.5 µm in diameter and a standard deviation of 11.11 µm were obtained using the
conventional double emulsion method. SEM and Image J size distribution images of
these microspheres highlight that these particles have a broad size distribution of 2-45
µm, evident in Figure 4.4a, b. Figure 4.4c, d represent SEM images of PPF microcapsules
prepared using the droplet microfluidic method when the flow rate for continuous phase
and disperse phase were set at 0.1 and 0.01 ml/min, respectively. These observations
demonstrate that by using the microfluidic device, spherical and discrete microspheres
with an average diameter of 52 µm and a standard deviation of 7 µm are formed. In
addition, the microfluidic approach gave much more uniform microspheres (50-65 µm)
compared to the conventional double emulsion method. The size of these microspheres
renders them suitable for mixing the prefabricated components in a syringe and
fabrication of microsphere/scaffold composites, as microsphere with the diameter ranged
from 1 to 110 are considered to be ideal for effortless injection of the composite through
a small needle (14-gauge needle) indicating very good handling properties.[18] The size
of the particles could be regulated by changing the flow rates of the two continuous and
disperse phases. When the flow rates of 0.2 and 0.01 ml/min were chosen for the
continuous phase and disperse phase, respectively, microparticles with an average
diameters of about 3 µm and standard deviation of 1.78 µm revealing the narrower size
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distribution of 1-10 µm are fabricated using the same microfluidic device. Lowering the
flow rate of the continuous phase to the 0.05 ml/min, the system could not produce any
droplets and microspheres. Our experimental results illustrate that the size of the
microparticles obtained using the microfluidic method are tunable by changing the flow
rate; however, only a narrow experimental window enabled microsphere formation.

Figure 4.4. SEM images of Rg1-loaded PPF microspheres from (a, b) double emulsion
method and (c, d) microfluidic method where the continuous phase flow rate and disperse
phase flow rate was 0.1 and 0.01 ml/min, respectively, and (e, f) microfluidic method
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where the continuous phase flow rate and disperse phase flow rate was 0.2 and 0.01
ml/min, respectively.

Figure 4.5. Image J number of size distributions for Rg1-loaded PPF microspheres.
prepared using (a) a double emulsion method, (b) microfluidic method where the
continuous phase flow rate and disperse phase flow rate was 0.1 and 0.01 ml/min,
respectively, and (c) microfluidic method where the continuous phase flow rate and
disperse phase flow rate was 0.2 and 0.01 ml/min, respectively.

4.3.2

Encapsulation efficiency of Rg1 in the PPF microspheres

The encapsulation efficiencies of the ginsenoside Rg1 in the PPF microspheres fabricated
using the conventional double emulsion method and microfluidic technique was
determined as explained in section 4.2.4. EE of Rg1 in PPF microspheres fabricated using
the microfluidics was quite satisfactory in the range of 73.48 ± 2.31% and 95.35 ± 0.82%,
exhibiting a 29.76% increase with increasing the average size of the microspheres. Rg1loaded PPF microspheres prepared by the conventional method had a lower EE (78.48 ±
1.64%). In explanation, the entrapment efficiency is affected by the volume of the
internal aqueous phase containing ginsenoside Rg1, vortex speed, internal PVA phase,
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and polymer viscosity.[19] However, it seems that the higher entrapment efficiency
achieved for the PPF microspheres obtained from the microfluidic approach compared to
that from the double emulsion method is due to the more uniform structure. In addition,
the mechanism of polymer precipitation is different for Rg1 encapsulation within the PPF
microparticles produced using the microfluidic and double emulsion methods. Fast
polymer precipitation on the surface of the dispersed phase can prevent drug loss into the
continuous phase and increase the encapsulation efficiency, as less drug diffuses into the
continuous phase.[32] The encapsulation efficiency of PPF microspheres prepared using
the microfluidics method increases with size since a lower ratio of disperse phase flow
rate to continuous phase flow rate was used for the production of larger monodisperse
particles, which may result in the fast solidification of microspheres and subsequently
higher encapsulation efficiency.[28] Thus, the microsphere size shows a direct effect on
the drug release, bioavailability, and the encapsulation efficiency.[23] Encapsulation
efficiency is an important factor in drug delivery, especially for valuable and expensive
bioactive compounds.[24] The microfluidic method, when the flow rate for the
continuous phase and disperse phase were 0.1 and 0.01 ml/min, respectively generated
monodisperse Rg1-loaded PPF microspheres with the narrow size distribution (Figure
4.5b). The encapsulation efficiency of 95.35 ± 0.82% was selected for further analyses as
explained in more detail below.

4.3.3

Fourier transform infrared (FTIR) spectroscopy of Rg1, PPF,
and Rg1-loaded PPF microspheres

To investigate the presence and chemical stability of PPF in the ginsenoside Rg1-loaded
PPF microspheres, the FTIR spectra of Rg1, pure PPF, and Rg1-loaded PPF microspheres
were measured and are compared in Figure 4.6. In the FTIR spectrum of Rg1 (Figure
4.6a), three major peaks appear at 3332, 1643, and 1011 cm-1, attributable to O-H, C=C,
and C-O stretching bands, respectively. The FTIR spectrum of PPF (Figure 4.6b) exhibits
several major characteristic peaks at 1713, 1645, 1250, and 1147 cm-1, attributed to the
C=O stretching, C=C stretching, asymmetric C-O-C stretching, and symmetric C-O-C
stretching bands, respectively.[8, 25] After ginsenoside Rg1 was loaded into the PPF, all
the PPF peaks are observed in the spectrum of Rg1-loaded PPF microspheres (Figure
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4.6c), confirming the structural stability of PPF during the formation of microspheres.
The peaks of ginsenoside Rg1 are not evident in the spectrum of Rg1-loaded PPF
microspheres, except a weak broad peak at 3332 cm-1, which is attributed to excellent Rg1
dispersion in the PPF matrix and the resulting low concentration of ginsenoside Rg1 on
the PPF microsphere surface.
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Figure 4.6. FTIR spectra of (a) ginsenoside Rg1, (b) PPF, and (c) Rg1-loaded PPF
microspheres prepared using microfluidic method.

4.3.4

X-ray diffraction analysis of Rg1, placebo PPF microspheres,
and Rg1-loaded PPF microspheres

XRD was used to study the physical state of the encapsulated Rg1 in the PPF
microspheres. As evident in the XRD pattern of Rg1-loaded PPF microspheres fabricated
using the microfluidic technique (Figure 4.7d), the crystalline peak at 2θ = 5° indicates
the semicrystalline nature of Rg1 disappeared after encapsulation within the PPF
microspheres, which confirms the amorphous state of Rg1 in the PPF microspheres.[28]
This also indicates that Rg1 is distributed uniformly in the polymer matrix, confirming the
FTIR results. Therefore, XRD analysis of the microspheres confirmed that ginsenoside
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Rg1 is dispersed molecularly into the PPF matrix, and that no crystals are present in the
Rg1-loaded matrices.[33]

Figure 4.7. XRD patterns of (a) background, (b) placebo PPF microspheres prepared
using microfluidic method, (c) ginsenoside Rg1, and (d) Rg1-loaded PPF microspheres
prepared using microfluidic method.

4.3.5

XANES spectroscopy of Rg1, PPF, and Rg1-loaded PPF
microspheres

XANES spectroscopy provides additional information about the structure and bonding
associated with the absorbing atoms and their immediate surroundings.[34] Thus, we can
probe the interaction between the drug carriers and drug molecules by tracking the
changes of the electronic structures (XANES spectra) of the drug carriers before and after
drug loading.[35] Figure 4.8a displays the C K-edge XANES spectra of the PPF
microspheres with/without Rg1 prepared using the microfluidic technique as well as pure
Rg1 for comparison. The spectrum of the pure PPF microspheres (green curve) is
characterized by features at 285.6 (“a”), 290.1 (“d”), and 294.5 (“e”) eV. Feature “a” and
“e” are attributed to the C=C π* and σ* transitions, while feature “d” is assigned to the
C=O π* transition.[36, 37] The spectrum of the pure Rg1 (blue curve) is a bit more
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complicated showing features at 286.9 (“b”), 289.1 (“c”), 290.1 (“d”), and 294.5 (“e”)
eV. Feature “b” is proposed to come from the C-O-C bond or C-OH π* transition.[38]
Feature “d” is attributed to the C-H* resonance, while the shoulder “c” at lower energy is
assigned to the C-H* resonance of the carbon not bonded to oxygen.[36] Feature “e”
corresponds to the C-C σ* and C-O σ* resonances.[36] Comparing the XANES spectra of
the PPF microspheres with/without Rg1 molecules showed that in the spectrum of the
Rg1-loaded PPF microspheres (red curve), i) the intensity of feature “a” drops off by
about 25% compared to that of pure PPF microspheres, ii) feature “a” becomes
broadened, and iii) a weak shoulder shows up at the lower energy side of feature “d”. The
broadening of feature “a” and presence of shoulder “c” in the spectrum of the Rg1-loaded
PPF microspheres are due to the contribution from Rg1 molecules (feature “b” and “c”),
which indicates that Rg1 molecules were successfully loaded into the PPF microspheres.
The decrease of the intensity of feature “a” relative to the total edge jump could be due
to: i) Rg1 molecules contributed to the total edge jump and ii) the decrease of the number
of carbon-carbon double bonds in the PPF polymer chain after Rg1 loading. If the Rg1
molecules were physically loaded or sealed in the PPF microspheres without chemical
interaction between each other, the Rg1 and PPF both contributed to the total edge jump
at the C K-edge, and the weight ratio between Rg1 and PPF would be about 1:3 that
resulted in the dropping of the “a” intensity by 25%. Figure 4.8b shows the linear
combination fitting result of the Rg1-loaded PPF microspheres (the weight ratio of Rg1
and PPF is 1:3). The fitting spectrum (black curve) matches well with the experimental
one (red curve) except the intensities of feature “a” and “b”. As shown in the inset of
Figure 4.8b, the intensity of feature “a” in the fitting curve is a bit stronger than that in
the experimental one, while feature “b” is weaker, which might be due to chemical
interaction between the Rg1 molecules and PPF microspheres. Here we proposed that
during the Rg1 loading process, some of the carbon-carbon double bonds in the PPF
broke to form carbon-carbon single bonds, which interacted with the Rg1 molecules via
C-O-C and C-C bonds. After the Rg1 loading, the decrease of the carbon-carbon double
bonds in the PPF and the presence of the C-O-C bond between the Rg1 and PPF lead to
the dropping of feature “a” and the rising of feature “b”, respectively.
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Figure 4.8. (a) C K-edge XANES spectra of pure PPF microspheres, ginsenoside Rg1,
and Rg1-loaded PPF microspheres prepared using microfluidic method. (b) Linear fitting
of the Rg1-loaded PPF microspheres prepared using microfluidic method. Inset shows the
π* resonance.

4.3.6

Release of ginsenoside Rg1 from delivery system in vitro

We assayed the kinetic profiles of in vitro release of ginsenoside Rg1 from monodisperse

132

microparticles fabricated using the microfluidic approach and polydisperse microparticles
prepared using the conventional double emulsion technique, as shown in Figure 4.9. In
general, Rg1 release behavior for all monodisperse and polydisperse PPF microspheres
exhibited a biphasic profile: an initial burst release in the first 2 days followed by a
decreased sustained release over a 40-day period. The release profiles show that the total
cumulative Rg1 release from the monodisperse microspheres and conventional
polydisperse microspheres are 48.7% and 88%, respectively. In addition, the initial burst
release varied from 18.5% to 56.5% for microfluidic microspheres and polydisperse
microspheres, respectively. Monodisperse microspheres prepared by the microfluidics
device released Rg1 more slowly than from the conventional polydisperse microspheres.
Furthermore, the monodisperse particles revealed a significantly smaller initial burst
release than that observed for the polydisperse microspheres. It has been shown the initial
burst release of entrapped bioactive agent is affected most by the viscosity of the polymer
solution used for the fabrication of microspheres;[19] however, the PPF microspheres for
both methods were fabricated using the same batch and viscosity of synthesized polymer.
In addition, it is known that the burst release depends on the rapid water penetration into
the polymer matrix; therefore, encapsulated molecules that are immediately accessible at
the periphery of the microspheres and/or in the aqueous channels inside the microspheres
are rapidly released upon contact with the release medium, PBS.[19] The smaller initial
burst and slower release kinetics from the conventional microspheres is attributed to
homogeneous mixing in the microfluidic device, leading to a more uniform and even
drug distribution in the interior of the microparticles, while the conventional
microspheres may have drug-rich domains near the surface of the microparticles most
likely caused by the inhomogeneous forces involved.[24] The conventional double
emulsion method produced a broad size distribution of the particles, particularly a high
number of small particles. These will contribute to the larger initial burst release and
faster overall kinetics observed in the conventional particles, owing to the larger surfacearea-to-volume ratio of the smaller particles.[24] In addition, the large amounts of Rg1
absorbed at the surface of the microparticles escape easily into PBS solution also
resulting in the larger observed initial burst and faster release kinetics.[23] Using the
microfluidics approach, PPF scaffolds could be rendered angiogenic by incorporation of
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Rg1-loaded PPF microspheres. It is expected that microsphere incorporation into PPF
scaffolds may result in a negligible burst release and a more sustained in vitro release
over a prolonged period of time.

Figure 4.9. Release profiles of ginsenoside Rg1 from monodisperse PPF microspheres.
prepared with microfluidic device and polydisperse PPF microspheres prepared using the
conventional double emulsion technique.

4.3.7

Angiogenesis effect/tube formation of HUVEC cell line

Figure 4.10 displays the tube formation of EA.hy926 cell line seeded in a growth factorreduced Matrigel-coated 96-well plate. This bioassay shows the tube formation in both
the absence and presence of ginsenoside Rg1 at different concentrations before loading
and after release from the PPF microspheres prepared using the microfluidic device.
After seeding for twelve to eighteen hours in the absence of angiogenic factor, HUVECs
cell line formed incomplete and narrow tube-like structures (control sample); however, in
the presence of Rg1 within the dose range of 1-32 μg/ml, elongated and robust capillarylike networks are observed to form, which were organized by a greater number of cells
compared with the control indicating the proangiogenesis activity of ginsenoside Rg1, as
shown in Figure 4.10b-g. Based on the obtained results, the functional concentration of
Rg1 was found to be 1 μg/ml, while the optimal concentration is 8 µg/ml, as seen in
Figure 4.10o demonstrating that 8 µg/ml of Rg1 stimulated tube formation by 2-fold over
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the control. To study the angiogenesis behavior of ginsenoside Rg1 after release from the
PPF microspheres, the extract liquid in 2 mL of medium from the 19th day to 20th day of
release was collected. The concentration of Rg1 was measured using UV-Vis
spectrophotometry, and diluted to different concentrations of 1-32 µg/ml. It was found
that tube formation stimulation activity of ginsenoside Rg1 did not change significantly
after release from the delivery carriers. This indicates that the examined PPF microsphere
delivery systems did not significantly affect the angiogenic activity of Rg1. Similarly,
ginsenoside Rg1 released from the PPF microspheres exhibits similar potency towards the
formation of networks of honeycomb-like or tube-like structures in the EA.hy926 cell
line in a dose-dependent manner, as illustrated in Figure 4.10i-n. These results
demonstrate that Rg1-induced tube formation is related to the dosage. Hence, Rg1
incorporation into PPF microspheres may result in a gradual in vitro release from the PPF
composites maintaining local in vivo concentrations at angiogenic levels for sufficient
time. Therefore, further optimization of the Rg1 pharmacokinetics is required to obtain a
release profile that coincides better with the normal rate of tube and bone formation.[39]
In addition, it should be noted that HUVECs' ability to form a network of tubular
structures across the surface of a Matrigel substratum is a complex phenomenon which
combines elements of attachment, migration, organization, and differentiation. The
complex organizational behavior of

HUVECs on Matrigel models the type of

coordinated activities that are relevant to angiogenesis by endothelial cells. Although the
in vitro Matrigel model does not represent true angiogenesis, it suggests that Rg1 is
important for many of the activities that are required for vessel formation.[40]
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extract-contained media from PPF microspheres.
Effect of ginsenoside Rg1 (before incorporation into PPF microspheres) on tube
formation of EA.hy926 cell line: control (a), 1 µg/ml (b), 2 µg/ml (c), 4 µg/ml (d), 8
µg/ml (e), 16 µg/ml (f), and 32 µg/ml ginsenoside Rg1 (g), Rg1-induced angiogenic tube
formation of EA.hy926 cell line cultured in media contained extract released from Rg1
loaded-PPF microspheres for the ninetieth to twentieth day of release at 1 µg/ml (i), 2
µg/ml (j), 4 µg/ml (k), 8 µg/ml (l), 16 µg/ml (m), and 32 µg/ml (n) ginsenoside Rg1
concentration compared to blank (h), and (p) a dose-dependent increase in the branching
points up to 32 μg/ml ginsenoside Rg1 released from Rg1-loaded PPF microspheres for
the 19th day to 20th day of release.

4.4 Conclusions
In this study, ginsenoside Rg1 was encapsulated in PPF microspheres comparing a
microfluidic and conventional double emulsion method, with the microfluidic method
generating microspheres of more uniform size. SEM, FTIR, and XRD analyses were
employed to examine the morphology, chemical stability, and physical state of Rg1 in the
microspheres. We also reported the C K-edge XANES study of the PPF microspheres
loaded with/without ginsenoside Rg1. XANES results confirmed that Rg1 was
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successfully loaded in the PPF microspheres and the weight ratio between Rg1 and PPF is
about 1:3. It is proposed that chemical interaction between the Rg1 and PPF took
place via C-O-C and C-C bonds during the Rg1 loading process. The monodisperse PPF
microspheres prepared using the microfluidic method (50-65 μm) exhibited a slower
release rate and a smaller burst effect compared to the polydisperse microspheres
produced using the double emulsion method (2-45 μm). Furthermore, the ginsenoside
Rg1 released from delivery systems showed tube formation stimulation effect on human
umbilical vein cell lines as Rg1 before loading into the PPF microparticles, which reveales
that the microsphere preparation method does not affect the bioactivity of ginsenoside
Rg1 in vitro. Monodisperse Rg1-loaded PPF microspheres could be incorporated to the
scaffold formulations to generate Rg1-releasing scaffolds serving as a synthetic
extracellular matrix that would enhance bone regeneration through improved
vascularization.
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Chapter 5
5

Hydroxapatite-TiO2-based Nanocomposites
Synthesized in Supercritical CO2 for Bone Tissue
Engineering: Physical and Mechanical Properties

Abstract
Calcium phosphate-based nanocomposites offer a unique solution towards producing
scaffolds for orthopedic and dental implants. However, despite attractive bioactivity and
biocompatibility, hydroxyapatite (HAp) has been limited in heavy load-bearing
applications due to its intrinsic low mechanical strength. In order to improve the
mechanical properties of HAp, in this work HAp nonaplates were grown from the surface
of one-dimensional titania nanorod structures by combining a co-precipitation and sol-gel
methodology using supercritical fluid processing with carbon dioxide (scCO2). The effect
of metal alkoxide concentration (1.1-1.5 mol/L), reaction temperature (60-80 °C), and
pressure (6000-8000 psi) on the morphology, crystallinity, and surface area of the
resulting nanostructured composites was examined using scanning electron microscopy,
transmission electron microscopy, X-ray diffraction (XRD) analysis, and BrunauerEmmet-Teller method. Chemical composition of the products was characterized using
Fourier transform infrared (FTIR), X-ray photoelectron spectroscopy (XPS), and X-ray
absorption near-edge structures (XANES) analyses. HAp nanoplates and HAp-TiO2
nanocomposites were homogenously mixed within poly(ε-caprolactone) (PCL) to
develop scaffolds with enhanced physical and mechanical properties for bone
regeneration.

echanical behavior analysis demonstrated that Young’s and flexural

modulus of PCL/HAp-TiO2 composites were substantially higher than PCL/HAp
composites. Therefore, this new synthesis methodology in scCO2 holds promise for bone
tissue engineering with improved mechanical properties.
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5.1 Introduction
Hydroxyapatite (Ca10(PO4)6(OH)2, HAp) nanoparticles have attracted great interest, as
their chemical and crystallographic structure is similar to the mineral phase of human
hard tissues, bone and teeth.[1] HAp has shown excellent biocompatibility, bioactivity,
and high osteo-conductivity. Thus, it has been extensively used in dental and medical
applications such as reconstructive and prosthetic materials for bone and teeth.[1-3]
However, the principal limitation in the clinical use of pure HAp as a load bearing
implant is its intrinsic brittleness and poor mechanical properties in the presence of body
fluids and under local loading.[4, 5] Generally, the size and morphology of the HAp
particles have a direct influence on its ability to reinforce materials.[6] Mechanical
properties of these HAp-based materials can potentially be improved by dispersing into
them one dimensional nanostructures including nanorods, nanofibers, or nanotubes.[7, 8]
It was previously shown that the morphology and size of HAp particles could be
controlled by the presence of cetyltrimethylammonium bromide (CTAB) and
polyethylene glycol (PEG) under hydrothermal conditions.[9, 10] Nevertheless, it is very
challenging to prepare HAp nanogeometries, as

HAp nanoparticles tend to

agglomerate.[5]
On the other hand, immobilization of a biocompatible metal/metal oxide, such as Al2O3,
ZrO2, SiO2, and TiO2 on the surface of the hydroxyapatite will enhance the mechanical
properties of HAp along with enhancing cellular responses and biocompatibility.[11, 12]
Among these HAp-based composites, HAp-TiO2 composites have attracted considerable
attention due to the combined advantages of both materials. Namely TiO2 is capable of
enhancing osteoblast adhesion[13] and inducing cell growth[14] by forming a chemical
bond with the living tissue as well as the bioactivity of the HAp.
These composite materials are suggested to demonstrate improved mechanical and
physical properties compared to pure HAp ceramics. Therefore, HAp-TiO2 composite
materials have recently been indicated for load-bearing biomedical applications.[15, 16]
In addition, HAp-TiO2 composites are able to decompose both bacteria and organic
materials, hence being beneficial in antibacterial applications.[17]
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HAp-TiO2 composites have been prepared by different methods such as sol-gel,[18, 19]
hydrothermal,[20]

combined

gravity/hydrothermal

processing,[5]

electrospinning

method,[16] microwave-assisted co-precipitation process,[11, 21] and so on. However,
obtaining a crystalline powder in most of these methods requires costly heat treatments at
high temperatures or for long reaction periods. Besides, they are not environmentally
friendly, and suffer scale-up problems.[11] Consequently, a more efficient synthetic
methodology has been explored to prepare HAp-TiO2 composites. Previously, direct solgel reactions in scCO2 have attracted much attention for synthesizing oxide nanomaterials
of unique morphologies.[22, 23] Recently, the Charpentier group introduced a one-step
sol-gel method to prepare TiO2 nanofibers and ZrO2-modified TiO2 nanotubes where
scCO2 was used as the functional solvent for both self-assembly and as the drying
agent.[24, 25] This method provides several advantages to tailoring the nanomorphology
by "tuning" the supercritical fluids temperature and/or pressure.[24, 26] Moreover, any
unreacted starting materials can be safely removed from the synthesized products by
supercritical fluid extraction (SFE) during the cleaning process, maintaining the porous
nanostructure of the product while providing clean products suitable for biomedical
applications.[25, 26]
The aim of this study was to develop a new synthetic procedure for the synthesis of HApTiO2 nanocomposites by combining co-precipitation and sol-gel method in scCO2. The
nanosized HAp-TiO2 particles are examined as a reinforcing phase in polycaprolactone
(PCL) matrix. PCL is a biocompatible and bioresorbable polyester used in numerous
medical and drug delivery applications.[27, 28] The degradation kinetics and preservation
of the mechanical properties make PCL an excellent candidate as a temporary joint
spacer in total joint prostheses.[29] It was found that Young’s and flexural modulus of
PCL/HAp-TiO2 composites are significantly higher than PCL/HAp composites confirmed
by uniaxial tensile and flexural testings. In addition, X-ray absorption near-edge
structures (XANES) spectroscopy that probes the local structure and bonding of the
absorbing atoms by monitoring the absorption coefficient above the absorption edge
using tunable X-rays from a synchrotron light source and provides information on
oxidation states, coordination, and symmetry of the system was applied to study the
composition of the HAp-TiO2 nanoparticles, showing that the weight ratio between
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anatase TiO2 and HAp is about 1:1.6. These nanosized PCL/HAp-TiO2 composites are
encouraging for the preparation of scaffolds for next generation bone tissue engineering
applications.

5.2 Experimental details
5.2.1

Materials

Calcium nitrate tetrahydrate (Ca(NO3)2.4H2O), diammonium hydrogen phosphate
((NH4)2HPO4), cetyltrimethylammonium bromide (CTAB), and polyethylene glycol PEG
400 were obtained from Sigma-Aldrich, Canada. All chemicals were of analytical grade
or higher and used as received. Titanium isopropoxide (TIP, 99.999%) trace metals basis,
glacial acetic acid (>99.7%), ammonium hydroxide (NH4OH, 30%), dichloromethane
(DCM, 99.5%), anhydrous ethanol (EtOH), and polycaprolactone (PCL) (MW 80,000
g/mol) were purchased from Sigma-Aldrich, Canada and used as received.

5.2.2

Characterization

The morphologies of the samples were examined using scanning electron microscopy
(SEM, Hitachi S-4500) and transmission electron microscopy (TEM, JEOL 2010F) with
a 200 keV Schottky field emission microscope (TEM/STEM). For SEM imaging,
samples were prepared by applying the powder directly to a carbon adhesive tape.
Samples were then coated with an ultrathin layer of gold to reduce charging problems.
For TEM analysis, the powdered samples were dispersed in methanol by sonication for 1
min, and then placed on a copper grid covered with holey carbon film, and dried by
normal evaporation. The bulk composition and elemental analysis of the HAp-TiO2
powders was analyzed using energy-dispersive Quartz XOne x-ray spectroscopy (EDX)
attached to a Hitachi S-4500 field emission SEM on three fields of view (n=3). Structural
analysis of the powders was performed using an Inel Powder Diffractometer. The
instrument was equipped with a Cu-X-ray radiation Tube, an Inel XRG3000 generator
and an Inel CPS 120 detector. The diffraction pattern data was processed with the IMAD
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program and the MATCH Software, which was used for phase identification from
powder diffraction data. ICDD PDF4+ database was used to search for reference patterns.
The thermogravimetric analysis (TGA) was carried out to study the thermal
decomposition behavior of the HAp and HAp-TiO2 nanocomposites. TGA analysis of the
synthesized nanostructures was performed using a thermogravimetric analyzer, TA
Instrument (TA-Q500), at a heating rate of 10 °C/min from room temperature to 1200 °C
under flowing air. X-ray photoelectron spectroscopy (XPS) analyses were carried out
with a Kratos Axis Ultra spectrometer using a monochromatic Al Kα source (15mA,
14kV). Samples were mounted on a non-conductive double-sided adhesive tape. The
Kratos charge neutralizer system was used on all specimens. Survey scan analyses were
carried out with an analysis area of 300 x 700 microns and a pass energy of 160 eV.
Spectra have been charge corrected to the main line of the carbon 1s spectrum set to
284.8 eV. Spectra were analyzed using CasaXPS software (version 2.3.14).
Synchrotron measurements were carried out at the high-resolution spherical grating
monochromator (SGM) beamline at the Canadian Light Source (CLS), the University of
Saskatchewan. The samples were mounted on conventional carbon tapes with an angle of
20° facing toward the photon beam. XANES spectra were recorded in total electron yield
(TEY) that was detected with the specimen current. All XANES spectra were normalized
to the incident photon flux collected on a refreshed Au grid.
The FTIR spectra of the samples were collected using a Bruker IFS 55 FTIR instrument
with an attached MCT detector. Specimens were prepared by mixing 4 wt % of each
sample with potassium bromide (KBr) and then pressing into a pellet. The spectra were
recorded within the range of 400-4000 cm-1 with a resolution of 4 cm-1 over 32 scans.
The specific surface areas and the average pores size of the powders were determined via
Brunauer-Emmet-Teller method and Barret-Joyner-Halenda (BJH) analysis of BET
isotherms using Tristar II 3020 (Micromeritics Instrument Corporation). All the samples
were degassed at 150 °C for 12 h.
Mechanical properties of PCL/HAp-TiO2 and PCL/HAp composites were determined
using an Instron 5943 universal testing machine (Instron, Canton, MA) equipped with a
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500 N (tension) load cell. For tensile testing, dogbone specimens with overall length of
60 mm and width of grip section of 10 mm were prepared by slicing the PCL/HAp and
PCL/HAp-TiO2 films and adding to a stainless steel mold. The mold was heated at 100
°C for 30 min and heat-pressed at 100 °C and 670 N for 2 min. Prepared specimens were
soaked in deionized water at 37 °C for 24 h prior to testing. Stress-strain relationships
were obtained from the load and displacement data. The Young’s modulus was
determined by calculating the slope of the linear portion of the stress-strain curve, and the
tensile strength was defined as the maximum stress achieved. For each group, 5
independent specimens (n=5) were tested in tension at a crosshead speed of 10 mm/min.
Flexural strength and flexural modulus of the nanocomposites were determined in
accordance with ASTM D790M-92 using a dynamic mechanical analyzer, DMA Q800
(TA instruments). Flexural testing samples, rectangular bar specimens (n=5) (50 mm  25
mm  2 mm), were prepared using the stainless steel mold heat-pressed following the
same procedure as tensile testing specimens. Prepared specimens were soaked in
deionized water at 37 °C for 24 h prior to testing, and placed on a three-point bending
apparatus with two supports spanning 40 mm from each other and loaded at the crosshead speed of 10 mm/min to the center of each specimen until failure. In an approach
similar to that of tensile testing, flexural modulus was calculated as the slope of the initial
linear region of the stress-strain curve, while flexural fracture strength was determined as
the maximum applied stress prior to failure.

5.2.3

Preparation of materials

5.2.3.1

Preparation of HAp nanoparticles using a combined coprecipitation and sol-gel method

The reactant molar ratio of Ca2+/PO43- was kept at 1.67 (stoichiometric ratio of HAp).
The general procedure is as follows: first, (NH4)2HPO4 (1.078 g, 0.008 mol) and CTAB
(2.083 g, 0.0056 mole) were dissolved in 33.3 ml of deionized water. The solution was
stirred for 30 min with a magnetic stirrer, then the pH value was adjusted to 4.5 by
adding pure acetic acid. After this, Ca(NO3)2.4H2O (3.228 g, 0.0135 mol) was dissolved
in 46.67 ml of deionized water and 6.67 ml of PEG 400 was simultaneously added to the
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solution under constant stirring for 20 min. Then, the mixed solution of Ca(NO3)2·4H2O
and PEG 400 was added to the latter dropwise under continuous magnetic stirring in air.
The pH of the solution was then adjusted to 9 using ammonia. The final milky-white
suspension was rigorously stirred at room temperature for 6 h. The resulting white
precipitates were separated from the suspension by centrifuging, washed 3X with ethanol
to remove the residual CTAB and PEG 400 and denoted as the HAp precursor (Figure
5.1). To synthesize the HAp nanoplates in scCO2, HAp precursor (3 g) was dispersed in
ethanol at the ratio of 1:1 by weight while vigorously stirring, and placed in a 10 mL
stainless steel view cell reactor, followed by the addition of CO2 using a high pressure
syringe pump (Isco 260D). The schematic diagram of the experimental setup can be
found in Sui et al.[23] The temperature and pressure in the view cell were controlled to a
range from 60 to 80 °C and 6000 psi as the optimized experimental conditions. The
precursor was stirred for one day using a magnetic stirrer with TFE stir bar. Stirring was
stopped after 24 h, while 4-5 days of aging were required for complete reaction. After
aging, the formed gel was washed continuously using CO2 at a rate of approximately 0.5
mL/min, followed by controlled venting at 0.5 mL/min to prevent collapse of the solid
network. The as-prepared powder was kept in a vacuum oven at 80 °C to remove
moisture.

Ca(NO 3 )2 .4 H2 O

PEG 400

Water

(NH4 )2 HPO4

Mixing

CTAB

Mixing

Adding calcium solution to
phosphate solution (dropwise)
pH adjustment to 9 using ammonia
Aging for 6 h, centrifuging, washing
3 times with anhydrous ethanol
HAp-Precursor

Water

pH adjustment to 4.5
using acetic acid
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Figure 5.1. Schematic representation of the preparation of HAp precursor.

5.2.3.2

Preparation of HAp-TiO2 nanocomposites using a combined coprecipitation and sol-gel method

In a typical experiment, the HAp precursor (1.5 g), prepared following the explained
procedure in section 3.3.1 was dispersed in ethanol (1.5 g) and placed in a 10 mL high
pressure view cell followed by quick addition of titanium isopropoxide (1 g) and acetic
acid (4 g) and heated/pressurized with CO2 to the desired temperature and pressure. A
magnetic stirrer with TFE stir bar was used for mixing the reaction mixture. The mixture
of HAp precursor, titanium isopropoxide, and acetic acid was dispersed in supercritical
CO2 at the studied temperature 80 °C and pressure range from 6000 to 8000 psi. The
reaction was kept under continuous stirring for 24 h, and 5-6 days of aging were required
for complete reaction, as shown in Figure 5.2. After aging, the formed gel was washed
with CO2 followed by controlled venting at 0.5 mL/min. After CO2 extraction and
venting, the resulting powders were subjected to further drying and calcination at 500 °C
in air for 2 h using a heating rate of 10 °C/min and a cooling rate of 0.5 °C/min to room
temperature.
For comparison of XANES study, TiO2 nanoparticles were synthesized following the
procedure presented in Salarian et al.,[30] and calcined at 450 °C and 750 °C.
Titanium
isopropoxide

Acetic
acid

HAp
precursor

Supercritical
CO2

Anhydrous
ethanol

Mixing

Mixing

TiO2 -Sol

HAp-Sol

Supercritical
CO2

Mixing
HAp-TiO2

Figure 5.2. Schematic representation of sol-gel process for producing HAp-TiO2
composites.
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5.2.3.3

Preparation of HAp-TiO2 nanocomposites using hydrothermal
technique

Similar to the synthesis of HAp precursor, (NH4)2HPO4 (1.213 g, 0.009 mol) and CTAB
(2.343 g, 0.0063 mol) were dissolved in 37.5 ml of deionized water, and the solution was
stirred for 30 min with a magnetic stirrer followed by adjusting the pH value to 4.5 using
acetic acid. After that, Ca(NO3)2·4H2O (3.632 g, 0.0152 mol) was dissolved in 52.5 ml of
deionized water and 7.5 ml of PEG 400 was simultaneously added to the solution while
stirring for 20 min. Then, the Ca(NO3)2·4H2O+PEG 400 solution was added to the
(NH4)2HPO4+CTAB solution dropwise with constant stirring. Simultaneously, TIP (1 g)
was mixed with acetic acid (6 g), and added dropwise to the reaction media (phosphate
solution). Ammonia was used to adjust the solution pH to 11. The final suspension was
transferred to a 125 ml stainless steel autoclave; then hydrothermally treated at 200 °C for
24 h. After reaction, any precipitates were separated from the suspension by
centrifugation at 5000 rpm for 10 min, washed 3X with ethanol, then freeze-dried to yield
the product (white powder).

5.2.3.4

Preparation of PCL/HAp-TiO2 and PCL/HAp composite

In order to produce PCL/HAp composites, HAp powders synthesized in scCO2 were
added to dichloromethane (DCM) and then stirred for 15 min, followed by sonication for
5 min. PCL was then added to the HAp/DCM suspension to produce a PCL/HAp slurry
containing the following ratios PCL:HAp (w/w): 90:10, 80:20, and 70:30. The PCL/HAp
slurry was cast in a glass dish, and the solvent evaporated in a fume hood. Finally, the
resulting PCL/HAp films were heat-pressed at 100 °C and 670 N for 2 min. PCL/HApTiO2 specimens were prepared following the same procedure using HAp-TiO2 powders
synthesized by combined co-precipitation and sol-gel method and hydrothermal
treatment.

5.3 Results and Discussion
5.3.1

SEM and TEM characterization of the as-synthesized HAp and
calcined HAp-TiO2 composites powders

The experimental conditions and characterization results for the as-synthesized HAp and
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calcined HAp-TiO2 composites powders are provided in Table 5.1.
Table 5.1. Synthesis conditions of HAp and HAp-TiO2 nanostructures in scCO2 and
characterization results (morphology and BET surface area).

Temperature

Pressure

C0 (TIP)

[°C]

[psi]

[mol l-1]

TiO2

60

6000

1.1

4

111

NanofiberNanotube

HAp-1

60

6000

-

-

60

Nanoplate

HAp-2

80

6000

-

-

72

Nanoplate

HAp-TiO21

80

6000

1.1

4

100

NanoplateThick sheet
type structure

HAp-TiO22

80

6000

1.5

4

170

Nanoplate on
the surface of
Nanorods

HAp-TiO23

80

8000

1.5

4

108

NanoplateNanorods

98

Oblong-shaped

HAp-TiO2h

(AcOH/TIP)
weight ratio

Hydrothermal treatment at 200 °C for 24 hours

BET

Morphology

[m2 g-1]

SEM micrographs of the synthesized materials (Figure 5.3(a-f)) and TEM images of
HAp-TiO2-2 and HAp-TiO2-h nanocomposite (Figure 5.3g&h) show that the HAp and
the HAp-TiO2 composites powders were composed of various nanostructures. SEM
image of the TiO2 nanoparticles calcined at 450 °C are shown in Figure 5.3a indicating
the formation of tube-like and fiber-like structure. More detailed information on the
experimental procedure of these TiO2 nanoparticles are presented in Salarian et al.[30]
Figure 5.3b&c show the plate-like particles of samples HAp-1 (150-250 nm in width) and
HAp-2 (40-100 nm in width), synthesized in ScCO2 using a system pressure of 6000 psi
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at 60 °C and at 80 °C, respectively. In general, we found slight changes in the
morphology and dimensions of the particulates when adjusting the reaction temperature
from 60 to 80 °C, although the higher studied reaction temperature (80 °C) gave
nanoplates with smaller dimensions and higher surface areas. SEM analysis of the
composite samples revealed that the initial concentration of TIP had a significant
influence on the morphology of the synthesized nanocomposites. Typically, at 80 °C and
6000 psi with initial concentration of 1.1 mol l-1 TIP (HAp-TiO2-1), HAp nanoplates
with 50-200 nm width and TiO2 particles having a thick sheet-type structure with 200 nm
width and 1-2 μm length were obtained (Figure 5.3d). At higher TIP concentration (1.5
mol/l), HAp nanoplates were formed on the surface of well-separated TiO2 nanorods with
a diameter of about 50-300 nm and lengths from 1 to 4 μm, as seen in the SE

and TE

images of HAp-TiO2-2 given in Figure 3.3 e&g. The effect of the reaction pressure on the
morphology of the nanocomposites was studied by varying the pressure from 6000 to
8000 psi, while keeping the temperature at 80 °C and the initial TIP concentration of 1.5
mol l-1. SEM analysis of the HAp-TiO2-3 (prepared at 8000 psi) revealed that the scCO2
pressure did not have a significant effect on the morphology of the synthesized
particulates (data not shown here). On the other hand, using the hydrothermal technique
resulted in the formation of oblong-shaped particles, as shown in Figure 5.3f&h.

153

154

Figure 5.3. SEM images of the (a) TiO2 nanotubes calcined at 450 °C, (b) as-prepared
HAp-1 nanoplates, (c) as-prepared HAp-2 nanoplates, (d) HAp-TiO2-1 nanocomposites
calcined at 500 °C, (e) HAp-TiO2-2 nanocomposites calcined at 500 °C, and (f) HApTiO2-h nanocomposites and TEM images of (g) HAp-TiO2-2 nanocomposites calcined at
500 °C and (h) HAp-TiO2-h nanocomposites. Arrows in Figure 5.3c indicate the voids
between aggregates of plate-like HAp secondary particles.

5.3.2

EDS analysis of HAp and HAp-TiO2 nanocomposites

To provide additional information on elemental analysis for the synthesized HAp-TiO2
nanocomposites, energy-dispersive spectroscopy (EDS) was used to map Ca, P, Ti, and
O. EDS is a widely utilized tool for bulk elemental analysis of samples where the X-rays
are generated in a region about 2 µm in depth. Figure 5.4 and Figure 5.5 clearly
demonstrate the presence of Ca, P, Ti, and O in the nanocomposites. From the EDS
elemental mapping of HAp-TiO2-2 nanocomposites (Figure 5.4), the rod like morphology
shows the presence of Ti, the major elemental component of TiO2, in the composites
(Figure 5.4c). It can also be seen that Ca (Figure 5.4e) and P (Figure 5.4d), found
exclusively in HAp, are uniformly distributed on the surface of the TiO2 rods. This
further confirms that the nanoplates are HAp grown on the surface of TiO2 rods.

Figure 5.4. EDS elemental mapping of HAp-TiO2-2 nanocomposites: (a) selected area on
the sample, (b) O mapping, (c) Ti mapping, (d) P mapping, and (e) Ca mapping.
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EDX elemental mapping of HAp-TiO2-h nanocomposites demonstrates a relatively
homogeneous distribution of Ti (Figure 5.5c), P (Figure 5.5d), and Ca (Figure 5.5e)
throughout the composite material. Thus, it can also be concluded that the oblong-shaped
particles of TiO2 and HAp are uniformly and homogeneously distributed within the
synthesized nanocomposites.

Figure 5.5. EDS elemental mapping of HAp-TiO2-h nanocomposites: (a) selected area on
the sample, (b) O mapping, (c) Ti mapping, (d) P mapping, and (e) Ca mapping.
The EDX spectra for HAp-2 and HAp-TiO2-2 are shown in Figure 5.6. The investigation
confirms the existence of Ca, P, O, and C elements for HAp-2 (Figure 5.6a) and Ca, P, O,
Ti, and C elements in the synthesized HAp-TiO2-2 nanocomposites (Figure 5.6b).
Calcium to phosphorus (Ca/P) atomic ratio of HAp-1 and HAp-2 powders (Table 5.2)
indicates a predominately stoichiometric HAp crystal (Ca/P≈1.67). In addition, there was
no significant difference among the Ca/P ratios of the HAp-TiO2 nanocomposites
synthesized at different conditions (reaction temperature, reaction pressure, and initial
concentration of TIP) and HAp-TiO2-h nanocomposites, exhibiting a lowered Ca/P
atomic ratio, likely reflecting higher PO43- content.
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Figure 5.6. EDX spectra of the (a) HAp-2 and (b) HAp-TiO2-2 nanocomposites.

Table 5.2. Ca/P atomic ratio of HAp powders and HAp-TiO2 nanocomposites.

Atomic %
Ca

5.3.3

P

Ca/P

Ti

HAp-1

21.9 ± 1.2

13.45 ± 1.7

1.63 ± 0.06

-

HAp-2

24.7 ± 2.3

14.97 ± 1.3

1.65 ± 0.06

-

HAp-TiO2-1

27.36 ± 1.8

17.2 ± 1.6

1.59 ± 0.04

5.8 ± 1.2

HAp-TiO2-2

27.6 ± 1.9

17.81 ± 1.3

1.53 ± 0.02

7.8 ± 1.1

HAp-TiO2-3

25.08 ± 2.2

16.5 ± 1.8

1.52 ± 0.05

5.9 ± 0.08

HAp-TiO2-h

21.85 ± 1.4

14.64 ± 0.9

1.49 ± 0.02

4.88 ± 0.06

XRD analysis of HAp and HAp-TiO2 nanocomposites

Figure 5.7 shows the XRD patterns for the HAp-2 and HAp-TiO2-2 and HAp-TiO2-h
nanocomposites in the 2θ range of 10-70°. In the XRD pattern of HAp-2 (Figure 5.7a), all
the diffraction peaks correspond to hexagonal HAp according to JCPDS: 09-432.[5] No
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impurities are observed in the pattern, indicating pure HAp. In Figure 5.7b&c (for HApTiO2 nanocomposites), the XRD patterns show all the diffraction peaks for HAp, along
with new intensive peaks at 2θ ≈ 25.2°, 37.7°, 53.8°, and 55° (shown by filled triangles)
which are the prominent characteristic peaks of anatase TiO2 assigned to the diffraction
of (101), (004), (105), and (211) planes of TiO2 anatase phase, respectively, confirming
the incorporation of titania into the HAp matrix. This perfectly coincides with the anatase
TiO2 JCPDS card data (file No: 21-1272). Meanwhile, the peak at 47.9° is consistent with
(213) Bragg reflection of HAp and (200) plane of TiO2 anatase.[5, 21, 31] From the XRD
patterns, it can be concluded that the unique HAp-TiO2 nanocomposites maintain HAp
crystal phase without phase transformation. Under the examined experimental conditions,
the HAp precursor is stable, with TIP precursors grown to form anatase TiO2 rod-like
crystals. For the composite samples it can also be observed that the intensity of the TiO2
peaks increases with the increase of the TiO2 content, while the intensity of the HAp
peaks decreases, as distinguishable in the XRD pattern of HAp-TiO2-2 nanocomposites
shown in Figure 4b compared to the HAp-TiO2-h nanocomposite (Figure 5.7c).
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Figure 5.7. XRD patterns of the (a) HAp-2, (b) HAp-TiO2-2, and (c) HAp-TiO2-h
nanocomposites. In Figure 5.7b&c, filled triangles are representing the prominent
characteristic peaks of anatase TiO2.

5.3.4

FTIR spectroscopy of HAp and HAp-TiO2 nanocomposites

The synthesized HAp and HAp-TiO2 nanocomposites were also analyzed by means of
FTIR. The FTIR spectra of HAp-2 nanoplates and HAp-TiO2-2 and HAp-TiO2-h
nanocomposites are displayed in Figure 5.8. Several characteristic peaks of HAp are
present in all the three spectra at 3570, 1095, 1034, 962, 633, 602, and 565 cm-1. The
peaks at 3570 and 633 cm-1 are attributed to the stretching and libration bands originating
from the OH- ion, respectively while the characteristic bands of PO43- ion appear at 1095
and 1034 (υ3), 962 (υ1), 602 and 565 cm-1 (υ4).[32-34] The well-preserved characteristic
peaks of HAp in the spectra of HAp-TiO2 nanocomposites suggest no significant
structural change or transformation of HAp during the formation of the HAp-TiO2
nanocomposites. This is fairly difficult to attain by using other synthesis methods,
confirming the superior temperature control provided by the proposed synthesis method
for HAp-TiO2 nanocomposites. The broad peaks at 3429 and 1635 cm-1 in Figure 3.8 a
are attributable to the O-H stretching and bending modes of the surface-absorbed water,
respectively. These peaks became more evident in the spectra of the synthesized HApTiO2 nanocomposites (Figure 5.8b&c), maybe also attributable to the structural hydroxyl
group in the nano TiO2.[35] In comparison to the spectrum of HAp (Figure 5.8a), there is
an extra broad peak in the region of 600-800 cm-1 in the spectra of HAp-TiO2
nanocomposites (Figure 5.8b&c), with the spectrum of HAp-TiO2-2 (Figure 5.8b) being
more evident. This broad peak may be due to the Ti-O-Ti band of TiO2 as revealed by
XRD.[36] Hence, these FTIR results confirmed the presence of TiO2 with intact HAp in
the synthesized HAp-TiO2 nanocomposites.
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Figure 5.8. Fourier transform infrared (FTIR) spectroscopy of the (a) HAp-2, (b) HApTiO2-2, and (c) HAp-TiO2-h nanocomposites.

5.3.5

BET analysis of HAp and HAp-TiO2 nanocomposites
synthesized in supercritical CO2

The N2 adsorption-desorption isotherms of the pure HAp-2 and HAp-TiO2-2
nanocomposites are plotted in Figure 5.9a&b, respectively. Both isotherms correspond to
type IV isotherms (IUPAC classification) with a capillary condensation step above 0.4
P/P0, which is typical of mesoporous structures.[37, 38] According to the IUPAC
classification, the isotherms have a type H3 hysteresis loop with the continuous nitrogen
uptake at very high relative pressure that is associated with aggregates of plate-like HAp
particles giving rise to slit-shaped pores.[39] The HAp-TiO2 nanocomposites show
significantly higher specific surface area, close to 170 m2/g with very homogeneous
mesopores that are clearly distinguished from the macropores as confirmed by its N2
physisorption isotherm (Figure 5.9b). The adsorption in the low relative pressure region
is a consequence of adsorption in micropores. The first hysteresis loop in the P/P0 range
of 0.4-0.6 corresponds to the small size mesopores generated from the void space
between the HAp crystallites.[39] Moreover, it exhibits another distinguished steep
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increase in the adsorption starting at P/P0 of 0.8. This nitrogen uptake at very high
relative pressure corresponds to the formation of macropores that start filling only at high
P/P0, close to 1.0. The observed macroporosity can be referred to the voids between
agglomerate of plate-like HAp primary particles, voids between the secondary
particles.[40] Pure HAp-2 exhibits surface area of about 72 m2/g, and compared with
HAp-TiO2 nanocomposites it showed a wide distribution of the pores and larger average
pore diameter as shown in Figure 5.9a. The capillary condensation step is much
pronounced and shifted to higher relative pressures, 0.6-0.8, for pure HAp with respect to
HAp-TiO2 composite, which reveals the dominance of larger mesopores.[37] The SEM
micrographs of pure HAp, Figure 5.3c, show aggregates of porous secondary particles.
Compared with HAp-TiO2 composite, the aggregates are larger, 0.3-0.8 μm, indicating
the presence of larger and less homogeneous macropores. Therefore, it is suggested that
in the case of HAp-TiO2 nanocomposite, the HAp agglomerates forming the slit like
pores tend to diminish in population and size. Also, the volume of the intercrystallite
HAp space is reduced, so it could be concluded that the mesopore size of HAp is altered
upon formation of TiO2. Farhangi and Charpentier synthesized TiO2 nanowires on the
graphene sheets in scCO2, reporting similar results.[41]

Figure 5.9. N2 adsorption/desorption isotherm of the (a) HAp-2 and (b) HAp-TiO2-2
nanocomposites.
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5.3.6

XPS measurements of HAp and HAp-TiO2 nanocomposites
synthesized in supercritical CO2

During the A chemical analysis of the HAp and HAp-TiO2 samples was performed using
XPS, and the core level spectra obtained for the samples of HAp-2 and HAp-TiO2-2 are
depicted in Figure 5.10. As illustrated in the survey scans (Figure 5.10a&e), the only
elements detected on the surface are Ca, P, O, and C for HAp-2 and Ca, P, O, Ti, and C
for HAp-TiO2-2 nanocomposites. The respective atomic percentages of those elements
are given in Table 5.3. No contaminant element other than carbon was detected. The
carbon concentration of 11.3 and 11.9% observed in HAp-2 and HAp-TiO2-2 composites,
respectively, is typical for organic contamination levels on clean surfaces.[18] This
contamination could be resulted from the chemisorption of CO2 molecules from the
atmosphere and from the reaction under ScCO2, unreacted acetic acid, and washing with
ScCO2. In the recorded spectrum for HAp-2, the high resolution XPS scan of the Ca 2p
region (Figure 5.10b) could be resolved into two peaks for Ca 2p1/2 and Ca 2p3/2 at
binding energies of 350.80 eV and 347.28 eV, respectively, which are related to
hydroxyapatite. In the high resolution P 2p XPS scan of HAp (Figure 5.10c), two peaks
for P 2p1/2 and P 2p3/2 are observed at 134.99 eV and 133.15 eV, respectively, which
correspond to P in hydroxyapatite. Figure 5.10d shows the core level spectrum of O 1s,
and the peaks at binding energies of 532.93 eV and 531.12 eV are attributed to the
adsorbed water in hydroxyapatite crystal and phosphate group, respectively.[11] The
calculated Ca/O and Ca/P ratios for the HAp-2 are 0.34 and 1.62, respectively, which are
very close to the theoretical values of 0.38 and 1.67 for HAp. The high resolution XPS
record of Ca 2p region of HAp-TiO2 (Figure 5.10f) shows peaks for Ca 2p1/2 and Ca
2p3/2 at bonding energies of 350.99 eV and 347.44 eV, respectively, and that of P 2p
represents two peaks for P 2p1/2 and P 2p3/2 at 134.12 eV and 133.28 eV, respectively
(Figure 5.10g). These peak positions coincide well with the Ca and P in hydroxyapatite,
as explained earlier, and only the negligible difference in binding energies of Ca 2p and P
2p core levels indicates the formation of HAp with similar stoichiometries in both HAp-2
and HAp-TiO2-2 nanocomposite. The O 1s XPS spectrum (Figure 5.10h) could be
deconvoluted into three distinct peaks indicating the presence of multiple O species on
the surface.[42] The sub-peak at binding energy of 529.59 eV is assigned to the lattice
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oxygen atoms TiO2 (Ti-O bonds), while the sub-peak peak at 533.36 corresponds to
adsorbed water in HAp crystal, and the other peak at 531.41 eV is due to contribution of
OH- groups on the surface, phosphate group, and/or defective oxide sites. In Figure 5.10,
the core level spectrum of Ti 2p could be resolved into two spin-orbit pairs of 2p3/2 and
2p1/2 with binding energies of 458.35 eV and 464.02 eV, respectively, which are
attributed to Ti in the 4+ state.[43] Therefore, the Ti detected in TiO2-HAp
nanocomposites is only the oxide (TiO2) derived from the TIP hydrolyzed in the
synthesis procedure. These XPS results confirm the formation of hydroxyapatite and
titania in the HAp-TiO2 nanocomposites, and also indicate that the HAp-TiO2
nanocomposite is stable under the reaction conditions. The calculated Ca/O and Ca/P
ratios for the HAp-TiO2-2 composite are 0.3 and 1.43, respectively. The obtained Ca/O
and Ca/P ratios can be considered close to the theoretical ones, as the XPS information is
mediated on the analyzed area constituted by TiO2 and HAp.[18] Consequently, due to
the matrix effect, the intensity and the resolution of the Ca 2p and P 2p signals in both
HAp-2 and HAp-TiO2-2 composite samples are lower than the ones detected for the same
elements in stoichiometric HAp powder.
Table 5.3. Atomic percentage of the elements detected in the HAp-2 and HAp-TiO2-2
samples.
Atomic %
Ca

P

O

C

Ti

HAp-2

19.3

11.9

57.5

11.3

-

TiO2-HAp-2

15.2

10.6

57.9

11.9

4.5

TiO2

HAp, OH

6.72

51.18

Compared to the theoretical value for Ca/O ratio, 0.38, the calculated Ca/O ratio for the
HAp-TiO2-2 composite corresponds to the oxygen excess that could be attributed to the
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presence of OH groups on the surface. It is reported that the hydroxyl groups, such as TiOH, remain in the sol-gel prepared materials promoting the osteointegration process [18].
Therefore, from the XPS results it could be suggested that the prepared HAp-TiO2
composites may exhibit enhanced bioactive properties. In order to confirm this
hypothesis, a study of in vitro biocompatibility of the synthesized nanocomposites is
planned as the next stage for this work.
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Figure 5.10. (a) XPS survey spectrum of the HAp-2 and core level spectra of (b) Ca 2p,
(c) P 2p, and (d) O 1s recorded from the HAp-2 and (e) XPS survey spectrum of the
HAp-TiO2-2 and core level spectra of (f) Ca 2p, (g) P 2p, (h) O 1s, and (i) Ti 2p recorded
from the HAp-TiO2-2.

5.3.7

XANES spectroscopies of TiO2, HAp, and
nanocomposites synthesized in supercritical CO2

HAp-TiO2

Figure 5.11 shows the Ti L3,2-edge XANES of the HAp-TiO2-2 nanocomposites in
comparison with TiO2 nanoparticles synthesized in supercritical CO2 following the
procedure presented in Salarian et al.[30] after calcination at 450 °C and 750 °C as
standard samples. X-ray diffraction studies of the TiO2 nanoparticles showed that the asprepared materials transferred from the amorphous to anatase phase during heat treatment
at 450 °C, while after calcination at 750 °C the transformation from anatase to rutile
occurs (data not shown here). Characteristic features of TiO2 can be observed that arise
from the transitions of Ti 2p electrons to unoccupied 3d electronic states. From the
XANES spectra of TiO2 standard samples, the peaks in the spectra can be understood as
due to the crystal field splitting of the d orbitals into t2g and eg under Oh symmetry
followed by local distortion resulting in a local symmetry of D2d and D2h for anatase
(TiO2 nanoparticles calcined at 450 °C) and rutile (TiO2 nanoparticles calcined at 750
°C), respectively. It can be seen that the most significant difference is the intensity ratio
of peak a and b, i.e. a is more intense than b in anatase (Figure 5.11a), but in rutile
(Figure 5.11b) this is reversed. The lowering of the Oh symmetry to D2d and D2h leads to
the 2p→eg transition further splitting into peak a and b at the L3-edge. The eg state is
more sensitive to the variation in symmetry; and thus, anatase and rutile phases can be
tracked by the relative ratio of peaks a and b.[44, 45] The spectrum of the HAp-TiO2-2
nanocomposites (Figure 5.11c) shows well-resolved features of the anatase phase, as can
be immediately identified by the intensity ratio between a and b. It indicates that the TiO2
in the nanocomposites is of anatase phase, which is consistent with the XRD results.
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Figure 5.11. Ti L3,2-edge XANES spectra of the (a) TiO2 nanoparticles calcined at 450
°C, (b) TiO2 nanoparticles calcined at 750 °C, and (c) HAp-TiO2-2 nanocomposite.
Figure 5.12 shows the Ca L3,2-edge XANES spectra of the HAp-TiO2-2 nanocomposites
and HAp-2 powders. Sharp peaks at 351.4 and 354.7 eV are observed, which come from
the transitions of 2p3/2 and 2p1/2 electrons to the empty 3d state of Ca2+ ion that yields this
spin-orbit doublet. The XANES spectrum of HAp-TiO2-2 nanocomposites (Figure 5.12b)
shows the same features to that of HAp-2 (Figure 5.12a), indicating that HAp was formed
in the sample. Ca L3,2-edge XANES results agree with the XRD results.
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Figure 5.12. Ca L3,2-edge XANES spectra of the (a) HAp and (b) HAp-TiO2-2
nanocomposite powders.
Figure 5.13(I) shows the O K-edge XANES spectra of the HAp-TiO2-2 nanocomposites
in comparison with HAp-2, anatase, and rutile TiO2. The peaks are from the transitions of
O 1s to 2p (for TiO2, O 2p states are hybridized with Ti 3d states). It can be seen that the
spectrum of the HAp-TiO2-2 nanocomposites (Figure 5.13(I) b) shows the features of
both anatase TiO2 and HAp (e.g.: peaks a and c are from anatase TiO2, and peaks b, d,
and e are from HAp). It agrees well with the Ti L3,2-edge and Ca L3,2-edge XANES
results, confirming that the prepared sample contains both anatase TiO2 and HAp. Since
the edge jump of the XANES spectrum is proportional to the quantities of the sample, the
compositional fractions of the HAp-TiO2-2 nanocomposites can be obtained by fitting a
linear combination of the spectra of their components to that of the composites. Figure
5.13(II) displays the linear fitting results of the HAp-TiO2-2 nanocomposites. The fitting
curve (red dash-dotted curve) is in good agreement with the experimental data (black
solid curve), illustrating that the weight ratio between anatase TiO2 and HAp is about
1:1.6. This also implies that the nanocomposite is uniform in the area being probedwhich
are essentially at the same retention times as that of the reference sample.
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Figure 5.13. (I) O K-edge XANES spectra of the (b) HAp-TiO2-2 nanocomposites in
comparison with (b) HAp-2, (c) TiO2 nanoparticles calcined at 450 °C, and (d) TiO2
nanoparticles calcined at 750 °C. (II) O K-edge linear fitting of the HAp-TiO2-2
nanocomposites.

5.3.8

TGA of HAp and HAp-TiO2 nanocomposites

The thermal analysis of the HAp-2 powder and HAp-TiO2-2 and HAp-TiO2-h
nanocomposites was performed under flowing air from room temperature to 1200 °C by
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TGA, as illustrated in Figure 5.14. The TGA curve of pure HAp is divided into four
stages based on heating in air, as illustrated in Figure 5.14a. The first stage from room
temperature to 240 °C corresponds to the evaporation of the physically absorbed water of
the product. The second stage is from 240 to 440 °C, which is attributed to the
combustion and carbonization of organic substance such as CTAB and unreacted acetic
acid. The third stage from 440 to 550 °C is caused by the decomposition of residual
organic materials. The forth stage took place between 550-1100 °C with a peak at 800 °C,
which is due to the partial decomposition of HAp to low-temperature phase of tricalcium
phosphate (β-TCP). It has been reported that HAp is likely to decompose at 800-900 °C
in air and 950 °C in vacuum,[46, 47] and the following chemical reaction is proposed:
Ca10(PO4)6(OH)2 = CaO + 3Ca3(PO4)2 + H2O (g)

(1)

For TiO2-HAp nanocomposites, the increase in peak area of the peak at 800 °C as
compared to pure HAp is due to both the partial dissociation of HAp to TCP as well as
the conversion of anatase TiO2 to the rutile phase of TiO2 crystal, as the transformation
from anatase to rutile occurs at temperatures between 400 and 1000 °C.[12] Moreover, it
has been reported that the reaction between HAp and TiO2 is feasible and expected to
happen at the temperature above ~750 °C, and β-TCP and CaTiO3 are formed.[47] The
related chemical reaction is as follows:
Ca10(PO4)6(OH)2 + TiO2 = 3Ca3(PO4)2 + CaTiO3 + H2O (g)

(2)

There is another possibility of formation of TCP through the direct dissociation of HAp,
as it can dissociate to Ca-orthophosphate and TCP by the following reaction:
Ca10(PO4)6(OH)2 = 2Ca3(PO4)2 + Ca4O(PO4)2 + H2O (g)

(3)

And the Ca-orthophosphate formed as a result of reaction (3) subsequently reacts with
TiO2 leading to the formation of TCP and CaTiO3.[47] The suggested reaction could be:
Ca4O(PO4)2 + TiO2 = CaTiO3 + Ca3(PO4)2

(4)

From the above discussion, the weight changes in this region should therefore be
correlated with TiO2 phase transformation and TCP and CaTiO3 formation (Eq. 2, 3, and
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4). Since TCP formation is widely reported in all the HAp-TiO2 compositions at or above
900 °C, it is highly likely that the weight loss must be due to TCP formation by reaction
(Eq. 2), while CaTiO3 formation does not produce recordable weight change. In any case,
the CaTiO3 formation can be described by two possible reactions (Eq. 2, 4). So, it could
be concluded that the presence of the titania modifies the thermal behavior with respect to
the pure HAp.

Figure 5.14. TGA spectrum of (a) HAp-2, (b) HAp-TiO2-2 nanocomposites, and (c)
HAp-TiO2-h nanocomposites.

5.3.9

Mechanical properties of PCL/HAp and PCL/HAp-TiO2
composites

The Young’s modulus and tensile strength of PCL/HAp and PCL/HAp-TiO2 composites
comprising 0-30% (w/w) HAp and HAp-TiO2 synthesized by the combined coprecipitation and sol-gel method and hydrothermal process were investigated. An
exponential increase in the Young’s modulus of PCL/HAp-2 and PCL/HAp-TiO2-2 was
observed with the increase in HAp-2 and HAp-TiO2-2 concentrations, respectively. For
example, the 20% (w/w) HAp-TiO2-2 added composite possesses the highest Young’s
modulus with more than a 4-fold increase from 155.2 MPa for PCL alone to 665.5 MPa.
Therefore, it could be concluded that the growth of titania nanorods followed by HAp
deposition on the surface of the TiO2 nanorods in supercritical CO2 highly influences the
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mechanical properties of reinforced composites. Moreover, the ultimate tensile strength
showed little variation between examined material groups, while a noticeable trend was
observed with respect to loading concentration. It was shown that the tensile strength of
PCL/HAp decreased from 9.3 for unfilled PCL to 6.47 MPa for PCL/HAp with
increasing the amount of filler, HAp-2, to 30%. In other words, the greater HAp-2
content results in an increase in the brittle nature of the composites. On the contrary, an
exponential increase in the tensile strength of PCL/HAp-TiO2 composites to 11.97 and
15.76 MPa for specimens containing 10-20% (w/w) HAp-TiO2 occurred. On the other
hand, compared to PCL/HAp-TiO2-h composite specimen containing 20% (w/w) HApTiO2-h, PCL/HAp-TiO2-2 composite clearly exhibits higher modulus and higher
maximum tensile strength. The strengthening effects observed for PCL/HAp-TiO2-2
composite over the PCL/HAp-TiO2-h composition were concluded to be due to the
morphology, size and, the preferred orientation. The comparison of the mechanical
properties of our resulting nanocomposites to the work of others is complicated by the
different measurement techniques utilized, although compared to cortical and cancellous
bone, the tensile strength of our PCL/HAp-TiO2-2 composites is considered to be
sufficient enough to preserve their structure and mechanical integrity for predictable
times, even under load-bearing conditions.
In addition, flexural modulus and flexural strength values of composites reflect its
resistance to flexural loading which is a combination of tension and compression forces.
Similarly, dramatic reinforcements in the flexural properties (FS and FM) were achieved
for PCL/HAp-TiO2-2 composites, as evident in Table 5.4. PCL/HAp-TiO2-2 composite
formulation containing 20 wt% HAp-TiO2-2 exhibited a roughly 3-fold increase in
flexural modulus and 2-fold increase in flexural strength compared to blank PCL. This
extraordinary mechanical reinforcement provided by PCL/HAp-TiO2-2 composites
exceeded the enhancements observed with PCL/HAp-2 composites, indicating the
importance of mechanical coupling between the TiO2 nanorods and the PCL matrix.
The SEM micrographs of the fracture surfaces of the PCL/HAp-TiO2 nanocomposite
loaded with 20 wt% HAp-TiO2 are shown in Figure 5.15. It can be seen that the
nanocomposite loaded with 20 wt% HAp-TiO2 exhibited a rough surface with partially
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broken or pulled out TiO2 rod like structures on their surface, shown by the arrows in
Figure 5.15b. This nanorod “pull out” effect may significantly increase the work of
fracture due to interfacial friction between the TiO2 nanorods and matrix resulting from
the high surface area of the nanorods and the strong interfacial shear strength between the
TiO2 nanorods and PCL matrix. Moreover, it is clear from Figure 5.15b and d that there
is a strong adhesion between the HAp-TiO2 and PCL matrix, as these partially pulled out
TiO2 nanorods take part in bridging the crack during propagation and bridge the cracks in
the matrix, seen in Figure 5.15c. Conversely, the unfilled PCL matrix displays a very
smooth fracture plane with the cracks propagating without any hindrance (data not shown
here).

Figure 5.15. SEM images of the fracture surfaces of (a) PCL/HAp and (b-d) PCL/HApTiO2 containing 20 wt% HAp and HAp-TiO2, respectively. Short arrows indicate
nanorods pullout and the long arrows indicate crack bridging by the TiO2 nanorods.

Table 5.4. Mechanical Properties of PCL/HAp and PCL/HAp-TiO2 composites.
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PCL:HAp-

PCL: HAp-

Young’s

Tensile

Flexural

Flexural

TiO2- 2

TiO2- h

modulus

strength

modulus

strength

(w/w)

(w/w)

(MPa)

(MPa)

(MPa)

(MPa)

100:0

-

-

155.2 ± 24.5

9.3 ± 2.9

247 ± 28.5

13.2 ± 1.6

90:10

-

-

379.6 ± 16.1

10.9 ± 2.5

551 ± 16.8

16.3 ± 0.3

80:20

-

-

352.8 ± 16.3

7.1 ± 0.9

485.8 ± 23.6

16.6 ± 2.2

70:30

-

-

238.2 ± 11.5

6.47 ± 1.4

425 ± 32.7

11.4 ± 0.6

-

90:10

-

355.2 ± 13.2

11.97 ± 3.6

744.6 ± 25.8

18.23 ± 2.62

-

80:20

-

665.5 ± 24.6

15.76 ± 0.9

716.3 ± 14.6

26.5 ± 0.7

-

70:30

-

467 ± 6

11.51 ± 1.9

512 ± 24.3

17.4 ± 0.9

-

-

100:20

241.8± 25.6

6.24 ± 1.9

423.6 ± 35.4

10.8 ± 1.7

5.4 Conclusions
A novel combined co-precipitation and sol-gel method in the green solvent, supercritical
carbon dioxide (scCO2), was successfully applied to derive an innovative HAp-titania
bioceramic with excellent chemical and structural uniformity. PCL/HAp-TiO2
composites with significantly improved physical and mechanical properties suitable for
tissue engineering was designed as described above. Our results showed that the
morphology of the HAp-TiO2 composites could be tailored by changing the initial
concentration of TIP and the reaction temperature. The formed HAp-TiO2
nanocomposites with a higher surface area and greater thermal stability compared to HAp
nanoparticles are particularly attractive as reinforcing fillers for biodegradable synthetic
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polymers. With a loading of 20% (w/w) TiO2-HAp, the obtained nanocomposites
exhibited a tensile modulus of 665.5 MPa, which is more than a 4-fold increase compared
to blank polymer. The presented work suggests that PCL/HAp-TiO2 nanocomposites may
be synthesized to match the mechanical properties of bone, and thus demonstrates the
potential for their use in orthopedic and dental implant materials.
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Chapter 6
6

Conclusions and Recommendations

6.1 Conclusions
The need for biodegradable polymer composite materials for bone regeneration is
increasing due to the aging of our population as well as the increase of traumatologic
injuries and necrosis-related bone resorption. Therefore, superior synthetic orthopaedic
materials and techniques are required for clinical practice. In orthopaedics, the demand
for synthetic bone cement materials can be fulfilled by using composite structures, as it is
possible to mimic better the structures of living materials, like bone, cartilage or teeth
using these composites. Polymer composites are combinations of two or more
components, usually containing an inorganic phase and a polymer phase that are
essentially insoluble in one another. Polymers have typically lower modulus and
deformation resistance than the inorganic phase, although provide processability to the
system. Thus, attempts are made to adjust the mechanical properties of polymeric
materials to approximate those of bone, using a composite structure.

The mechanical performance of any kind of nanocomposite reflects the interaction
between the various phases. If there is adhesion between the two phases either chemical
or physical, even at low strains, stress transfer can take place across the interface, which
allows the filler to share the stress and provide a reinforcing effect. The successful
reinforcement of poly(propylene fumarate) matrix by nanostructured titania fibers shows
that the incorporation of one-dimensional nanomaterials is a promising technique for
augmenting the mechanical properties of PPF-based bone cements. A novel
functionalizing technique using the ring opening reaction of maleic anhydride was
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applied to PPF in order to establish chemical adhesion between the nanofillers and
organic polymer matrix. The major outcomes from these studies include:
(1) TiO2 nanofibers up to a certain limit of loading exhibit homogenous dispersion in the
functionalized polymeric continuous phase.
(2) Reinforcement using TiO2 nanofibers is a promising technique only when there is a
homogenous distribution of the nanomaterials to provide strong adhesion with the
continuous phase.
(3) The obtained reinforcing effect of the TiO2 nanofibers is attributed mainly to the
strong interfacial chemical adhesion between the TiO2 nanofibers and the functionalized
PPF matrix.
It is very important for an orthopaedic surgeon to be able to easily monitor and evaluate
the healing and loosening processes to differentiate between bone, bone cement, and
osteolysis. Incorporation of TiO2 nanofibers into a cement formulation will not provide
sufficient radiopacity to the PPF matrix at the optimum level of loading, which seems to
be a major limitation for the potential application of the nanocomposites as bone cement
materials. In an attempt to address this limitation, this study demonstrated a novel
pathway to develop an alternative radiopacifier for PPF-based bone cements which also
acts as a reinforcing agent. The modification of the titania nanotubes was performed
through a novel sol-gel reaction in supercritical CO2.
(1) TiO2 nanofibes were successfully modified with radiopaque Sr2+ component using a
sol-gel methodology in supercritical CO2.
(2) This process offers several advantages over conventional sol-gel processes including:
producing well-defined nanostructure, very good dispersion, high conversions, high
surface areas, simple operating procedure, e.g. one-pot synthesis, mild operating
conditions, e.g. 60 °C and 6000 psi, and environmental benignness.
(3) Nanostructured Sr-doped TiO2 material was incorporated into the PPF-based bone
cement formulations as reinforcing fillers presenting a homogeneous dispersion of the
nanomaterials with strong chemical adhesion with the matrix while keeping the
radiopacity of the cement intact.
Blood vessels are an important component of bone formation and maintenance, and the
bone tissue differentiation is related to the local presence of blood vessels. The local
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release of a pro-angiogenic mediator leads to more intensive angiogenesis in the necrotic
defect area, and thus improves osteogenesis and bone regeneration. Therefore, novel
ginsenoside Rg1-releasing PPF microspheres were fabricated using both a conventional
double emulsion and a microfluidic method.
(1) The microfluidic approach produced more uniform sized microspheres (50-65 µm)
compared to the more polydisperse microspheres prepared the W/O/W emulsion method
(2-45 µm).
(2) The monodisperse microspheres produced by the microfluidic method were found to
exhibit a slower release rate and a smaller burst effect than the polydisperse microspheres
formed by the double emulsion method.
(3) The PPF microspheres obtained from the microfluidic approach demonstrated higher
encapsulation efficiencies, which is a very important factor in drug delivery, especially
for valuable and expensive bioactive compounds.
(4) Rg1-induced tube formation is related to the dosage, and tube formation stimulation
activity of ginsenoside Rg1 did not change significantly before and after release from the
PPF microspheres.
(5) Monodisperse microspheres generated by microfluidic devices are believed to
enhance drug release kinetics, reproducibility, and bioavailability. Therefore, the
monodisperse Rg1-loaded PPF microspheres are expected to significantly increase blood
vessel density and vascular perfusion in necrotic defects and increased bone formation.
In addition, immobilization of the biocompatible TiO2 on the surface of the
hydroxyapatite will enhance the mechanical properties of HAp along with enhancing
cellular responses and biocompatibility. A novel combined co-precipitation and sol-gel
methodology using supercritical fluid processing with carbon dioxide (scCO2) was
proposed to improve the mechanical properties of hydroxyapatite with HAp nonoplates
grown from the surface of one-dimensional TiO2 nanorods. Then, a novel
polymer/ceramic composite network of poly(ε-caprolactone) (PCL) and HAp-TiO2 with
improved mechanical properties was developed for bone regeneration and bone tissue
engineering applications. The rationale for the design of the nanocomposite consists of
synthetic polymer, PCL, in combination with nanoscale synthetic HAp-TiO2 was based,
in part, on the natural nanocomposite structure of bone tissue.
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(1) The particle diameter and length, morphology, and BET surface area of the HAp-TiO2
composite materials was tunable by adjusting the metal alkoxide concentration, reaction
temperature, and pressure.
(2) Morphologies of the HAp-TiO2 compound varied from nanoplate-thick sheet type
structure to Nanoplate-Nanorods.
(3) HAp-TiO2 nanocomposites were homogenously mixed within poly(ε-caprolactone)
(PCL) to develop scaffolds with enhanced physical and mechanical properties for bone
regeneration.
(4) The significant increase in the Young’s and flexural modulus observed for PCL/HApTiO2 composite over the PCL/HAp composition were concluded to be due to the
morphology, size and, the preferred orientation. Due to the small diameters and large
aspect ratios of TiO2 nanorods (large surface area), an intimate interface with the polymer
matrix is formed, and the intrinsic properties of the HAp-TiO2 fillers contribute to an
increase in the mechanical strength and stiffness of composites. In addition, there is a
strong adhesion between the HAp-TiO2 and PCL matrix, and partially pulled out TiO2
nanorods will impart the bridging of the crack during propagation and bridge the cracks
in the PCL matrix.

6.2 Recommendations
The intended use of nanocomposite materials described in this thesis will be to provide
temporary mechanical strength and conditions for new bone growth into a skeletal region
deficient in trabecular bone of femoral head as well as tissue engineering which offers a
promising alternative to conventional therapies by potentially enabling the regeneration
of normal native tissues.
The following recommendations will be useful in the future investigations of this study:
i)

N-Vinyl pyrrolidone (NVP) is normally used as a crosslinking reagent in PPFbased formulations, but any unreacted NVP after in situ polymerization is of
concern on account of its toxicity. In addition, even if titania is an established
biocompatible material, nanomaterials are well known to exhibit completely
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different characteristics at their nanodimensions, often being more toxic. This is
attributed to their larger surface area, enhanced chemical reactivity, and easier
penetration into cells. Therefore, the PPF-based polymer networks using NVP as
a crosslinking reagent and reinforced with TiO2 nanofibers needs to be evaluated
in terms of cell adhesion, proliferation, and cytotoxicity in a rat model system. In
addition, the in vitro growth of osteoblast onto the reinforced cement composites
and in vivo biocompatibility should be explored.
ii)

The synthesis part of the composite biomaterials or composite-Rg1 construct
should degrade in a controlled fashion into nontoxic molecules that the body can
metabolize or excrete and then allow the usual process of remodeling to optimize
the mechanical properties of the newly formed bone. It has been reported that the
poly(vinyl pyrrolidone) (PVP) crosslinks in the crosslinked PPF networks might
be non-degradable. Thus, the degradation reaction of the PPF-based polymer
networks and TiO2-PPF-based bone cement composite networks needs to be
studied, and the degradation products should be isolated and characterized by
instrumental analysis (1H and 13C NMR).

iii)

The sol-gel methodology using supercritical fluid processing with carbon dioxide
(scCO2) to modify the titania nanofibers with strontium atom needs to be
optimized in terms of concentration of strontium atom in the nanofibers. In
addition, the effect of synthesis conditions including metal alkoxide
concentration, reaction temperature, and pressure on the morphology,
crystallinity, and chemical and physical state of modified nanofibers need to be
studied by HRTEM, XPS and XRD.

iv)

Functionalization reaction of PPF with maleic anhydride (MA) needs to be
optimized. The extent of functionalization could be adjusted by varying the pH of
the reaction medium.

v)

An injectable, in situ polymerizable, biodegradable poly(propylene fumarate)
(PPF) scaffold with embedded ginsenoside Rg1-delivering PPF microspheres
should be developed for bone regeneration. Then, the performance of the
ginsenoside Rg1-releasing scaffold is evaluated by observing in vitro cell
differentiation of pre-osteoblast and in vivo bone formation in a rat model system
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of irradiated osseous defects compromised in their vasculature as well as the tube
formation of human umbilical vein endothelial cells (HUVEC) to examine the
angiogenesis behavior of the PPF-based Rg1 delivery systems. In addition, the
release profiles in vitro should be measured to monitor how the fabricated
microsphere-containing scaffold could gradually releases agniogenic modulator.
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